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During the bloodstream stage of the Trypanosoma brucei lifecycle, the parasite exists 
in two different states: the proliferative slender form and the non-proliferative, 
transmissible, stumpy form. The transition from the slender to stumpy form is 
stimulated by a density-dependent mechanism and is important in infection 
dynamics, ordered antigenic variation and disease transmissibility. The slender to 
stumpy transition and the contribution of stumpy formation to within-host dynamics 
have been difficult to analyse, however, because cell-type specific markers have been 
restricted to imprecise morphological criteria.  
 
PAD1 is a recently identified stumpy-specific protein which acts as a molecular 
marker for stumpy formation and a functional marker for transmission. Here, the 
control of stumpy-specific gene expression via the 3’UTR has been analysed, 
identifying that there are repressive elements in the 3’UTR preventing inappropriate 
expression during the slender life stage. Further, both pleomorphic and monomorphic 
transgenic reporter cell lines utilising the PAD1 3’UTR have been created that report 
on stumpy formation in vitro and these have been used for the analysis of stumpy-
inducing chemical compounds.  
 
Finally, a sensitive and accurate qRT-PCR assay has been developed and optimised 
that faithfully reports both parasitaemia and stumpy formation throughout host 
infection. Using a chronic infection rodent model, stumpy levels have been 
monitored on the basis of conventional morphological and cell cycle assays, as well 
as by qRT-PCR for PAD1 expression. The results define the temporal order of events 
that result in the generation of stumpy forms early in a parasite infection and 
thereafter describe the dynamics of slender and stumpy forms in chronic infections 
extending over several weeks. This quantitative data has allowed the mathematical 
modelling of transmission competence in trypanosome infections, suggesting 
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Members of the order Kinetoplastida comprise a highly diverged group of eukaryotic 
organisms which are named after their unique mitochondrial DNA which forms a 
structure known as the kinetoplast. These organisms are biologically intriguing due 
to the vast differences in their molecular and cellular biology compared to other 
eukaryotes, this reflecting their evolutionary divergence. However, they have 
received particular attention due to a number of the species within this order causing 
life-threatening and debilitating disease: Trypanosoma brucei, Trypanosoma cruzi 
and Leishmania species (such as L. major, L. infantum and L. braziliensis) are human 
pathogens causing Human African Trypanosomiasis, Chagas disease, and 
leishmaniasis respectively.  
  
Human African Trypanosomiasis (HAT), or sleeping sickness, is caused by the 
protozoan parasite, Trypanosoma brucei subspecies T.b. gambiense and T.b. 
rhodesiense. The parasite is transmitted between mammalian hosts through the tsetse 
fly vector. The ability of trypanosomes to infect both domestic and wild animals 
means that non-human hosts in affected regions can act as a reservoir for the parasite, 
confounding control of the disease. Moreover, vaccination approaches have not been 
considered feasible because these parasites evade mammalian immune responses by 
frequently changing the proteins on their surface in an extreme form of antigenic 
variation. Due to the severity and prevalence of the disease, as well as the lack of 
efficient disease management, African trypanosomiasis remains an important public 
health issue and is considered by the World Health Organisation (WHO) to be a 
neglected tropical disease (http://www.who.int/en).  
 
Trypanosomes differentiate between distinct life stages in order to prepare for, and 
adapt to, the different environments they encounter during their life cycle 
(Vickerman, 1965b; Vickerman, 1985). During the bloodstream stage of the life 
cycle, trypanosomes exist as either proliferative ‘slender forms’ or non-proliferative, 
transmissible, ‘stumpy forms’ (Vickerman, 1965b; Vickerman, 1985), with 




The proportion of these types changes during the course of infection, this apparently 
being governed by the density of parasites in the blood (Vassella et al., 1997). The 
bloodstream trypanosome population is adapted to promote parasite maintenance in 
the mammalian blood and transmission to tsetse flies. Thus, the proliferation of 
slender forms contributes to the establishment of parasite numbers in the blood and, 
through antigen variation, to immune evasion. In contrast, the irreversible division-
arrest of stumpy forms acts to control the expansion of parasite numbers in the 
mammalian bloodstream and so prolongs host survival. This, combined with the 
preferential survival and the adaptations for differentiation of stumpy forms upon 
tsetse uptake, increases the probability of disease transmission (Tyler et al., 2001).  
 
As the dynamic balance between slender and stumpy forms in mammalian hosts 
plays a pivotal role in trypanosome infection and transmission, understanding the 
molecular events implicit in the slender to stumpy form transition and their 
subsequent differentiation to tsetse-midgut forms (procyclic forms) is of interest and 
importance, though poorly understood. The absence of markers distinguishing 
slender from stumpy forms has hindered our understanding of the transmission 
biology of trypanosomes, as has the difficulty in successfully generating stumpy 
forms in culture. Here the analysis of stumpy formation in Trypanosoma brucei is 
revisited with the use of a new molecular marker for the stumpy-life stage, PAD1 
(Dean et al., 2009) which is differentially expressed between slender and stumpy 
forms at both the mRNA and protein level. 
 
1.2 Human African Trypanosomiasis 
Human African Trypanosomiasis is caused by two subspecies of Trypanosoma 
brucei; namely T.b. gambiense and T.b. rhodesiense. T.b. gambiense causes chronic 
disease in west and central Africa (Figure 1.1), with infections lasting years. T.b. 
rhodesiense causes acute infection in east and southern Africa (Figure 1.1), with 
infections lasting from weeks to months. There has been recent concern that the 
regions affected by the two sub-species may be beginning to overlap (Picozzi et al., 




The trypanosome is transmitted between hosts by the tsetse fly from the genus 
Glossina. The distribution of African trypanosomes is restricted to 36 countries in 
sub-Saharan Africa due to the limited distribution of the tsetse vector (Figure 1.1). 
The disease is therefore localised into foci where both people and tsetse exist in the 
same area, which is often in rural populations with limited access to healthcare 
(Fevre et al., 2008). Overall prevalence is low, as transmission through the tsetse fly 
is inefficient, with as few as 0.1% of tsetse harbouring mature parasites ready to 
infect the mammalian bloodstream (Brun et al., 2010). However, in rural foci, the 
local prevalence can be very high, having a large impact on small communities 




Figure 1.1 The distribution of HAT and the tsetse fly vector in Africa. (A) HAT affects 36 
countries in sub-Saharan Africa. T.b. gambiense causes HAT in west and north Africa whereas T.b. 
rhodesiense causes HAT in east and south Africa. (B) Various species of the tsetse fly vector are 
predicted to be distributed throughout sub-Saharan Africa. The distribution of HAT is limited by the 
distribution of the tsetse vector. Figures from (A) (WHO, 2000) and (B) the Environmental Research 
Group Oxford (http://ergodd.zoo.ox.ac.uk/tseweb/index.htm), using satellite imagery.  
 
As well as being a human pathogen, T.b. rhodesiense is a zoonosis, with animals 
acting as an important reservoir for disease (Welburn et al., 2001). The parasite can 




HAT due to their large numbers and close proximity to humans. The cattle form of 
trypanosomiasis is known as nagana, meaning ‘depressed’ in Zulu: It causes 
weakness, thinning and discharge from the eyes and the animal will die. Although 
T.b. gambiense has been identified in animals, such as domestic pigs (Simo et al., 
2006), they are not thought to play as important a role in transmission as for T.b. 
rhodesiense.  
 
Due to the distribution of the disease, it is difficult to estimate the number of cases of 
HAT per year (Fevre et al., 2008). WHO currently estimates that there are 
approximately 50,000-70,000 current cases of HAT (WHO, 2006). As well as 
causing mortality, HAT causes morbidity and the estimated disability-adjusted life 
years (DALYs) lost through HAT in 2000 were 1,534,845 (WHO, 2003). Along with 
the effect on human health, the inability to farm cattle in tsetse dense locations and 
the death of cattle due to nagana means that African trypanosomes have a huge 
economic effect in affected regions. It is difficult to assess the burden of the disease, 
which in turn makes it difficult to assess the value of different intervention strategies 
such as population screening, vector control and treatment of the animal reservoir 
(Allsopp, 2001; Fevre et al., 2008). 
 
Over recent history, the number of cases of HAT has fluctuated according to the 
levels of population screening for the disease. As T.b. gambiense infection is often 
undiagnosed, active screening for, and treatment of, otherwise undiagnosed cases can 
reduce the prevalence of HAT within an area. This is turn reduces the risk of 
transmission. Indeed, in the early 20
th
 century disease levels were reduced through 
population screening programmes (Figure 1.2). However, from the 1970s-1990s civil 
unrest caused surveillance programmes to stop and the displacement of populations 
infected with the disease, causing the number of HAT cases to rise once again 
(Barrett, 1999; Brun et al., 2010). Re-introduction of population screening has started 
to reduce HAT cases once more, demonstrating the value of these programmes 
(Barrett, 2006; Brun et al., 2010). However, as the disease is that of rural 
populations, it can often be difficult to access the affected areas and provide the 






Figure 1.2 The number of cases new cases of T.b. gambiense compared to the population actively 
screened from 1939-2006.  The number of cases reporter (bars) decreased throughout the 1940-50’s 
due to increased active screening (circles). After active screening stopped in the 1970s-1990s the 
number of new cases rose once again. An increase in population screening since 1997 has seen the 
number of new cases begin to fall again. Figure from (Brun et al., 2010) 
 
1.2.1 Symptoms 
Trypanosomes are extracellular parasites, which exist in the blood and lymph of the 
mammalian host, before crossing the blood-brain barrier into the CSF later in 
infection. The disease can be divided into two clinical stages correlating with the 
location of the parasite and the associated symptoms: the early haemolymphatic stage 
and the later neurological stage. In the early stage of the disease, symptoms include 
intermittent fever, headache and joint pain. At this stage many cases are undiagnosed 
due to the lack of specific symptoms, despite availability of effective treatment for 
this stage of the disease (see section 1.2.2). The later stage of the disease occurs 
when the trypanosomes move into the CNS.  
 
The blood-brain barrier separates the brain parenchyma from the circulating blood 
and is formed from the tightly bound epithelial cells that line the cerebral capillaries 
and selectively prevents the passage of molecules from the bloodstream into the 
brain. It is thought that the parasites move into the brain through an active process 
that causes damage to the blood-brain barrier over time and appears to be linked to 




the parasites cross the blood-brain barrier and enter the CNS the neurological 
symptoms occur. These symptoms include, but are not limited to, the disruption of 
circadian rhythm, after which the disease is named sleeping sickness, as well as 
sensory impairment, confusion, motor defects such as slurred speech and lack of 
coordination as well as psychiatric effects such as aggressive behaviour and 
irritability as reviewed in (Brun et al., 2010; Kennedy, 2006). For T.b. gambiense the 
infection lasts, on average, 3 years with approximately equal time in the early and 
late stage of disease (Checchi et al., 2008) whereas T.b. rhodesiense infection lasts 
only weeks or months and so progression to the late stage occurs much faster. 
Although the disease progresses at different rate, infection with either T.b. gambiense 
or T.b. rhodesiense always causes coma and death if untreated. 
 
1.2.2 Current drug treatments for HAT 
For the treatment of HAT there are only currently four compounds licensed and used 
on their own, Pentamidine, Suramin, Eflornithine and Melarsoprol, although a fifth, 
Nifurtimox, is increasingly used in combination with Eflornithine. All these drugs 
have associated toxicity and all require hospitalisation for a complex intramuscular 
or intravenous administration regime. The drug of choice depends on the infecting 
species and the stage of disease (Figure 1.3). Early stage HAT can be treated 
effectively with Pentamidine for T.b. gambiense and Suramin for T.b. rhodesiense 
with limited side effects (Figure 1.3). However, many cases are undiagnosed at this 
early stage (see section 1.2) and as such many of the cases presented are in the 
neurological stage of the disease. For the second stage of T.b. gambiense infection, 
Eflornithine is effective, but is expensive and requires a rigorous administration 
programme (Figure 1.3). For the second stage of T.b. rhodesiense infection, and 
often in cases where Eflornithine is not available for T.b. gambiense infections, the 
arsenic-based drug, Melarsoprol is used (Figure 1.3). Melarsoprol has severe side 
effects, including post-treatment reactive encephalopathy (PTRE), which causes 
coma and death in 5-10% of patients. Despite the risk associated with this drug, HAT 





Figure 1.3 Drugs currently licensed for use against HAT. Figure from data gathered in (Barrett et 
al., 2007; Brun et al., 2010) 
 
1.2.3 New developments in the treatment of HAT 
HAT is a disease afflicting a limited number of very poor populations and as such it 
is not a financially attractive target for pharmaceutical companies (Barrett et al., 
2007; Trouiller et al., 2002). Fortunately, WHO currently receive the licensed drugs 
free of charge from the pharmaceutical companies Bayer and Sanofi-Aventis. WHO 
then distribute the drugs through Médecins Sans Frontières. However, all current 
drug treatments have associated toxicity and require hospitalisation for complex 
treatment regimes, hence, there is a requirement for the production of new, safe, and 
easy to administer, compounds for the treatment of HAT. It is not thought possible to 





Encouragingly, various initiatives to drive the development of new drugs against 
HAT, and other neglected disease, have been established in recent years. These 
include, but are not limited to: the foundation of the Drugs for Neglected Diseases 
initiative (DNDi), which is a non-profit collaborative project for the research and 
development of new treatments for HAT, among neglected other disease; the 
Wellcome Trust has established the Drug Discovery Unit at the University of 
Dundee for the translation of academic research into drugs for clinical trial for 
neglected disease; The Bill and Melinda Gates Foundation have committed large 
sums of money to the funding of the improvement of diagnostics and drug treatments 
for a variety of diseases including HAT; finally, the Foundation for Innovative New 
Diagnostics (FIND) are improving existing diagnostic methods, and developing new 
ones, which, in combination with active screening programmes, should help to 
decrease HAT prevalence.  
 
New potential drugs and drug targets are beginning to emerge. A pro-drug which 
could be administered orally, pafuamidine maleate (also known as DB289), has 
undergone clinical trials for use against early-stage HAT (Ansede et al., 2004). 
Unfortunately, the drug was shown to cause renal disease in a number of healthy 
volunteers and at least two HAT patients, causing the clinical trial for this drug to be 
discontinued (Pholig, 2008), although related drugs are now being studied (Wenzler 
et al., 2009). The NMT (myristoyl-CoA-protein N-myristoyltransferase) gene has 
been identified as a potential drug target (Price et al., 2003) and inhibitors have been 
shown to cure trypanosomiasis in mice by acting directly on the protein (Frearson et 
al., 2010) providing a validated drug target for HAT. Hopefully, in the future, new 
drugs which can be delivered orally with limited toxicity will be available for the 
treatment of both early and late-stage HAT. 
 
1.2.4 Vector control 
As well as treatment of those affected with HAT, efforts are being made to prevent 
the transmission of the disease in the first place via vector control (Allsopp, 2001). 




this method is environmentally undesirable. Fly traps infused with odours that attract 
the tsetse can reduce the density of tsetse around communities or farms. However, 
these methods require sustained commitment to the clearing of tsetse from an area, 
otherwise the tsetse re-populate the cleared area. Historically, sustained commitment 
has not been observed, largely due to political unrest and financial instability 
(Allsopp, 2001). Finally, sterile males can be introduced into the environment, but 
this is unlikely to cause eradication of the tsetse in the large expanse of mainland 
Africa (Brun et al., 2010). Due to the key role played by tsetse in HAT, vector 
control should play a key role in disease management given adequate commitment.  
 
1.3 Antigenic Variation  
The trypanosome is an extracellular parasite, which, during the bloodstream stage of 
the lifecycle (see section 1.6.1), exists in the blood and tissue fluids of the host. As 
such, the parasite is fully exposed to the host immune system. To evade clearance by 
the host, trypanosomes undergo antigenic variation: at any one time the parasite 
surface is composed of only one type of surface antigen, the variant surface 
glycoprotein (VSG) coat. The parasite periodically switches the VSG such that those 
cells expressing the current antigen will be recognised and cleared by the immune 
system whereas those parasites expressing a new VSG will avoid antibody clearance 
and populate the next wave of parasitaemia (see section 1.7, Figure 1.8).  
 
At some of the telomeres of the mega-base chromosomes, there are bloodstream-
expression sites (BES) which are polycistronic units containing one VSG gene 
flanked upstream by 70bp repeats and numerous expression-site associated genes 
(ESAGs), reviewed in (Rudenko, 2000). Only one BES is expressed at any one time, 
so that only one VSG is present on the surface at any one time. There are two classes 
of VSG gene: intact genes and pseudogenes, of which there are approximately 200 
and 1000 respectively (Barry et al., 2005; Berriman et al., 2005) located at the end of 
telomeres on minichromosomes or in subtelomeric regions. Intact genes are activated 
either by being relocated into the active BES by homologous recombination, using 




activation of the BES in which that gene is present. The pseudogenes are able to 
form mosaic genes by gene conversion (Barry et al., 2005; Berriman et al., 2005). 
The differential activation rates within and between these two groups of VGS genes, 
along with the contribution of the slender to stumpy transition, gives rise to ordered 
antigenic variation which ensures the parasite does not exhaust the VSG repertoire 
(Lythgoe et al., 2007). Additionally, the capacity to form mosaic genes provides the 
parasite with a large repertoire of VSG genes that allows survival in the host for 
many years and makes the possibility of the production of vaccines unlikely.   
 
1.4 The trypanosome cell 
Trypanosomes are single cell diploid organisms with many of the organelles existing 
in just a single copy (Matthews, 2005) (Figure 1.4). The positions of the organelles 
within the cell are consistent and are shown in Figure 1.4. The shape of the 
trypanosome cell is defined by the microtubule cytoskeleton (Sherwin and Gull, 
1989), of which, all the sub-pellicular microtubules lie in the same orientation with 
the positive ends at the posterior end of the cell (Robinson et al., 1995), with the 
exception of a specialist subset of four that form part of the flagellar attachment zone 




Figure 1.4 Trypanosome cell architecture. The location of the major structural features of the 




1.4.1 The flagellum 
Trypanosomes have a single flagellum which is required for cell motility (Bastin et 
al., 1998) and plays a role in the cell cycle and morphogenesis (Kohl et al., 2003; 
Moreira-Leite et al., 2001; Robinson et al., 1995). The flagellum is composed of both 
the 9+2 axoneme and the paraflagellar rod (PFR) which is required for motility 
(Bastin et al., 1998; Sherwin and Gull, 1989). The flagellum is attached to the cell 
body along its length at the flagellum attachment zone (FAZ), following a left-
handed helix (Kohl et al., 1999; Sherwin and Gull, 1989). The FAZ is a cytoskeletal 
structure which lies under the plasma membrane from the basal body to the anterior 
of the cell and which plays a role in cytokinesis (Kohl et al., 2003) (see section 
1.5.1). At the base of the flagellum is the basal body which is connected to the 
kinetoplast by a filament structure called the tripartite attachment complex (TAC) 
which allows for segregation of the daughter kinetoplasts by the basal bodies during 
the cell cycle (see section 1.5.1) (Ogbadoyi et al., 2003; Robinson and Gull, 1991).  
 
1.4.2 The flagellar pocket 
The flagellum exits the cell body at the flagellar pocket, which is an invagination of 
the plasma membrane located at the posterior of the cell (Figure 1.4). In 
trypanosomes the flagellar pocket is the only site of endocytosis and exocytosis for 
the cell (Field and Carrington, 2009). Due to this, the flagellar pocket is in close 
vicinity to the single Golgi and to the endoplasmic reticulum. Endocytosis plays an 
important role in protecting the trypanosome in the mammalian blood as they 
undergo antibody clearance by endocytosis of VSG-bound antibodies. These bound 
antibodies move to the flagellar pocket at the posterior of the cell, by hydrodynamic 
forces as the trypanosome swims forward (Engstler et al., 2007). This helps to 
protect the cells against complement-lysis. Indeed, in stumpy forms, where the rate 
of endocytosis is greater, antibodies are cleared faster than in slender forms, allowing 
stumpy forms to persist for longer in the host which may be important for 





1.4.3 The mitochondrion and kinetoplast 
Trypanosomes have a single mitochondrion whose activity is considerably different 
between life stages. In slender bloodstream forms it is relatively repressed, with no 
cristae present. The cells obtain their energy entirely from glycolysis using glucose 
as the main energy source since it is abundant in the mammalian bloodstream (Priest 
and Hajduk, 1994). Unusually, glycolysis occurs in an organelle called the 
glycosome and not in the cytosol. Stumpy form trypanosomes also obtain their 
energy from glucose, but the mitochondrion is elaborated in preparation for the 
differentiation to the procyclic life stage (see section 1.6). Procyclic forms have a 
fully developed mitochondrion as they produce ATP via oxidative phosphorylation 
using the amino acid proline as the main energy source in the tsetse midgut (Priest 
and Hajduk, 1994).  
 
The mitochondrial genome in trypanosomes is called the kinetoplast. The kinetoplast 
is a network of DNA with interlocked maxi and mini circles. The maxi circles 
express mitochondrial genes, with many of these genes requiring RNA editing to 
form mature mRNAs (Benne, 1994; Benne et al., 1986): the mini circles encode 
guide RNAs for such editing (Sturm and Simpson, 1990). Dyskinetoplasty, i.e. loss 
of the kinetoplast, can arise in bloodstream forms, both naturally (i.e. T.evansi and 
T.equiperdum) and by chemical mutagenesis (Schnaufer et al., 2002). These cells are 
unable to survive as the procyclic life stage due to the requirement for mitochondrial 
function at this stage. 
 
1.5 The trypanosome cell cycle  
The trypanosome cell cycle requires the replication and segregation of both the 
nuclear and mitochondrial DNA. Additionally, many of the organelles exist in single 
copy and therefore these also need to be duplicated and segregated equally to create 
two viable daughter cells (Sherwin and Gull, 1989). As such the cell cycle is tightly 
controlled (Robinson et al., 1995; Woodward and Gull, 1990) (Figure 1.5). The cell 
cycle in trypanosomes in closely linked with differentiation between life stages 




1.5.1 Events during the trypanosome cell cycle 
During the trypanosome cell cycle, both the nuclear DNA and the kinetoplast must 
be replicated and segregated although these events are not synchronised between the 
two (Figure 1.5A). The first step of the cell cycle is the kinetoplast entering S phase 
(Woodward and Gull, 1990). There is elongation and maturation of the pro-basal 
body into a new mature basal body, posterior to the original basal body, out of which 
the new flagellum forms (Sherwin and Gull, 1989; Woodward and Gull, 1990). In 
procyclic forms the new flagellum tracks along the side of the old flagellum and 
remains physically associated with the old flagellum at the distal tip of the new 
flagellum by the flagella connector (FC) (Moreira-Leite et al., 2001) which is 
produced either before or concurrently with the formation of the new flagellum 
(Briggs et al., 2004). This structure dictates the location of the new flagellum and the 
associated cytoskeletal structures such as the FAZ. Thus, the FC provides a method 
of cytotaxis for cell morphology during the trypanosome cell cycle (Moreira-Leite et 
al., 2001). Despite the important role played by this structure in procyclic forms, a 
flagellar connector is not present in bloodstream forms and the new flagellum does 
not follow the path of the old flagellum as closely (Briggs et al., 2004).  
 
While the flagellum continues to elongate, the nuclear DNA enters S phase 
(Woodward and Gull, 1990), then the basal bodies begin to separate. As the basal 
bodies are attached to the kinetoplast, via the tripartite attachment complex 
(Ogbadoyi et al., 2003; Robinson and Gull, 1991), the movement of the basal bodies 
causes segregation of the two kinetoplasts (Ogbadoyi et al., 2003; Robinson and 
Gull, 1991). This also results in the production of a second flagellar pocket (Moreira-
Leite et al., 2001). Kinetoplast segregation can occur before the end of nuclear S-
phase or during G2 (Siegel et al., 2008). As kinetoplast segregation occurs prior to 
mitosis, the cells are intermittently 2K1N (2 kinetoplasts, 1 nucleus).  
 
The nucleus then undergoes mitosis, without the breakdown of the nuclear envelope. 
There is a mitotic-entry checkpoint where the nuclear DNA must have successfully 
undergone S phase before mitosis can begin (Ploubidou et al., 1999). There does not, 




with cytokinesis progressing even if mitosis fails (Ploubidou et al., 1999; Robinson 
et al., 1995). Rather it appears that correct kinetoplast segregation is the required 
cell-cycle checkpoint for entry into cytokinesis (Ploubidou et al., 1999). A cleavage 
burrow forms from the anterior end of the cell, at the end of the FAZ (Kohl et al., 
2003; Robinson et al., 1995), and moves towards the posterior end between the two 
flagella which separates all the duplicated organelles into the two daughter cells 
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Figure 1.5 The order of events during the T.brucei cell cycle. (A) A summary of the order of key 
events during the cell cycle. (SN, nuclear S phase; M, mitosis; C, cytokinesis; SK, kinetoplast S phase; 
D, kinetoplast division; A, kinetoplast segregation). (B) The cell cycle in (i-iv) procyclic forms and (v-
viii) bloodstream forms. The segregation of the kinetoplast is more limited in bloodstream forms than 
procyclic forms (compare iii with vii). In procyclic forms the duplicated nucleus and kinetoplast form 
a KNKN configuration as in (iv) where as in bloodstream forms they form a KKNN configuration as 




Although the cell cycle has been characterised in great detail, most of the analysis 
has been carried on procyclic forms. There are, however, differences in the cell cycle 
at different life-stages. In bloodstream forms, as previously mentioned, there is no 
FC, and the daughter kinetoplasts and nuclei are in a KKNN arrangement rather than 
a KNKN arrangement as seen in procyclic forms (Briggs et al., 2004) (Figure 1.5). It 
may be that in the procyclic forms the FC is required due to the large migration 
required between segregated daughter basal bodies and kinetoplasts, whereas it is not 
required in the bloodstream form where there is much less segregation between the 
kinetoplasts (Briggs et al., 2004). Alternatively, it may be that the bloodstream forms 
use some other similar structure in place of the FC (Briggs et al., 2004). 
 
The cell cycle is intimately linked with differentiation in trypanosomes (Matthews 
and Gull, 1994a; Matthews and Gull, 1994b). At six points throughout the life cycle 
the parasite must differentiate between cell cycle arrested and proliferative forms or 
vice versa (see section 1.6). Additionally, asymmetric cell division facilitates the 
changes in cell morphology in at least one of these differentiations (section 1.6.2) 
(Sharma et al., 2008; Van Den Abbeele et al., 1999). 
 
1.6 The trypanosome life cycle 
Trypanosomes encounter many different environments throughout their life cycle: 
they pass from the blood of the mammalian host to the midgut of the tsetse vector in 
a tsetse bloodmeal, they then migrate from the midgut to the salivary glands before 
entering a new mammalian host. The trypanosome must differentiate between 
different life stages, pre-adapted or adapted for survival and function in each 
environment (Vickerman, 1965b; Vickerman, 1985). During differentiation the 
parasite undergoes various morphological changes: there are changes in the size and 
shape of the parasite; changes in the relative positions of the kinetoplast and the 
nucleus; the length and positioning of the flagellum (Vickerman, 1965b; Vickerman, 
1985), (Figure 1.6). There are also major changes in gene expression, energy 
metabolism and cell cycle status, with many of the life-stages being cell cycle 





Figure 1.6 Schematic diagram of the life cycle of Trypanosoma brucei. The developmental cycle of 
the trypanosome in the mammalian host and tsetse vector is depicted showing changes in the 
morphology, VSG expression, proliferation, location, and the mitochondrion. Division occurs in 
forms labelled with *.  (Figure from Vickerman, 1985.) 
 
1.6.1 The bloodstream stages 
During the bloodstream stage of the life cycle, trypanosomes exist as either slender 
forms or stumpy forms (Vickerman, 1965b; Vickerman, 1985), with transitional 




slender forms are proliferative and ensure maintenance of parasitaemia within the 
host. In order to evade the host immune system, the slender forms undergo antigenic 
variation (see section 1.3). In the glucose-rich mammalian bloodstream, slender 
forms obtain their energy by glycolysis. Therefore, in this stage, the mitochondrion is 
relatively repressed (Vickerman, 1965b). At high parasitaemia, a proportion of the 
slender forms differentiate to the non-proliferative stumpy forms. Although 
previously subject to some controversy (Bass and Wang, 1991), the stumpy forms 
are the transmissible form, pre-adapted to life in the tsetse vector (Dean et al., 2009). 
Differentiation of the slender to stumpy forms shall be discussed in section 1.7. As 
the stumpy forms are pre-adapted to life in the tsetse vector, elaboration of the 
mitochondrion is observed, in preparation for the change in energy metabolism in the 
new environment (Priest and Hajduk, 1994; Vickerman, 1965b). These events occur 
in natural pleomorphic trypanosomes. In the laboratory however, monomorphic cells 
which are unable to undergo stumpy formation have been created due to serial 
passage. Monomorphic cells are a useful tool in the laboratory: they are easier to 
culture than pleomorphic cells, they have a reduced rate of antigen switching, 
allowing antigenic variation to be studied in close detail, and they can be induced to 
differentiate to the procyclic life stage in vitro allowing the molecular events in the 
bloodstream to procyclic differentiation to be studied in the laboratory.  
 
1.6.2 The tsetse stages 
When trypanosomes are taken into the tsetse midgut they differentiate into procyclic 
forms. The differentiation from bloodstream to procyclic forms is well characterised 
and will be discussed in section 1.8. The procyclic forms move from the 
endoperitrophic space through the peritrophic membrane and into the ectoperitrophic 
space. The procyclic form uses proline as the main source of energy and as such, 
there is elaboration of the mitochondria (Priest and Hajduk, 1994).  
 
The ectoperitrophic space becomes dense with parasites and they migrate to the 
proventriculus and as they do, differentiate to the proventricular mesocyclic form. 




the epimastigote form via an asymmetric cell division (Sharma et al., 2008; Van Den 
Abbeele et al., 1999), which creates a short epimastigote and another long daughter 
cell which is thought to die. The epimastigote form moves to the salivary glands and 
attaches to the epithelial cells via the flagellum.  
 
Epimastigotes differentiate to proliferative premetacyclics and then to attached, cell-
cycle arrested, metacyclics which express the VSG coat. The nascent metacyclic 
become detached to form free mature metacyclics ready for injection into a new 
mammalian host. It is while in the salivary glands that the trypanosome undergoes 
meiosis (Bingle et al., 2001), but this stage of the life-cycle is not yet well 
characterised. 
 
Figure 1.7 Internal organs of a tsetse fly. Proliferative procyclic forms enter the midgut before 
migrating to the proventriculus where they differentiate to epimastigotes. They then migrate from the 
proventriculus to the salivary glands where they differentiate to the metacyclic form. Figure from 
(Sharma et al., 2009). 
 
1.7 The slender to stumpy transition  
The slender to stumpy transition plays an important role in trypanosome infection 
dynamics: it is involved in prolonged host survival, ordered antigenic variation (see 
section 1.3) and transmission to the tsetse vector (see section 1.7.1).  
 
During the course of a trypanosome infection, the parasitaemia fluctuates due to two 
factors: antigenic variation (section 1.3) and the slender to stumpy transition (Figure 
1.8) (Tyler et al., 2001). As the immune system recognises and clears all parasites 




which have switched to a new antigen type will then proliferate to form the next 
wave of parasitaemia.  
 
 
Figure 1.8 The slender to stumpy transition plays a key role in infection dynamics.  Slender 
forms proliferate in the bloodstream causing parasitaemia to rise. As the density of the parasites 
increase a proportion of slender cells differentiate into the non-proliferative stumpy forms. The 
stumpy forms are the transmissible form, able to establish a tsetse midgut infection if taken up in a 
blood-meal. The slender to stumpy transition and antigenic switching both contribute to a fall in 
parasitaemia. The parasitaemia then rises again as slender cells, expressing a new antigen variant, 
proliferate. The pattern then continues throughout the infection. By preventing the uncontrolled 
growth of the slender forms the parasitaemia does not rise to lethal levels in the host, thus prolonging 
host survival. Figure from (Matthews et al., 2004). 
 
However, oscillations in parasitaemia can occur independently of the host immune 
system due to stumpy formation (Tyler et al., 2001). As the parasitaemia in the blood 
increases, a proportion of slender cells differentiate to stumpy forms in a density 
dependent manner (see section 1.7.3). As the stumpy forms are cell cycle arrested, 
the parasitaemia peaks and then falls as these non-proliferative stumpy cells die out. 
The combination of antigenic variation and stumpy formation prevents the 
parasitaemia from rising uncontrollably and therefore prolongs host survival. Indeed, 




stumpy formation, the parasitaemia rises uncontrollably and is lethal to the host 
(Tyler et al., 2001). 
 
1.7.1 The role of stumpy formation in transmission competence 
Stumpy cells persist longer than slender cells in the face of the developing immune 
response in the mammalian bloodstream (Balber, 1972; McLintock et al., 1993). This 
is probably not caused by antigenic variation: being irreversibly arrested in the 
bloodstream stumpy forms are unlikely to be able to undergo the DNA 
recombination events important for antigen switching. Rather, they withstand 
antibody clearance more effectively than slender cells because they preferentially 
clear bound antibody by hydrodynamic flow, whereby parasite-bound 
immunoglobulin is swept backward by the swimming action of the trypanosome in 
the blood and is then internalised and degraded (Engstler et al., 2007). This may 
ensure that there are stumpy forms present throughout the infection to ensure 
transmissibility, given that tsetse bites can be a rare event with seasonal influences 
(Baylis, 1997).  
 
T.b.gambiense infections last, on average, 3 years (Checchi et al., 2008), hence, each 
infected individual acts as a reservoir for the disease for a substantial length of time. 
For T.b.rhodesiense, which kills humans much faster, cattle and other animals can 
harbour infection, providing a disease reservoir (see section 1.2). Due to the 
fluctuations in parasitaemia and in the proportions of poorly transmissible slender 
forms and transmissible stumpy forms it may be that there are fluctuations in 
transmission capacity. Given that tsetse bites are rare, and show seasonality (Baylis, 
1997), any variations in transmission capacity could potentially play an important 
role in progression of the disease in endemic areas. A recent analysis of the 
relationship between parasite morphology and tsetse infectivity did not reveal a 
correlation between stumpy forms and infectivity (Janelle et al., 2009), however, this 
may reflect the requirement of only one parasite for tsetse infectivity (Maudlin and 
Welburn, 1989). Indeed, in cattle there are periods during chronic infection, where 




den Bossche et al., 2005). This, combined with the likelihood of co-infection with 
different trypanosome strains during the course of a chronic infection (Balmer and 
Caccone, 2008), generates the potential for complex infection dynamics with 
important possible implications for disease spread. Further data on the dynamics of 
proportions of slender and stumpy parasites relative to the total parasitaemia over a 
chronic infection would help to better understand the role of this transition in 
transmission and may allow the consequences of potential therapeutic strategies to be 
predicted (see section 1.12).  
 
1.7.2 The temporal order of events 
Differentiation between life cycle stages and the progression of the cell cycle are 
intimately linked in trypanosomes (Matthews and Gull, 1994b; Szoor et al., 2006). 
Slender forms are proliferative, yet stumpy forms are arrested in G0/G1. The slender 
to stumpy transition, therefore, requires exit from the cell cycle as well as a series of 
morphological changes and stumpy-specific gene expression including the changes 
necessary for mitochondrial elaboration. Both experimental and mathematical studies 
have been carried out in an attempt to elucidate the temporal order of events during 
this transition.  From both forms of analysis it appears that the commitment of a 
slender cell to differentiate to a stumpy form precedes at least one final cell division, 
if not more, which in turn precedes morphological change (Matthews and Gull, 
1994a; Savill and Seed, 2004; Tyler et al., 1997). These analyses have been hindered 
by the lack of molecular markers for the stumpy life stage (see section 1.9).  
 
1.7.3 Stumpy induction factor 
The slender to stumpy transition can occur independently of the host (Seed and 
Sechelski, 1988; Vassella et al., 1997) and correlates with increased cell density 
(Hesse et al., 1995; Reuner et al., 1997; Seed and Black, 1997; Vassella et al., 1997), 
with parasite-parasite signalling operating through a form of quorum sensing. This is 
proposed to occur through the production by slender forms of a signal, termed 
Stumpy Induction Factor (SIF), which accumulates and stimulates stumpy formation 




molecular mechanisms of its reception are currently unknown. However, SIF is 
known to be able to pass through a filter with a 500Da cut-off and so is proposed to 
be a small metabolite or pheromone-like molecule. It is also known to be stable at 
37C for at least 27 days and able to resist degradation by heating at 90C for 15 
minutes (Vassella et al., 1997).  
 
It was thought that the SIF signal was transmitted via the cAMP pathway, although 
the cAMP signalling pathway in trypanosomes is poorly understood (see Box 1). It 
was demonstrated that cAMP levels varied throughout the bloodstream stage of the 
lifecycle, with cAMP levels, per cell, increasing with parasitaemia during rat 
infections with pleomorphic cell lines (Mancini and Patton, 1981). The cAMP levels 
then fell as the population differentiated into the stumpy forms. In the second peak of 
parasitaemia, the cAMP levels again began to rise as the slender forms proliferated, 
suggesting that cAMP level was somehow related to morphological change.  A 
monomorphic cell line, by contrast with the pleomorphic cells, maintained a low 
level of cAMP throughout the infection, regardless of cell density, supporting this 
hypothesis. 
   
When it was recognised that stumpy formation was induced by the parasite-derived 
SIF, it was shown that cell permeable cAMP, as well as the phosphodiesterase 
inhibitor, etazolate, could mimic the action of SIF in a pleomorphic cell line 
(Vassella et al., 1997). This provided further support for the theory that cAMP is 
involved in the transmission of the SIF signal. Indeed, later, it was also shown that 
cell permeable cAMP was able to induce stumpy or ‘stumpy-like’ formation in a 
monomorphic cell line (Breidbach et al., 2002), suggesting that monomorphs are able 
to differentiate to stumpy forms, but are unable to perceive SIF, and that the addition 







However, this hypothesis was thrown into doubt when more recent evidence 
demonstrated that the hydrolysis products of the readily hydrolysable analog of 
cAMP, 8-pCPT-2’-O-Me-cAMP, have anti-proliferative effects and can also induce 
stumpy-formation, but with greater potency that cAMP (Laxman et al., 2006). 
Indeed, hydrolysis resistant cell permeable cAMP did not cause stumpy formation 
(Laxman et al., 2006), arguing against a conventional cAMP signalling pathway in 
stumpy induction (Laxman and Beavo, 2007; Laxman et al., 2006). Moreover, RNAi 
knockdown of the T.brucei PDEB family causes an increase in cAMP without 
causing stumpy formation (Oberholzer et al., 2007). Additionally, it was 
demonstrated that etazolate is a poor inhibitor of T.brucei PDEs and therefore the 
Box 1: cAMP signalling in trypanosomes 
 
In the classical mechanisms of cAMP signalling in eukaryotes, cAMP is 
synthesised by adenylyl cyclases (ACs) from ATP and degraded into AMP by 
phosphodiesterases (PDEs). cAMP acts mainly via the effector protein, protein 
kinase A, which in turn phosphorylates transcription factors and therefore results 
in changes in gene expression. Clearly, given the lack of transcriptional control in 
trypanosomes (see section 1.10), this is highly unlikely to be the mechanism by 
which cAMP acts in trypanosomes (Seebeck et al., 2001). 
 
Numerous ACs have been identified in trypanosomes but the ligands of these are 
yet to be described (Alexandre et al., 1996). Five genes encoding four families of 
PDE (A-D) have also been identified (Kunz et al., 2006). RNAi against the both of 
the two PDEB genes causes cell death in bloodstream forms but not in procyclic 
forms correlating with a reduced increase in intracellular cAMP in procyclic forms 
compared to bloodstream forms upon RNAi induction (Oberholzer et al., 2007).  
 
Although these components of the classical cAMP signalling pathway have been 
identified, it is not clear how cAMP signalling occurs in trypanosomes due to the 
lack of identification of effector molecules (Laxman and Beavo, 2007; Seebeck et 
al., 2001). Potential cAMP binding proteins have been identified by bioinformatic 




anti-proliferative effect is not likely caused by an increase in intracellular cAMP 
(Laxman and Beavo, 2007). Interestingly, etazolate is an adenine/adenosine analog 
and it is the hydrolysis product, 8-pCPT-2’-O-Me adenosine (also an adenosine 
analog) that is suggested to be causing the anti-proliferative and stumpy-inducing 
effects of the hydrolysis products of cAMP (Laxman et al., 2006). The authors 
propose that the adenosine analogs could be targeting either cyclin-dependent 
kinases, which play a role in the cell cycle (Hammarton, 2007) or mitogen-activated 
protein kinases, which have been implicated in stumpy formation (Domenicali Pfister 
et al., 2006) and will be discussed below. Overall, it is not yet clear what role cAMP 
or its hydrolysis products plays in stumpy formation, but it is unlikely to be due to a 
classic cAMP signalling mechanism given the current data.  
 
The trypanocidal drug, eflornithine (or DFMO) has been reported to cause stumpy 
formation (de Gee et al., 1984) and additional compounds such as troglitazone 
(Denninger et al., 2007), and Z-Phe-Ala-CHN2 (Scory et al., 2007) have also been 
proposed to mimic SIF activity in vitro, inhibiting cell growth and generating 
morphologically “stumpy-like” forms. The biological significance of these different 
treatments, however, has been difficult to assess in the absence of a functional 
molecular marker for stumpy forms. With DFMO treatment, although cells appear 
morphologically stumpy and have increased mitochondrial activity, there is also an 
increase in the number of multinucleated cells (de Gee et al., 1984) implying an 
unphysiological transformation. Indeed, in the case of troglitazone, the “stumpy” 
cells were not, unlike naturally occurring stumpy forms, arrested in G0/G1 
(Denninger et al., 2007).  
 
It has been shown that kinases are likely to play a role, downstream of SIF, in the 
stumpy induction pathway. Firstly, knock-out of the protein kinase, ZFK (Zinc 
Finger Kinase) in pleomorphic bloodstream cells resulted in decreased cell growth 
and increased slender to stumpy differentiation in culture, although no effect on 
parasitaemia was observed in mice infections (Vassella et al., 2001b). Similarly, 
TbMAPK5 knock-out resulted in increased stumpy formation in pleomorphic cell 




(Domenicali Pfister et al., 2006). Interestingly, monomorphic TbMAPK5 knock-out 
cells grew normally and did not undergo stumpy formation. This suggests that the 
TbMAPK5 is involved in the stumpy induction pathway, perhaps either by affecting 
the sensitivity of the cell to SIF, or by affecting the downstream pathway 
(Domenicali Pfister et al., 2006).  
 
1.8 The bloodstream to procyclic differentiation 
When a tsetse fly ingests a trypanosome-infected blood-meal, both slender and 
stumpy form parasites enter the tsetse midgut. Although subject to some controversy 
(Bass and Wang, 1991), it is generally thought that stumpy forms are pre-adapted to 
life in the tsetse midgut and only they differentiate efficiently to the tsetse-midgut 
procyclic form (Dean et al., 2009; Vickerman, 1965b). Cytological evidence based 
on in vitro differentiation experiments suggests that bloodstream forms can only 
transform to procyclic forms from a given point in the cell cycle, namely within the 
G1, or the quiescent G0, phase (Ziegelbauer et al., 1990). As stumpy forms are 
uniformly arrested as a population in G0/G1 and can accumulate to near homogeneity 
in experimental infections, this allows for their efficient and synchronous 
differentiation to procyclic forms. In contrast, proliferative slender cell populations 
are asynchronous in their cell-cycle and must reach G0/G1 before differentiation 
(Matthews and Gull, 1994b). Additionally, as cells enter the tsetse midgut, they are 
exposed to harmful proteases and changes in their environmental pH. The stumpy 
forms are more resistant than slender forms to the effects of such stresses (Nolan et 
al., 2000) and as such are more likely to endure the transition from the bloodstream 
to the tsetse midgut. Moreover, stumpy forms have an elaborated mitochondrion 
compared to slender forms, enabling them to quickly begin oxidative 
phosphorylation as they enter the glucose-poor tsetse midgut (Priest and Hajduk, 
1994; Vickerman, 1965b).  
 
The molecular mechanism by which bloodstream trypanosomes perceive their 
change in environment and initiate differentiation to procyclic forms once in the 




concentrations (>3mM) of citrate or cis-aconitate (CCA) could induce differentiation 
of bloodstream form trypanosomes to procyclic forms in vitro (Brun and 
Schonenberger, 1981; Czichos et al., 1986; Hunt et al., 1994). The biological 
relevance of this signal was in doubt, however, as these levels exceed the 
concentrations of CCA that a trypanosome would be exposed to in the tsetse midgut 
(Hunt et al., 1994). However, in 2004 Engstler and Boshart discovered that a drop in 
temperature from 37°C to 20°C could significantly increase trypanosome sensitivity 
to CCA, potentially matching levels present within the tsetse blood-meal (Engstler 
and Boshart, 2004). Since, this temperature drop was compatible with that 
encountered by trypanosomes as they entered tsetse flies feeding at the cooler 
ambient temperatures of dusk or dawn, CCA could be considered physiologically 
relevant. Since temperature drop also allows some molecules regulated access to the 
parasite surface, Engstler and Boshart proposed a model whereby an unknown 
surface protein responsible for the reception of the differentiation signal would be 
retained within the cell in the bloodstream (i.e. when at 37°C) and then trafficked to 
the cell surface in response to the cooler temperatures associated with tsetse uptake 
(Baylis, 1997; Engstler and Boshart, 2004).  
 
The molecular basis of this model, however, was unknown until a gene family 
encoding surface carboxylate transporters known as PAD proteins (Proteins 
Associated with Differentiation) was recently identified (Dean et al., 2009). Indeed, 
two of the encoded PAD proteins (PAD1, PAD2) were shown to be expressed in 
stumpy forms but not in slender forms and were found to be required for perception 
of CCA at physiological concentrations (Dean et al., 2009). Matching the predictions 
of Engstler and Boshart, PAD2 was also demonstrated to be confined to the 
parasite’s flagellar pocket region at 37°C but released to the cell surface at 20°C, 
thereby demonstrating the redistribution of the transporter in response to cold shock 
(Dean et al., 2009; Engstler and Boshart, 2004). Such thermoregulatory events are 
increasingly recognised as being important in insect-borne parasites, including in 
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Figure 1.9 PAD protein expression and localisation act as control points for differentiation. 
Slender cells proliferate in the bloodstream of the mammalian host. As parasite density increases, 
slender cells produce SIF which induces production of stumpy forms. Stumpy forms express PAD 
proteins (denoted by X) whereas slender forms do not. This ensures only the transmissible stumpy 
forms are able to detect the differentiation signal. Upon ingestion in a tsetse blood-meal and exposure 
to a drop in temperature there is up-regulation and a relocation of at least one PAD protein (PAD2) to 
the cell surface. Retention of PAD2 within the cell prior to cold shock ensures stumpy forms do not 
differentiate prematurely. Stumpy forms then differentiate to procyclic forms synchronously in 
response to CCA. Slender forms do not perceive the signal and are sensitive to proteolytic and 
potential pH stress in the tsetse midgut and therefore do not survive. Figure from (MacGregor and 





The differential expression and localisation of the PAD proteins provides two levels 
of control during the differentiation to procyclic forms (Figure 1.9). First, differential 
expression of PAD proteins between slender and stumpy forms ensures only the pre-
adapted transmissible stumpy forms are able to receive the differentiation signal. 
Second, the differential localisation between stumpy cells at 37°C and 20°C ensures 
that only cells in the appropriate environment (i.e. the tsetse midgut) are able to 
receive the signal. As citrate is present in blood at ~130µM (Jacobs and Lee, 1964), 
this secondary control point could be crucial to prevent premature differentiation to 
procyclic forms whilst within the host, this signal only being detected upon 
temperature reduction in the tsetse blood-meal. 
 
Before the discovery of PAD proteins, it was already established that the activity of a 
protein tyrosine phosphatase TbPTP1, inhibits the differentiation of stumpy forms 
whilst in the bloodstream, this block being removed upon uptake by the tsetse fly 
(Szoor et al., 2006). Recently, it was demonstrated that TbPTP1 acts via a 
downstream phosphatase TbPIP39, which stimulates differentiation (Szoor et al., 
2010). A model for the early events in bloodstream to procyclic differentiation has 
been proposed (Figure 1.10) whereby TbPTP1 acts downstream of the PAD proteins 
as an effector of the CCA signal (Szoor et al., 2010). Specifically, CCA inhibits 
activation of TbPTP1 which in turn prevents the dephosphorylation of TbPIP39 by 
TbPTP1. Then, the active, phosphorylated form of TbPIP39 is targeted to the 
glycosome where it promotes differentiation. Similarly, exposure to proteases (Hunt 
et al., 1994; Sbicego et al., 1999) or pH stress (Rolin et al., 1998) in the tsetse midgut 
might also trigger differentiation, either in a complementary manner or as 
independent cues (Rolin et al., 1998). Although the role of these other environmental 
cues is yet to be fully understood, the discovery of the PAD proteins provides the 
first molecular insight into the environmental sensing mechanisms used by the 






Figure 1.10 A model for the early events in bloodstream to procyclic form differentiation. The 
CCA signal is transported into the cell via the PAD proteins which are expressed on the surface of 
stumpy form cells. CCA inhibits the activation of TbPTP1 by TbPIP39 (as well as by indirect 
mechanisms). Once TbPTP1 is inactivated, TbPIP39 is phosphoylated and moves to the glycosome, 
promoting differentiation. Without the CCA signal, TbPTP1 is active and dephosphorylates TbPIP39, 
preventing differentiation and acting as a molecular block to differentiation. Figure from (Szoor et al., 
2010). 
 
1.9 Markers for the stumpy life stage 
One of the key reasons that the differentiation from bloodstream forms to procyclic 
forms has been so well studied is that there are clear molecular markers to 
distinguish each developmental stage. Furthermore, the development between the 
bloodstream and procyclic forms can be easily mimicked in vitro and occurs 
synchronously. Contrasting with this, the absence of markers distinguishing slender 
from stumpy forms has hindered our understanding of the transmission biology of 
trypanosomes, as has the difficulty in successfully generating stumpy forms in 
culture and the lack of synchronicity in which the population differentiates.  
 
In earlier studies, various markers have been used to identify stumpy forms, 
including morphology, mitochondrial activation, cell-cycle arrest and the capacity of 
cells to differentiate synchronously to the procyclic form (Breidbach et al., 2002; 
Denninger et al., 2007; Laxman et al., 2006; Reuner et al., 1997; Tyler et al., 1997). 




subjective and time consuming and is complicated by the presence of 
morphologically intermediate forms in the population. Similarly, differentiation 
analyses are time-dependent and require population assays, rather than the analysis 
of individual cells. Finally, mitochondrial activation, often visualised through the 
activity of dihydrolipoamide dehydrogenase in the diaphorase assay, may also be 
activated under non-physiological stress conditions.  
 
With the identification of PAD1 as a surface molecule that identifies cells that are 
functionally competent for transmission (Dean et al., 2009), as well as developments 
in parasite culture and transfection (Vassella and Boshart, 1996), the route has been 
opened up to dissect trypanosome transmissibility at the level of individual cells as 
well as in the infecting parasite population (see section 1.12) 
 
1.10  Gene expression in African trypanosomes 
In the 26Mb T.brucei genome there are 11 mega-base size chromosome and 
numerous smaller intermediate and mini-chromosomes, together encoding over 9000 
predicted genes (Berriman et al., 2005). The architecture of the trypanosome genome 
is unusual compared to other eukaryotes in that genes are arranged into large 
polycistronic units which seem to lack RNA Polymerase II (PolII) promoters (Figure 
1.11). Indeed, gene expression in trypanosomes is unusual in that it is controlled 
almost entirely post-transcriptionally.  
 
1.10.1 Transcription  
In T.brucei RNA polymerase I (PolI), as in other eukaryotes, transcribes the 
ribosomal RNA genes. However, unusually, PolI also transcribes some protein 
coding genes, namely the bloodstream VSG genes and the procyclic form procyclin 
genes, which are the major surface proteins for the respective life stages. There are 
PolI promoters, both in the rRNA loci and upstream of the VSG and procyclin genes 
(Figure 1.11). RNA polymerase III (PolIII) in trypanosomes transcribes the tRNA as 







Figure 1.11 A schematic representation of a generic T.brucei chromosome. RNA polymerase I 
transcribes the ribosomal RNA (rRNA) genes and the mRNA for the major surface protein genes for 
the bloodstream and procyclic life stages. RNA polymerase II transcribes the majority of the protein 
coding genes, although there is a lack of RNA polymerase II promoters. RNA polymerase III 
transcribes the tRNA and small nuclear RNA. This diagram does not represent any one chromosome, 
but rather illustrates typical features of the genomic architecture of the trypanosome. Figure from 
(Clayton, 2002). 
 
T.brucei PolII transcribes the mRNA (Figure 1.11) as well as the splice leader (SL) 
RNA (see section 1.10.2). For the SL RNA there is a PolII promoter (Luo et al., 
1999). However, for all of the PolII transcribed protein coding genes there are no 
discernable promoters. Indeed, as already mentioned, the vast majority of protein 
coding genes are arranged in polycistronic units where all the genes within a unit lie 
in the same orientation and are co-transcribed. Polycistronic units are separated by 
strand switch regions, where the genes in the neighbouring unit then lie in the 
opposite direction. It appears that it is at these divergent and convergent strand 
switch regions that PolII initiates and terminates transcription, respectively. 
Recently, it was demonstrated that there are specific chromatin modifications at these 
probable PolII transcription start and stop sites, such that there is an open chromatin 
structure at sites of transcription initiation (Siegel et al., 2009). Hence, trypanosome 
PolII transcription initiation is dependent on chromatin structure.  
 
Genes within a polycistronic unit most often do not represent families of genes with 
either common function or common patterns of expression, with gene expression 
controlled largely at the post-transcriptional level (see section 1.11), although some 
small clusters of differentially expressed genes have recently been identified (Veitch 
et al., 2010). Once the polycistronic unit is transcribed the pre-mRNA must be 




1.10.2 mRNA processing 
Once the protein coding mRNA has been transcribed, the transcript must be 



















Figure 1.12 mRNA processing in trypanosomes.  Transcription occurs in polycistronic units which 
are required to be processed into independent mRNAs. Trans splicing of the downstream ORF is 
coupled to polyadenylation of the upstream ORF. A pyrimidine-rich motif between the two is 
important for controlling the location of this process (Matthews et al., 1994). AAAA, represents the 
polyA tail. Figure modified from (Vanhamme and Pays, 1995). 
 
First, the SL RNA is modified co-transcriptionally (Mair et al., 2000) such that the 
transcript then has a hyper-modified 5’ end (Bangs et al., 1992; Perry et al., 1987). 
The first 39-bp of the processed SL RNA is then added to the 5’end of the mRNA 
transcripts via trans-splicing: this resolves the large polycistronic transcript into the 
individual mRNAs, each with a 5’cap (Figure 1.12) (De Lange et al., 1984; 
Milhausen et al., 1984; Parsons et al., 1984). This occurs downstream of a 
pyrimidine rich motif (Matthews et al., 1994). In trypanosomes there is no known 
polyadenylation signal. The polyadenylation is coupled to the addition of the 5’ cap 
of the downstream OFR and is dependent on the location of the polypyrimidine motif  




be more than one polyadenylation site relatively close to one another, reflecting the 
lack of a precise polyadenylation signal. Indeed, recent genome-wide analysis of 
polyadenylation sites in bloodstream and procyclic life-stages revealed that, for 
transcripts with high coverage, there were as many as 10 polyadenylation sites, on 
average, for each gene (Siegel et al., 2010).   
 
1.11  Post transcriptional control of gene expression 
During the trypanosome life cycle, the parasite must differentiate in order to adapt to 
the varying environments in which it must survive. These differentiation events are 
associated with changes in large-scale changes gene expression, as has been 
demonstrated in genome-wide analysis of mRNA abundance between life-stages and 
during differentiation (Jensen et al., 2009; Kabani et al., 2009; Queiroz et al., 2009; 
Siegel et al., 2010). Due to the lack of transcriptional control in T.brucei, gene 
expression is controlled largely at the post-transcriptional level by both mRNA 
stability and translational control. 
 
1.11.1 mRNA stability and translational control 
In other eukaryotes, mRNA degradation is generally initiated by deadenylation and 
subsequent decapping resulting in 5’-3’ cytoplasmic exonuclease activity and 3’-5 
degradation by the exosome, reviewed in (Clayton, 2002). In trypanosomes, there are 
two main pathways for mRNA degradation. The first, similar to other eukaryotes, 
involves deadenylation and then decapping, which results in both 5’-3’ and 3’-5’ 
exonuclease activity by the cytoplasmic exonuclease, XRNA, and the exosome, 
respectively (Estevez et al., 2001; Haile et al., 2003; Irmer and Clayton, 2001; Li et 
al., 2006). The second pathway involves the rapid degradation of highly unstable 
mRNAs dependent on XRNA, without the requirement for deadenylation (Irmer and 
Clayton, 2001; Li et al., 2006; Schwede et al., 2009).  
 
As well as by mRNA stability, post-transcriptional gene expression is controlled by 
translation. One mechanism by which translation controls gene expression in 




expressed genes use favoured codons. Indeed, a strong correlation has been 
demonstrated between codon usage and gene expression, suggesting that codon bias 
is a key contributor to differential gene expression in trypanosomes (Horn, 2008). 
For stage regulated gene expression, developmental control can be determined by 
RNA-binding proteins causing the association of bound mRNAs with the 
translational apparatus, such as in the case of TbZFP3 binding to EP1 mRNA (see 
section 1.11.3) (Paterou et al., 2006; Walrad et al., 2009). On a more global scale, in 
stumpy form trypanosomes, there is decreased protein synthesis compared to slender 
form trypanosomes (Brecht and Parsons, 1998). This is due to decreased association 
of mRNA with ribosomes during the stumpy life stage, likely due to decreased 
initiation of translation by some unknown mechanism (Brecht and Parsons, 1998). 
How some genes, such as PAD1, escape this global repression of expression to be 
upregulated in stumpy forms is unknown.  
 
1.11.2 Cis-acting signals in gene regulation 
In trypanosomes, regulation of transcript-specific gene expression is controlled 
predominantly by cis-acting signals in the 3’UTR of the mRNA which recruit 
regulatory RNA-binding proteins and result in differential gene expression between 
life stages. Many procyclic-specific genes have destabilising AU-rich elements 
(AREs) in the 3’UTR, which cause them to be highly unstable during the 
bloodstream life-stage, thus preventing expression (Mayho et al., 2006). For 
example, cytochrome oxidase (COX) complex genes are developmentally regulated 
in that they are expressed during the procyclic but not bloodstream life-stage. An 
analysis of the control of COX gene expression revealed that regulatory regions in 
the 3’UTRs control translation efficiency, and mRNA stability, in a stage-specific 
manner (Mayho et al., 2006). The effects of 3’UTR regulatory signals will be 
transmitted through the actions of RNA binding proteins (section 1.11.3). As well as 
linear sequences, secondary structures in the 3’UTRs likely contribute significantly 
to the regulation mRNA stability, with the RNA binding proteins binding to these 




specific regulatory signals due to difficulties in predicting the secondary structure of 
RNA molecules.  
 
The majority of protein coding genes are transcribed by PolII (section 1.10.1), but 
the most well studied 3’UTR is that of the procyclic genes, the major surface proteins 
of the procyclic life-stage, which are transcribed by PolI (Biebinger et al., 1996). It 
may be that PolI is utilised for transcription of the major surface proteins in order to 
obtain very high levels of protein expression (Biebinger et al., 1996; Clayton, 2002). 
There are four procyclin genes (EP1, EP2, EP3 and GPEET) which are differentially 
expressed within the procyclic life-stage as they have similar, but distinct 3’UTRs 
(Vassella et al., 2001a). The EP1 procyclin 3’UTR is composed of three regulatory 
stem loops: In bloodstream forms, Loop I contains a positive element, Loop II 
contains a negative element and Loop III contains a 16mer which acts as an anti-
repressor of the Loop II element (Furger et al., 1997; Hehl et al., 1994). During the 
bloodstream life stage, EP1 procyclin mRNA is rapidly degraded due to the presence 
of an ARE in the Loop II region of the 3’UTR (Furger et al., 1997; Irmer and 
Clayton, 2001; Mayho et al., 2006).  
 
1.11.3 Trans-acting factors in gene regulation 
Regulatory signals in the 3’UTR of mRNAs are transmitted through the action of 
trans-acting RNA binding proteins. There are a large number of potential RNA 
binding proteins encoded in the trypanosome genome (De Gaudenzi et al., 2005) and 
a few have been validated and characterised. For example, in procyclic forms, the 
RNA binding protein TbZFP3 specifically associates with EP1 and GPEET mRNA 
rather than EP2 and EP3 mRNA (Walrad et al., 2009). It positively regulates 
expression of EP1 in the procyclic life stage by binding the Loop II and Loop III 
region on the 3’UTR, potentially competing with an unknown negative regulator 
(Walrad et al., 2009). Although TbZFP3 is expressed constitutively throughout the 
trypanosome life cycle, it only associates with the polysomes during the procyclic 




expression by association with the translational apparatus in a stage specific manner 
(Walrad et al., 2009).   
 
The EP1 RNA binding protein, TbZFP3, has a CCCH zinc finger binding domain 
which is essential for procyclin mRNA association (Walrad et al., 2009). In other 
eukaryotes, CCCH zinc finger proteins have been shown to regulate post-
transcriptional expression by both mRNA degradation and translational control 
(Kramer et al., 2010). A recent in silico analysis of the T.brucei genome revealed 48 
potential CCCH zinc finger proteins which, with experimental validation, may prove 
to be further RNA binding proteins (Kramer et al., 2010), the characterisation of 
which may help further understanding of the mechanisms of post-transcriptional 
gene expression in trypanosomes. 
 
The RNA binding protein, TbDRBD3, is part of a ribonucleoprotein complex that 
has been shown to bind to and stabilise a subset of mRNAs, with the majority 
encoding membrane proteins (Estevez, 2008). This is suggestive of specific RNA 
binding proteins controlling regulation of functionally related groups of proteins as a 
post transcriptional regulon (Estevez, 2008). Indeed the PUF9 RNA binding protein 
has been shown to stabilise mRNAs involved in the cell cycle, specifically during S 
phase, again indicative of functionally related groups of proteins being regulated by 
common RNA binding proteins (Archer et al., 2009). Furthermore, genome-wide 
analysis does demonstrate that, perhaps unsurprisingly, functionally related mRNAs 
show tightly regulated expression patterns (Queiroz et al., 2009). In the case of both 
TbDRBD3 and PUF9, association is dependent on specific sequences within the 
3’UTR of the mRNA (Archer et al., 2009; Estevez, 2008).  
 
Although the identification and characterisation of 3’UTR recognition motifs and 
RNA binding proteins is underway, there is still much to be learned about the way in 
which RNA binding proteins recognise specific mRNAs and regulate post-
transcriptional gene regulation, particularly between the different life stages. Further, 
much of the work so far has focused on stage specific gene regulation between 




and stumpy forms. A large number of genes are differentially expressed between 
slender and stumpy forms (Jensen et al., 2009; Kabani et al., 2009). Recent whole-
genome microarray analysis, comparing slender, stumpy and procyclic forms, 
revealed two motifs overrepresented in the 3’UTRs of transcripts enriched in the 
stumpy life stage and one of these motifs showed positional enrichment suggesting 
that it may be a context dependent regulatory signal (Kabani et al., 2009). It may be 
that further bioinformatic analysis of databases such as these will identify further 
potential stage-specific regulatory signals in stage-specific 3’UTRs. However, due to 
the likely vital role of RNA secondary structure in 3’UTR control (Clayton, 2002), 
and the difficulties in predicting RNA secondary structure in silico, experimental 
analysis will still be required. Indeed, the recently identified PAD1 is clearly up-
regulated at both the mRNA and protein level in stumpy form cells compared to 
slender forms (Dean et al., 2009). Experimental analysis of the control of gene 
expression of PAD1 may reveal further stumpy-specific regulatory signals which 
may provide the potential for the identification of stumpy-specific RNA binding 
proteins (see section 1.12).  
 
1.12  PAD1 as a tool for analysis of the stumpy life stage 
The stumpy life stage plays a crucial role in trypanosome infection dynamics and 
transmission yet has been difficult to study due to a lack of molecular markers for the 
life stage (see section 1.9). A new molecular marker for the stumpy life stage has 
recently been identified. PAD1 is up-regulated in stumpy forms compared to slender 
forms at both the mRNA and protein level (Figure 1.13) (Dean et al., 2009). PAD1 is 
therefore a molecular marker for the stumpy life stage and for transmission 
competence (Dean et al., 2009). 
 
PAD1 provides a tool for the analysis of stumpy formation, both in vivo and in vitro 
as well as the study of stumpy-specific gene expression. By analysing the regulation 
of gene expression of PAD1, mechanisms of control of repression of expression in 
slender forms and alleviation of repression in stumpy forms may be identified. 




specific gene expression, reporter cell lines for the stumpy life stage can be created. 
These can then be used to monitor stumpy formation in vitro either in response to 
media containing SIF, or fractions thereof. Alternatively, identification of chemical 
inducers of stumpy formation may identify downstream targets of the SIF signal. 
Together these could provide data on the identity of SIF and the stumpy induction 
pathway. Finally, by monitoring PAD1 expression relative to parasitaemia 
throughout chronic in vivo infections, data on the dynamics of the slender to stumpy 
transition could be generated. This data could then be fed into existing models of 
stumpy formation (Savill and Seed, 2004) and allow refinement of those models. 
This will provide better understanding of the transmission strategy of trypanosomes 
and may allow for the potential consequences of therapeutic interventions to be 
predicted and tested. Moreover, comparing the onset of PAD1 expression with 
traditional markers of stumpy formation such as cell cycle arrest and morphology 






Figure 1.13 PAD1 is differentially expressed between the slender and stumpy life stages. (A) 
PAD1 mRNA is expressed at high levels in stumpy forms compared to slender forms. (B) PAD1 
identifies stumpy cells and transmission competence. Cells which are morphologically slender (white 
arrow) do not express PAD1 on their surface. Cells which do not express PAD1 are not transmission 
competent, as measured by EP procyclin protein expression after induction of differentiation to the 





1.13  Aims 
The aim of this thesis was to study stumpy formation, with the use of PAD1 as a 
molecular marker for the purpose of better understanding stumpy-specific gene 
expression, the stumpy induction pathway and transmissibility in trypanosome 
infections.  
 
The key aims were as follows: 
 
 Identify the regulatory signals controlling stumpy specific gene expression of 
PAD1.  
 
 Create stumpy-specific reporter cell lines for the analysis of stumpy 
formation in vitro.  
 
 Develop a method to track parasite transmissibility during chronic 



























































2.1 Trypanosome strains 
All monomorphic cell lines used are based on the Trypanosoma brucei brucei 
Lister427 strain. A speculative history of the origin of this strain has been 
documented (http://tryps.rockefeller.edu/ DocumentsGlobal/lineage_Lister427.pdf) 
by George Cross at the Rockefeller University    
 
Two pleomorphic trypanosome stains were used in this study. The first is strain T.b. 
brucei AnTat1.1, used for mice infections and harvesting of slender or stumpy cells 
from mice. The second is T.b. brucei AnTat1.1 90:13 (Engstler and Boshart, 2004), a 
culture adapted pleomorphic cell line used for the creation of the pleomorphic 
reporter cell line in Chapter 4.  
 
2.2 Trypanosome culture 
Bloodstream monomorphic trypanosomes were grown in HMI-9 media (Appendix 
A) supplemented with a final concentration of 20% foetal calf serum (FCS, Gibco) 
and 100U/ml penicillin and streptomycin (Gibco) at 37C in 5% CO2 (Hirumi and 
Hirumi, 1989). Cells were grown at a concentration of 1 x 10
5
 to 5 x 10
6





 filter cap flasks (Greiner Bio-One 690175 and 658 175 
respectively). Cells were counted using a Beckman Z2 Coulter particle count and 
size analyser. All trypanosome work was carried out using sterile techniques.  
 
Cultured pleomorphic trypanosomes were grown in HMI-9 media supplemented with 
20% FCS and 100U/ml penicillin and streptomycin at 37C in 5% CO2 with the 
addition of 1.1% methyl cellulose (McCulloch et al., 2004). Presence of methyl 
cellulose in the media requires that cells be counted using a haemocytometer. 
However, for the pleomorphic reporter cell line (Chapter 4) more accurate cell counts 
were required for the assay of CAT reporter gene expression. Thus for experiments 
involving analysis of CAT expression methyl cellulose was not added to the media 





Cell lines were stored at -80C or in liquid nitrogen. For cell lines from culture, 10ml 
of exponential phase cultures were centrifuged at 800g for 10 minutes in order to 
pellet the cells. The pellet was resuspended in 500µl of media. To this, 500µl of 
HMI-9 supplemented with 14% glycerol was added slowly. This was left for 2 
minutes before being transferred into a cryovial and stored at -80C. For cell lines 
from whole mouse blood, blood was harvested by cardiac puncture (section 2.3). The 
blood obtained was divided into 100µl aliquots in cryovials. To this, 100µl of HMI-9 
supplemented with 14% glycerol was added slowly.  This was left for 2 minutes 
before being transferred into a cryovial and stored at -80C. After two days at -80C 
cell lines could be transferred to a liquid nitrogen storage tank for longer term 
storage.  
 
2.3 Trypanosome infections in mice 
All mice used in this study were strain MF1. All mouse husbandries were carried out 
by the staff of the March Building, University of Edinburgh. All mouse handling was 
carried out by Deborah Hall or Prof. Keith Matthews according to the conditions of 
Home-Office personal and project licenses.  
 
For the harvest of slender forms and for chronic infections, no immunosuppressant 
was used. For the harvest of stumpy form trypanosomes, mice were injected with 
200-250µl of 25mg/ml cyclophosphamide the day before infection to suppress the 
immune system of the mouse to allow for accumulation of a high parasite density.  
 
To monitor parasitaemia throughout an infection, a tail snip was made and blood 
collected for a wet smear. Parasitaemia was then estimated from the wet smear by 
microscopy. For analysis of chronic infections (Chapter 5), 10µl tail blood was 
collected daily in 10µl capillary tubes (Camlab DMP010) (section 2.12.1) and dry 





Total blood was harvested from mice by cardiac puncture using a Microlance 0.6 x 
25mm needle and a 2ml syringe containing 250µl of 2% sodium citrate. 
Trypanosomes were purified from whole blood through an anion exchange resin 
column (Whatman 4057200) at pH7.8 in 30ml Buchner flasks.  
 
2.4 Cloning and DNA manipulations 
2.4.1 PCR amplification 
PCR amplification was carried out in 0.2ml PCR tubes (Axygen 321-10-051) in a 
Thermo Electron Corporation PCR SPRINT thermal cycler. A typical 50µl reaction 
is shown below. 
 
PCR:   10µl 5x Flexibuffer 
   3µl 25mM MgCl2 
   4µl 2.5mM dNTPs 
   2µl 25µM Forward primer 
   2µl 25µM Reverse primer 
   0.5µl Taq Polymerase (5units/µl) 
   2µl AnTat1.1 genomic DNA (approx. 50ng/µl) 
   26.5µl dH2O  
 
Reaction conditions: 95C for 5minutes 
30x [95C for 30 seconds, 55C for 45 seconds, 72C for 1 
minute] 
   72C for 4 minutes 
 
2.4.2 Oligonucleotides 
All oligonucleotides used in this thesis were produced by Sigma Aldrich and are 




No. Name Sequence 
 
Amplification of the full length PAD1 5' and 3'UTR 
1 PAD1 3'UTR For (BamHI) TTAGGATCCGCTTAGGGGAGCCAGTGGAGGGC 
2 PAD1 3'UTR Rev (XhoI) TTACTCGAGGGCAATGTTTTGTACAGTACGCTCAG  
23 PAD1 3'UTR Rev (BsmAI) TAATGCTTGAGACGGCAATGTTTTGTACAGTACGCTCAG 
20 PAD1 5'UTR For (XhoI) TTACTCGAGAAACATGGACAGTCAACATCTCCATATG 
21 PAD1 5'UTR Rev (HindIII) TTAAAGCTTGGCAATGTTTTGTACAGTACGCTCAG 
Determining the PAD1 3'UTR polyadenylation site 
Along with primer 24 (PAD1 PolyA Round 1) and 1 (PAD1 PolyA Round 2) 
67 ADAPT dT(15) GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTT 
68 AUAP GGCCACGCGTCGACTAGTAC 
Creating the PAD1 3'UTR deletion series 
62 PAD1 3'UTR 1-21 (BamHI) TTAGGATCCGGCGGCTTCCTGACGTTTATTCAAC 
63 PAD1 3'UTR 1-175 (BamHI) TTAGGATCCCTTTGTCTATACATATCGCATACCATTAG 
28 PAD1 3'UTR 1-207 (BamHI) TTAGGATCCACGGTGCGCCAACTCTGGTAAACG 
39 PAD1 3'UTR 1-265 (BamHI) TTAGGATCCATATTGTACGAGCAGTCCATGCATTA 
40 PAD1 3'UTR 1-354 (BamHI) TTAGGATCCGAACACACCAACTTATATCGTTAAATTC 
29 PAD1 3'UTR 1-391 (BamHI) TTAGGATCCCTCTCGTTTATCGATAAAAGTTCG 
41 PAD1 3'UTR 1-502 (BamHI) TTAGGATCCCACTCTTCACCCGTGGAAACACC 
30 PAD1 3'UTR 1-609 (BamHI) TTAGGATCCCCTATCTCGTCTTCATATCTTTACTGC 
42 PAD1 3'UTR 1-776 (BamHI) TTAGGATCCAAACTTAATGCTTTCATTTCTCCCTTTTTG 
Creating internal deletions of the PAD1 3'UTR 
For PAD1 3'UTR 386-564, along with primers 1 and 23 
49 1st PAD1 3'UTR 386-564 Rev (HindIII) TAAAAGCTTTGAAGAATTTAACGATATAAGTTGGTGTG 
50 2nd PAD1 3'UTR 386-564 For (HindIII) TAAAAGCTTTGCAGACCAACACAGGCACCCCAA 
For PAD1 3'UTR 354-624, along with primers 1 and 23 
57 1st PAD1 3'UTR 354-624 Rev (XhoI) TAACTCGAGATATAGTGACTGGTGTTGTTGTATCG 
58 2nd PAD1 3'UTR 354-624 For (XhoI) TAACTCGAGTATCTTTACTGCTTGTTATAATTTTGTC 
Inserting a section of the PAD1 3'UTR into the CAT449 construct 
Along with primer 40 
72 PAD1 3'UTR 624 Rev (BamHI) TTAGGATCCTGAAGACGAGATAGGTAGCACTACG 
Amplification of reporter genes 
For amplification of both GFP and CFP 
3 GFP/CFP For (HindIII) TTAAAGCTTATGGTGAGCAAGGGCGAGGAGCTG 
4 GFP/CFP Rev (BamHI) TTAGGATCCTTACTTGTACAGCTCGTCCATGCCG 
For amplification of GUS 
5 GUS For (HindIII) TTAAAGCTTATGTTACGTCCTGTAGAAACCCCAAC 
7 GUS Rev (BglII) TTAAGATCTTCATTGTTTGCCTCCCTGCTGCGG 
qRT-PCR of PAD1 and TbZFP3 
24 qRT-PAD1 For GACCAAAGGAACCTTCTTCCT 
25 qRT-PAD1 Rev CACTGGCTCCCCTAAGCT 
17 qRT-ZFP3 For CAGGGGAAACGCAAAACTAA 
19 qRT-ZFP3 Rev TGTCACCCCAACTGCATTCT 




2.4.3 DNA agarose gel electrophoresis  
DNA agarose gels were used to visualise DNA as well as for separating different 
length DNA fragments and gel purification of those fragments of interest. Most often 
a 1% agarose gel was used; however, for separation of particularly large fragments of 
DNA (i.e. above 2kb) a 0.8% agarose gel was used. To prepare a 1% agarose gel, 1g 
of agarose power is dissolved in 100ml 1x TAE buffer (Appendix A) by heating. 
Once dissolved the agarose was allowed to cool to approximately 60C before 
adding 4µl Safeview (NBS Biologicals). The gel was then poured into a gel tray 
containing a gel comb. Once the gel was set, the comb is removed and the gel tank is 
filled with 1x TAE buffer. Samples are loaded into the wells and ran at 100-125V for 
25-35 minutes. In all cases a 200-10,000bp DNA ladder (Eurogentic SmartLadder 
MW-1700-10) was ran alongside the samples for estimation of fragment size.  
 
2.4.4 DNA purification  
DNA is purified to remove contaminants such as salts, proteins or primers from 
previous reactions which may interfere with future reactions. DNA can be purified 
from solution (i.e. after a PCR reaction) or from an agarose gel when it is desirable to 
purify single-sized fragments of DNA within a mixed population (i.e. after the 
removal of an insert from a plasmid via digestion both the plasmid and insert can be 
gel purified to separate one another). In both cases, DNA was purified using a 
NucleoSpin Extract II kit (Machery-Nagel) following manufacturer’s instructions.  
 
2.4.5 Restriction digests 
Restriction digests were carried out at the optimum temperature for the restriction 
enzyme in the optimum buffer in a 30µl reaction volume according to manufacturers’ 
recommendations. All enzymes and buffers were from either Promega or NEB. 
Double digests were carried out where an appropriate buffer and reaction 
temperature were available, otherwise sequential digestions were required. Digests 





Ligation reactions were typically carried out in a 10µl volume at 4C overnight or at 
room temperature for 4-5 hours. A control with no digested insert was always 
included.  
 
Ligation reaction: 1µl 10x Promega T4 DNA Ligase buffer  
   0.5µl Promega T4 DNA ligase (3U/µl) 
   1µl Digested vector (approx 200-500ng/µl) 
   7.5µl Digested insert 
 
2.4.7 Transforming bacteria  
For transformation, chemically competent laboratory stocks of XL-1 blue E.coli cells 
are maintained and stored at -80C. On ice, 5µl of the ligation reaction (section 2.4.6) 
or 1µl of prepared plasmid is added to 100µl of competent bacteria and left for 30 
minutes. The cells are heat shocked at 42C for 30 seconds in a water bath. To allow 
the cells to recover before selection, 250µl of L-broth is added to the cells and 
incubated at 37C for 45 minutes with shaking. The cells are then plated onto 
selective LB agar plates (1mg/ml ampicillin) and incubated at 37C overnight. All 
plasmids used in this thesis contain an ampicillin resistance gene. Thus, the 
following day, only cells with the plasmid will have formed colonies. The colonies 
can then be used to prepare DNA (section 2.4.8) in order to confirm that they have 







2.4.8 Small-scale preparation of plasmid DNA: Mini-prep 
For small-scale plasmid DNA preparation a mini-prep is carried out. Mini-prep DNA 
is used to test for the correct ligation, and often sequence, of an insert into a plasmid. 
See section 2.4.10 for the method of sequencing.  
 
A discrete colony of interest on an LB agar plate is picked with a sterile pipette tip 
and used to inoculate 3ml of LB agar. In all cases described in this thesis the colonies 
were ampicillin resistant and therefore 1mg/ml ampicillin was also added to the 
culture. The culture is grown overnight at 37C with shaking. The following day 
1.5ml of culture is transferred to a 1.5ml eppendorf tube and centrifuged at 10,000g 
for 5 minutes at room temperature. The supernatant is removed and 100µl of 
Solution I is added to the pellet. The pellet is resuspended by rapping the eppendorf 
along a rack and 200µl of Solution II is added. The tube is mixed by inversion and 
left to incubate for no more than 5 minutes at room temperature. Then, 150µl of pre-
chilled Solution III is added; the tube is again mixed by inversion and incubated on 
ice for 5 minutes. The sample is then centrifuged at 10,000g for 10 minutes at room 
temperature. The supernatant is then transferred to a fresh eppendorf containing 
900µl of 100% ethanol. The sample is mixed by inversion and incubated at -20C for 
1 hour to allow precipitation of the DNA. The sample is then centrifuged at 10,000g 
for 10 minutes at room temperature. The supernatant is discarded and 500µl of 70% 
ethanol is added to the pellet. The sample is centrifuged at 10,000g for 5 minutes at 
room temperature and the supernatant is removed. The pellet is allowed to air dry for 
approximately 15 minutes. The pellet is then resuspended in 50µl of dH2O 
containing 1µl 10mg/ml RNase. The pellet is allowed to dissolve for 5 minutes 







2.4.9 Large-scale preparation of plasmid DNA: Midi-prep 
For large-scale plasmid DNA preparation a midi-prep was used. Midi-prep DNA is 
of a higher concentration and purity compared to mini-prep DNA and is used for 
trypanosomes transfections (section 2.5). For midi-preps the QIAGEN
®
 Plasmid 
Midi Kit (Cat. No. 12145) was used following manufacturer’s instructions. The 
procedure is outlined below.  
 
In a 2000ml autoclaved conical flask, 200µl of liquid culture is added to 200ml of 
LB broth containing 200µl 1mg/ml ampicillin. The culture is grown at 37C 
overnight with shaking. The following day, the culture is centrifuged at 4000g for 30 
minutes at 4C. The supernatant is removed and 4ml of Buffer P1 (containing 
100µg/ml RNase) is added to the pellet. The pellet is resuspended and 4ml of Buffer 
P2 is added. The tube is mixed by inversion and left to incubate for no more than 5 
minutes at room temperature. Then, 4ml of pre-chilled Buffer P3 is added; the tube is 
again mixed by inversion and incubated on ice for 15 minutes. The sample is then 
centrifuged at 20,000g for 30 minutes at 4C. The supernatant is then transferred to a 
fresh tube and spun again at 20,000g for a further 15 minutes at 4C. Meanwhile, a 
QIAGEN-tip 100 column is equilibrated with 4ml of Buffer QBT: the solution passes 
through the column by gravity. The supernatant is applied to the column. The column 
is then washed twice with 10ml Buffer QC. The DNA is then eluted in 5ml of Buffer 
QF. To precipitate the DNA, 3.5ml of isopropanol is added to the eluate. The 
solution is mixed by inversion and centrifuged at 15,000g for 30 minutes at 4C. The 
supernatant is removed with care taken to avoid disrupting the pellet. The pellet is 
washed in 2ml 70% ethanol and centrifuged at 15,000g for 10 minutes at 4C. The 
supernatant is removed and the pellet is air-dried for 5 minutes at room temperature. 





2.4.10 DNA sequencing  
DNA sequencing was carried out at the School of Biological Sciences Sequencing 
Service, (The GenePool), University of Edinburgh. Samples were prepared in 6µl 
volumes with 3.2µM primer and up to 500ng template DNA.  
 
2.4.11 Mapping of the PAD1 3’UTR polyadenylation site 
To map the PAD1 3’UTR polyadenylation site in stumpy forms, stumpy AnTat1.1 
RNA was used in a reverse-transcriptase (RT) reaction followed by two rounds of 
nested PCR (Chapter 3). 
 
RT-Reaction:   2µg stumpy AnTat1.1 RNA in 10µl total volume 
    1µl 50mM ADAPT (67) primer 
   4µl 5x AMV RT Buffer 
   1µl 40U/µl RNasin RNase inhibitor (Promega N211A) 
   2µl 2.5mM dNTPs  
   1µl 10U/µl AMV Reverse transcriptase (Promega M510A) 
   1µl 0.1mM 1, 4-dithio-DL-threitol (DTT)  
    
Reaction conditions: 37C 10 minutes 
42C 1 hour 
 
The cDNA produced was then used in two rounds of nested PCR, firstly with primers 
AUAP (68) and PolyA Round 1 (24) and then with AUAP (68) and PolyA Round 2 
(1), as in section 2.4.1. For details of primers see section 2.4.2, Table 2.1. The 
products from the second round of PCR were resolved on an agarose gel (section 
2.4.3). There was one prominent band which was excised and gel purified (section 
2.4.4). The PCR product was then cloned into pGEM-T-Easy (Promega A137A) and 
transformed into bacteria (section 2.4.7). Five transformant colonies were selected 
and used to make mini-prep DNA (section 2.4.8). The DNA was then sequenced 




2.5 Trypanosome transfection 
2.5.1 Preparing the DNA for transfection by electroporation  
A digested DNA plasmid is purified using a NucleoSpin Extract II kit (as described 
in section 2.4.4) and eluted with 4x 50µl dH2O to give a total eluate volume of 
200µl. To concentrate the DNA by ethanol precipitation, 20µl 3M Na Acetate is 
added to the purified DNA and mixed by vortex. To this, 500µl of 100% ethanol is 
added and mixed by vortex. This is then incubated at -80C for at least 1 hour in 
order to precipitate the DNA. The mixture is centrifuged at 18,000g for 10 minutes at 
4C and the supernatant removed. The DNA pellet is air-dried for 5 minutes and then 
resuspended in 5µl 1mM Tris-HCl, pH8, 0.1mM EDTA.  
 
2.5.2 Transfection of monomorphic trypanosomes by 
electroporation 
For transfection of monomorphic bloodstream form cells, 4 x 10
7
 cells from a 
logarithmically growing culture were centrifuged at 800g for 10 minutes in order to 
pellet the cells. The cells were resuspended in 100µl Mirius Bio Ingenio™ 
Electroporation solution (MIR 397) and 5ul of DNA is added. Cells were transfected 
by electroporation in the Amaxa Nucleofector® II (20800714) using program “CD4 
T-cells X-001” in Mirius Bio Ingenio™ cuvettes (MIR 50120). Cells were then 
allowed to recover in 25ml of pre-warmed HMI-9 overnight. 
 
The following day the culture was centrifuged at 800g for 10 minutes to pellet the 
cells. Cells were resuspended in selective media and transferred to 24 well plates 
(2ml/well) and serial dilutions were set up (neat, 1/10, 1/100, 1/1000). After 5-7 
days, all untransfected cells were dead and remaining live cells were transfectants. 
From each positive well, the culture is diluted 1/5 into 5ml in 6-well plates and then 






2.5.3 Transfection of pleomorphic trypanosomes by 
electroporation  
A mouse was injected intraperitoneally (IP) with T.b brucei AnTat1.1 90:30 cells. At 
3 days post infection, the population of cells were slender in morphology as 
determined by microscopy. The mouse blood was harvested by cardiac puncture. 
Using a sterile 1.5ml eppendorf tube, the blood was centrifuged at 4000g for 10 
minutes, separating the blood into plasma, in the upper layer, and red blood cells, in 
the lower layer. Between the two layers is the buffy coat which is the fraction 
containing white blood cells, platelets and trypanosomes. The plasma was removed 
from the upper layer using a pipette. The buffy coat was then taken, with care to 
avoid red blood cells. The buffy coat was resuspended in 200µl of Mirius Bio 
Ingenio™ Electroporation solution (MIR 397) and split into two Mirius Bio 
Ingenio™ cuvettes (MIR 50120). To one cuvette, 5µl of DNA was added, to the 
other 5µl of dH2O was added as a negative control. The cells were then 
electroporated in a Nucleofector® II (20800714) using program “CD4 T-cells X-
001”. Cells were then allowed to recover in 25ml of pre-warmed HMI-9 containing 
1.1% methyl cellulose for 2 hours. After 2 hours, cells were counted using a 
haemocytometer. If cell concentration was higher than 1 x 10
5 
cells/ml then the 
culture was diluted to this concentration. Cells were transferred to 24 well plates 
(1ml/well) and serial dilutions were set up (neat, 1/2, 1/4 and 1/8) before recovering 
overnight.  
 
The following day, 1ml of pre-warmed and pre-equilibrated 2x selective media was 
added to each well. After 5-7 days, all untransfected cells were dead and remaining 
live cells were transfectants. From a positive well 1ml of media is taken, centrifuged 
at 4000g for 10 minutes to pellet the cells. The transfectants are then resuspended in 
200µl media and injected IP into a cyclophosphamide-treated mouse (section 2.3). 
Once the infection has a detectable parasitaemia and cells are still slender in 
morphology (approximately 3 days post infection) the cells are harvested by cardiac 




200µl aliquots and stored at -80C for short term storage and in liquid N2 for long 
term storage. 
 
2.5.4 Drug concentrations 
All transfectants were selected and grown in the presence of the appropriate drug(s). 
The concentrations of each drug used in this thesis are below.  
 
0.5µg/ml Puromycin (Calbiochem 5404411) 
0.5µg/ml Phleomycin (InvivoGen ant-ph-2p) 
3µg/ml Hygromycin (InvivoGen ant-hm-1) 
 
2.6 Differentiation to procyclic forms 
Bloodstream stage trypanosomes were induced to differentiate to procyclic forms by 
the addition of 6mM cis-aconitate and a drop in temperature from 37C to 27C. 
Percentage differentiation of a population was measured by the percentage of EP 
positive cells as determined by flow cytometry (section 2.7).  
 
2.7 Flow cytometry  
2.7.1 Fixation of cells for flow cytometry  
All samples were processed in 5ml polystyrene round bottom tubes (BD Flacon 
352052). Approximately 1-5 x 10
6
 cells were centrifuged at 800g for 5 minutes at 
4°C. The supernatant was removed and cells were washed by filling the FACS tube 
with cold PBS and centrifuging at 800g for 5 minutes at 4°C. The supernatant was 
removed and 500µl of fixative (2% formaldehyde, 0.05% glutaraldehyde in PBS) 
was added. Cells were resuspended in the fix by lightly rapping the tube along a rack 
and left overnight at 4°C. After fixation, samples being analysed for differentiation to 




being analysed for expression of a fluorescent protein were washed twice in cold 
PBS to remove the fix and then resuspended in 500µl of PBS.   
 
2.7.2 EP procyclin antibody staining of cells for flow cytometry 
Control cells both positive and negative for EP Procyclin were stained concurrently 
with experimental samples. Cells were washed twice in cold PBS to remove the fix. 
Cells were then blocked in 200µl of blocking solution for 20 minutes at 4°C to 
prevent unspecific antibody binding. To remove the blocking solution the FACS 
tubes were filled with cold PBS and centrifuged at 800g for 5 minutes at 4°C. The 
supernatant was removed and cells were stained with 200µl of primary antibody for 
1 hour at 4°C. Cells were then washed once in cold PBS and 200ul of blocking 
solution was added and left for 20 minutes at 4°C. The blocking solution was 
removed as previously and cells were stained in 200µl of secondary antibody for 1 
hour at 4°C. Cells were washed twice in cold PBS and resuspended in 500µl of PBS.  
 
Blocking solution: 2% BSA in PBS 
Primary antibody:   Anti-EP-Procyclin (VH Bio Ltd CLP001A) diluted 1:500 in 
blocking solution 
Secondary antibody:  Anti-Mouse IgG (whole molecule)-FITC (Sigma F6275) 
diluted 1:500 in blocking solution. 
 
2.7.3 Analysis by flow cytometry 
Stained cells were analysed by flow cytometry using a Beckton Dickinson 
FACSCalibur machine with CellQuest Pro software. Positive and negative samples 
were used to determine the machine settings, often with the assistance of Martin 
Waterfall, University of Edinburgh. In all cases, 1-2 x 10
5 
cells/sample were 







2.8 Immunofluorescent analysis  
2.8.1 Preparing a microscope slide  
To prepare a slide from an in vitro liquid culture of trypanosomes, 1ml of 
logarithmically-growing cell culture was centrifuged at 4000g for 5 minutes. The 
supernatant was discarded, and the cells were resuspended in approx 30-40µl media. 
15µl of cells were added to each slide and spread carefully across the slide with the 
length of a 1ml pipette tip. The slides were allowed to air-dry before being fixed and 
stored in 100% methanol at -20C until required. 
 
To prepare a slide for immunofluorescence from an in vivo infection approximately 
5-10µl of tail blood (see section 2.3) is added to a slide. The blood is then spread 
across the slide with a second, clean, slide. The slides are allowed to air-dry before 
being fixed and stored in 100% methanol at -20C until required. 
 
2.8.2 Immunofluorescence 
Slides stored in methanol are re-hydrated in 1x PBS for 5 minutes. For chronic 
infections (Chapter 5) slides were stained for the infecting AnTat1.1 VSG. For this, 
100µl primary antibody (Rabbit Anti-AnTat1.1 VSG diluted 1/20,000 in 1x PBS) 
was added to each slide and placed in a humidity chamber for 45 minutes. Slides 
were then rinsed in 1x PBS for 3x 5 minutes before adding 100µl Anti-Rabbit IgG 
(whole molecule)-FITC (Sigma F0382) secondary antibody (diluted 1/50 in 1x PBS). 
After 45 minutes in a humidity chamber, the slides are again rinsed in 1x PBS for 3x 
5 minutes. To visualise the nucleus and kinetoplast, 50µl of 1ug/ml 4’,6-diamindino-
2-phenylindole (DAPI) was then added to each slide and incubated for 2 minutes in a 
humidity chamber and washed once in 1x PBS. A cover slip was mounted onto the 
slide with 40µl of Mowiol (Appendix A) with 1mg/ml p-Phenylenediamine (PDA) 
and left to set at 4C overnight in the dark. When staining for AnTat1.1 VSG was not 
required, slides were stained with DAPI alone. Slides were analysed on a Zeiss 




2.9 CAT Assays  
2.9.1 CAT sample preparation  
CAT protein expression was measured using a CAT ELISA kit (Roche 
11363727001) according to the manufacturer’s instructions. A precise cell count was 
taken immediately prior to sample preparation (section 2.2). Where appropriate, 
trypanosomes were growing logarithmically and at a concentration of 1-2 x 10
6
 
cells/ml. In some cases, due to experimental treatment (i.e. treatment with growth 
inhibiting drugs), this was not possible but samples were processed in the same 
manner.  
 
To prepare a sample, 1ml of trypanosome culture was centrifuged in a 1.5ml 
eppendorf tube at 4000g for 5 minutes. The supernatant was then removed and the 
cell pellet was washed 3 times in 1ml of cold 1x PBS, on each occasion the sample 
was centrifuged at 4000g for 5 minutes and the supernatant was removed. After the 
last wash the PBS was carefully removed before addition of 1ml of 1x Lysis buffer 
(provided in the CAT ELISA kit). Cells were resuspended in the lysis buffer by 
rapping the eppendorf tube along a tube rack and incubated for 25 minutes at room 
temperature. The sample was then centrifuged again at 4000g for 5 minutes to 
remove cell debris. The supernatant was divided into 2x 500µl into fresh eppendorf 
tubes and snap frozen in liquid nitrogen. The samples were then stored at -80°C until 
required.  
 
2.9.2 CAT ELISA 
All reagents were included in the CAT ELISA kit and working dilutions were 
prepared as per the manufacturers instructions. For each ELISA performed, a 
standard calibration curve ranging from approximately 91ng/ml to 2.8ng/ml 
(depending on batch) was prepared from a supplied stock of CAT enzyme. This was 
to ensure that all sample readings were within the linear range of the assay. Any 
samples which lay outside the linear range were diluted 1:10 or 1:100 as appropriate 









The ELISA was carried out in the supplied microplate wells which are pre-coated 
with an Anti-CAT antibody. To each well, 200µl of CAT standards or experimental 
sample (neat or diluted) were added and incubated at 37°C for 1 hour. Wells were 
then washed 5 times with 250µl of washing buffer. After removal of the last wash 
200µl of Anti-CAT-DIG was added to each well and incubated at 37°C for 1 hour.  
Wells were washed 5 times with 250µl of washing buffer. After removal of the last 
wash 200µl of Anti-DIG-POD was added to each well and incubated for 37°C for 1 
hour. Wells were then washed 5 times with 250µl of washing buffer. After removal 
of the last wash 200µl of POD substrate was added to each well and incubated at 
room temperature for 15-20 minutes to allow colour change (colourless to green) to 
develop. The absorbance of the samples was measured at 405nm using a BioTek 
ELx808 Absorbance Microplate Reader with Gen5 data analysis software.  
 
2.10  GUS Assay 
GUS enzyme activity was assayed via a colour change reaction which was quantified 
by an absorbance reading. 4-Methylumbelliferyl--D-glucopyranosiduronic acid 
(MUG) is used as a fluorescent substrate for the - glucuronidase (GUS) enzyme (as 
recommended by Prof. I. Roditi, University of Bern) where 50% v/v substrate/lysis 
solution is added to the trypanosome culture in 96-well plates and absorbance 
measured after 2 hours of incubation at 37C, with an excitation wavelength of 
355nm and emission wavelength of 460nm on a BioTek Flx800 Fluorescent 
Microplate Reader with Gen5 data analysis software. 
 
GUS substrate/lysis solution:  1mM MUG 
     0.82M Tris-HCl pH8 
     0.6% SDS 





2.11  Alamar blue assay 
Alamar Blue 
® 
(Serotec) is a chemical which changes colour in response to the redox 
potential of culture media and therefore can be used to measure cell growth. For the 
purpose of incorporating a measure of cell growth into the GUS assay described in 
section 2.10, Alamar Blue
® 
was used. For the assay 10% v/v Alamar Blue
® 
was 
added to cells that had been treated with drug for 44 hours in 96-well plates. Cells 
were incubated with the Alamar Blue
® 
for 4 hours and fluorescence was measured at 
540nm and 595nm on a BioTek ELx808 Absorbance Microplate Reader with Gen5 
data analysis software. Various controls were incuded in the assay, namely media 
only without Alamar Blue
®
, media plus Alamar Blue
®
 and untreated cells plus 
Alamar Blue
®
. The decrease in growth after drug treatment was then determined by 
the following calculation: 
 
% Growth =  (((Absorbance of treated cells at 450nm)-(Absorbance of treated cells 
at 595nm) x R0)/ ((Absorbance of untreated cells at 450nm)-
(Absorbance of untreated cells at 595nm) x R0)) x 100 
 
Where R0= ((Absorbance of media plus Alamar Blue
®
 at 450nm)-(Absorbance of 
media without Alamar Blue
®
 at 450nm))/ ((Absorbance of media plus 
Alamar Blue
®
 at 495nm)-(Absorbance of media without Alamar 
Blue
®
 at 495nm)) 
 
2.12  Quantitative RT-PCR from whole blood 
Before beginning bench surfaces and pipettes are cleaned with 70% ethanol and filter 
tips are used throughout. Care is taken at all points to avoid contamination by 






2.12.1 Sample preparation  
From an infected mouse, 10µl of whole blood was collected using a 10µl capillary 
tube (Camlab DMP010) and immediately transferred into 20µl Nucleic Acid 
Purification Lysis Solution (ABI 4305895) with 10µl 1x PBS, pre-chilled on ice. The 
solution was mixed by flicking the tube and was stored at -80C until required.  
 
For the purposes of production of a standard curve, the concentration of parasites in 
the blood was required to be known. In this case, slender or stumpy parasites were 
harvested and purified from a mouse infection (section 2.3). The cells were counted 
using a Beckman Z2 Coulter particle count and size analyser and a known number of 
cells were centrifuged at 800g for 10 minutes to pellet the cells. The parasites were 
then resuspended in a known volume of blood such that the final concentration of 
parasites per ml blood could be calculated. This blood was divided into 10µl aliquots 
added to 30µl lysis mix (see above) before being stored at -80C. These standard 
curve samples were processed in the same manner as experimental samples.  
 
2.12.2 RNA extraction from whole blood  
RNA was extracted using an ABI Prism 6100 Nucleic Acid PrepStation according to 
manufacturer’s instructions. The platform takes 96-well RNA purification trays (ABI 
4305673) to which the sample and appropriate washes are applied, and pulls the 
flow-through into the waste collection by applying a vacuum across the wells. A 
splashguard (ABI 4311758) was used in order to prevent contamination between 
wells. All RNA extractions were carried out using the ‘RNA Blood-DNA’ 
programme. For this, wells were pre-wet with 40µl of RNA Purification Wash 
Solution 1 (ABI 4305891) and then 40µl of lysate (section 2.12.1) was added to each 
well. An 80% vacuum was applied to the wells for 3 minutes. Wells were washed 
with 650µl of RNA Purification Wash Solution 1 and the wash was removed by 
applying an 80% vacuum to the wells for 3 minutes. Wells were then washed with 
650µl of RNA Purification Wash Solution 2 (ABI 4305890) and the wash was 




apply directly to the bottom of the well, 50µl of AbsoluteRNA Wash Solution (ABI 
4305545) was added to the wells and incubated for 15 minutes. The AbsoluteRNA 
Wash Solution contains a DNase which should remove genomic DNA from the 
sample. Due to the labile nature of DNase this was defrosted on ice with care taken 
not to destroy the DNase mechanically. Without removing the AbsoluteRNA Wash 
Solution, 400µl of RNA Purification Wash Solution 2 was added and this was 
incubated for 5 minutes before removal by applying an 80% vacuum to the wells for 
3 minutes. The well was washed twice more with RNA Purification Wash Solution 2, 
firstly with 650µl and then 400µl, each time removing the wash by applying an 80% 
vacuum to the wells for 3 minutes. A 90% pre-elution vacuum was applied for 5 
minutes to remove any remaining wash solution before moving the purification try 
from the waste collection position to the sample collection position. To elute the 
sample, 100µl of Nucleic Acid Purification Elution Solution was added to each well 
and a 20% vacuum was applied to the wells for 2 minutes. Samples were eluted into 
a MicroAmp Optical 96-well Reaction Plate (ABI 4306737), sealed with an adhesive 
film (ABI 4311971) and stored at -80°C until use.  
 
2.12.3 Treatment of RNA with TURBO DNase  
Despite the treatment of the RNA with a DNase during the extraction procedure 
(section 2.12.2), DNA contamination was still present in the RNA. Thus, an 
additional DNase treatment was added after RNA extraction using an Ambion 
TURBO DNA-free kit (Applied Biosystems AM1907) according to manufacturers’ 
instructions. A typical 50µl reaction is shown below.  
 
DNase reaction: 5µl 10X TURBO DNase Buffer 
44µl RNA (extracted as section 2.12.2) 
1µl TURBO DNase  
 
The reaction is mixed gently and incubated at 37C for 30 minutes before 
deactivating the DNase with 0.1 volume of DNase Inactivation Reagent (in this case, 




to disperse the DNase Inactivation Reagent. The sample is centrifuged at 4000g for 
1.5 minutes and the RNA is transferred to a fresh tube with care taken not to transfer 
any DNase Inactivation Reagent which may interfere with downstream reactions. 
The RNA is stored at -80C until use and care is taken to avoid repeated freeze thaw 
cycles.  
 
2.12.4 cDNA production  
cDNA is produced using the ABI High-Capacity cDNA Reverse Transcription kit 
(ABI 4368813) according to manufacturer’s instructions. A typical reaction is 
described below. This kit uses random primers to initiate cDNA production. The 
cDNA reaction uses a 2x master mix, however, as the RNA is treated with Turbo 
DNase the RNA must be diluted 1:2 in dH2O as the Turbo DNase buffer can inhibit 
the reverse transcriptase reaction at higher concentrations. A typical 20µl reaction is 
shown below.  
 
RT reaction:   10µl Turbo DNase-treated RNA (diluted 1:2 in dH2O)    
   2µl 10x RT Buffer 
   0.8µl 25x dNTP Mix (100mM) 
   2µl 10x RT Random Primers 
   1µl MultiScribe Reverse Transcriptase 
   3.2µl Nuclease-free dH2O (Promega P1195) 
 
Reaction Conditions: 25°C 10 minutes 
   37°C 120 minutes 
   
The reaction is carried out in 0.2ml PCR tubes (Axygen 321-10-051) in a Thermo 
Electron Corporation PCR SPRINT thermal cycler. Controls which replace the 
reverse transcriptase with dH2O are used to ensure that there is not any 





2.12.5 Quantitative RT-PCR  
Quantitative RT-PCR (qRT-PCR) was carried out on an ABI StepOnePlus RT-PCR 
machine to amplify either PAD1 or TbZFP3 mRNA. Reactions were carried out in 
25µl volumes, as detailed below. A melt curve was added to the end of each qRT-
PCR to ensure that there was only one amplification product. For TbZFP3, a standard 
curve was for absolute quantification of parasite number. For PAD1 the CT 
method of data analysis was used for relative quantification, using TbZFP3 as an 
internal control (for details see Chapter 5). The data was analysed using the ABI 
StepOne software version 2.  
 
PAD1 qRT-PCR Reaction: 12.5µl Power SYBR Green PCR Master Mix (ABI 
4367659) 
 0.75µl 10µM Primer 24 
 0.75µl 10µM Primer 25 
 4µl dH2O 
 7µl cDNA (section 2.12.4) diluted 1/10 
 
ZFP3 qRT-PCR Reaction: 12.5µl Power SYBR Green PCR Master Mix (ABI 
4367659) 
 2.25µl 10µM Primer 17 
 2.25µl 10µM Primer 19 
 1µl dH2O 
 7µl cDNA (section 2.12.4) diluted 1/10 
 
Reaction Conditions: 95C 10 minutes 
 40 x [95C for15 seconds, 60oC for 1 minute] 





2.13  Northern blot analysis 
Before beginning bench surfaces and pipettes were cleaned with 70% ethanol and 
filter tips are used throughout. All equipment that to come into contact with the RNA 
(flasks, gel tank, sandwich boxes etc) was washed with detergent, rinsed in dH2O, 
sprayed with 70% ethanol and allowed to air dry before use.   
 
2.13.1 RNA sample preparation  
To collect RNA samples, 25ml of logarithmically growing cell culture was 
centrifuged at 800g for 10 minutes. In some cases, the use of a logarithmically 
growing culture was not possible (after drug treatment) but the procedure remained 
the same. The pellet was resuspended in 600µl RLT buffer from a QIAGEN RNeasy 
Mini Kit (74106) supplemented with 10µl -mercaptoethanol/ml to lyse the cells. 
The lysate was then stored at -80C until processing. Upon thawing, the lysate was 
homogenised by vortexing at full speed for 1 minute. The RNA was then extracted 
using the “Purification of Total RNA from Animal Cells Using Spin Technology” 
protocol from the QIAGEN RNeasy Mini Kit, which uses an RNeasy spin column, 
according to manufacturers instructions. RNA was eluted into 40µl water. RNA was 
stored at -80C and care was taken to avoid repetitive freeze-thaw cycles and was 
always thawed on ice.  
 
2.13.2 Ribo-probe preparation  
The entire CAT ORF was cloned into the pGEM T easy vector (Promega A137A) by 
Dr Adam Mott, University of Edinburgh. Upon amplification of the CAT ORF from 
the vector, the amplicon contained T7 and SP6 polymerase binding sites. The 
amplicon was used to produce digitoxin (DIG) labelled single-stranded RNA that 
was anti-sense to the CAT mRNA transcript by a Roche DIG RNA labelling kit (11 
175 025 910) following manufacturers instructions. The DIG-labelling reaction was 





Ribo-probe reaction: 2µg template 
   4µl NTP Mix (from kit) 
   2µl 0.1M DTT  
   2µl 40U/µl RNasin RNase inhibitor (Promega N211A) 
   4µl Reaction buffer (from kit) 
 
The reaction mixture was incubated at 37C for 2 hours before the addition of 4µl 
DNaseI (from kit). The reaction was then incubated at 37C for 15 minutes in order 
to remove any DNA template. The reaction was terminated with the addition of 4µl 
200mM EDTA, pH8. To the reaction, 5µl 4M LiCl and 75µl ice cold 100% ethanol 
was added, mixed well and put at -80C overnight. The following day the solution 
was centrifuged at 12,000g for 15 minutes at 4C to pellet the RNA. The RNA pellet 
was then washed with 50µl 70% ice cold ethanol and centrifuged again. The 
supernatant was removed and the pellet was allowed to air dry for 10 minutes before 
being resuspended in 100µl of water containing 2µl 40µ/µl RNase inhibitor 
(Promega N211A). The probe was then stored at -80C.  
 
2.13.3 RNA agarose gel preparation 
To create a 1.2% agarose RNA gel in a total final volume of 150ml, 1.8g of agarose 
was dissolved by heating in 120ml of dH2O. Once dissolved, 15ml of 10x MOPS, 
10.5ml of dH2O and 4.5ml of 37% formaldehyde is added in a chemical fume hood. 
The gel is poured into a gel tray containing a 16-well gel comb with care taken to 
avoid bubbles. This is left to set in a chemical fume hood.  
 
To prepare the RNA for loading onto the gel, an equal quantity of RNA from each 
sample (0.2-2µg in a volume less than 6µl) is added to 9µl formamide, 3µl of 37% 
formaldehyde, 2µl of 10x MOPS and 2µl of RNA gel loading buffer. The sample is 
then heated to 65°C for 5 minutes in order to remove any secondary structure in the 




running buffer for 90 minutes. Where less than 16 wells are required, the centremost 
wells are used preferentially. To ensure an equal quantity of RNA has been loaded in 
each lane, the gel is stained with 20µl of 10mg/ml ethidium bromide in 200ml of 1x 
MOPS for 15 minutes with shaking. The gel is de-stained by washing at least twice, 
but often more, in dH2O for 30 minutes with shaking. The gel is then visualised and 
photographed using a Fotodyne Incorporated UV transilluminator. This allows 
visualisation of the ribosomal RNA within a sample, allowing identification of any 
lanes which have been under or over loaded. 
 
2.13.4 Assembling and dismantling the northern blot 
Northern blotting was performed using capillary transfer onto a positively charged 
nylon membrane. The blot was assembled as follows. A plastic tray was filled up to 
approximately 2cm of 10x SSC (Appendix A). A sandwich box was placed upside 
down in the tray. A gel tray the same size as that used to create the agarose gel was 
then placed upside down on the sandwich box. A piece of chromatography paper 
(Fisher CHR200) pre-wet in 10x SSC was placed over the gel tray and down into the 
10x SSC in the plastic tray to create a wick for buffer transfer. The agarose gel was 
then placed upside down onto the chromatography paper. Clingfilm was wrapped 
around the gel and over the plastic tray to prevent evaporation to the environment. A 
piece of positively charged nylon membrane (Roche 11 417 240 001) pre-wet in 10x 
SSC was placed on top of the gel and this was rolled flat using a 10ml plastic pipette 
to remove any bubbles between the gel and the membrane. The membrane was 
handled only using plastic tweezers throughout. Two pieces of chromatography 
paper, pre-wet in 2x SSC, are placed on top of the membrane and again rolled flat to 
remove any bubbles. On top of this, two inches of paper towels are placed, followed 
by a flat piece of plastic (for even weight distribution) and finally a heavy catalogue 
to act as the weight. The blot is left to transfer overnight. The next day, the blot is 
dismantled and the nylon membrane is allowed to dry. The RNA is UV cross linked 
to the membrane using a Stratalinker (0.120 joules, 254nm). The blot is then stored 
for up to one week at room temperature until hybridisation.  




2.13.5 Hybridisation of the blot 
Once wet, care is taken not to let any part of the membrane dry. The membrane is 
pre-hybridised in 10ml of pre-warmed hybridisation buffer in a hybridisation tube at 
68°C for 1 hour in a hybridisation oven (Techne Hybridiser HB-1D) with rotation. 
To 100µl of hybridisation buffer, 2µl of ribo-probe is added and this is heated at 
99°C for 5 minutes. The heated probe in buffer is added to 7ml of hybridisation 
buffer pre-warmed to 68°C. The pre-hybridisation buffer is removed and the probe in 
hybridisation buffer is added to the membrane. The membrane is then hybridised 
overnight at 68°C with rotation.  
 
2.13.6 Detection  
After an overnight hybridisation, the blot is washed at 68°C, twice in 100ml 2x SSC 
with 0.1% SDS for 30 minutes and then once in 100ml 0.5x SSC with 0.1% SDS for 
30 minutes. The membrane is removed from the hybridisation tube and all following 
steps are performed in sandwich boxes. The membrane is rinsed in 100ml of RNA 
wash buffer for 1 minute at room temperature. The membrane is then blocked in 
50ml Maleic Acid buffer with 1% DIG blocking reagent (Roche 11 096 176 001) for 
1 hour at room temperature with shaking. After pouring off the blocking solution, the 
membrane is then incubated in 50ml of Maleic Acid buffer with 1% DIG block and 
1.5U of Anti-DIG (Anti-Digoxigenin-AP Fab Fragments Roche 11 093 274 910) for 
30 minutes at room temperature with shaking. The membrane is then washed 3 times 
in RNA wash buffer for 10 minutes before being incubated in 50ml of RNA 
detection buffer for 2 minutes, both at room temperature.  
 
The membrane is placed in a sleeve of heat sealable polyethylene (known as Bag W) 
and 10µl of 25mM CDP-Star Chemiluminescence substrate (Roche 11 685 627 001) 
in 1ml of RNA detection buffer is applied evenly over the surface and left for 2 
minutes. The Bag W is closed over the membrane and excess CDP-Star is removed 
using paper towels to drive the solution out from between the sleeve of Bag W. The 
sleeve is sealed with a Hulme Martin Impulse heat sealer and incubated at 37°C for 




To visualise the blot by X-ray film, the membrane is placed in an X-ray cassette and 
taken to a dark room. Once in a dark room a Kodak blue sensitive autoradiography 
film (GRI) is placed in the cassette on top of the membrane and exposed for 5 
minutes initially. After 5 minutes the film is developed in a Compact X2 X-ray 
processor. Further films are exposed for either a longer or shorter duration depending 
on the result from the 5 minute exposure.  For quantification of northern blots, the 
membrane, instead of being exposed to film, is visualised by chemilumminescence 
on a Syngene Gbox with GeneSnap software using no light and no filter settings. 
mRNA levels are then normalised using the ethidium bromide staining of the 
ribosomal RNAs on the northern gel as a loading control for each sample. The 
quantification is carried out using GeneTools software.  
 
2.14  Bioinformatics, statistics and production of figures 
All graphs in this thesis were produced using GraphPad Prism 4 software. All 
statistics were carried out using either GraphPad Prism 4 or Minitab 15. At various 
points in this thesis a general linear model (GLM) was used to analyse the data. One 
of the assumptions of a GLM is that the data is normally distributed and this was 
always tested before proceeding to analysis. If data was not normally distributed, the 
data was transformed (for example, by logarithmic transformation) before analysis. 
In all cases, a p-value of less than 0.05 was considered to be significant (i.e. given 
the null hypothesis, the probability of observing the data is less than 5%).  
 
Immunofluorescent images were manipulated (addition of a scale bar, cropping of 
image and adjustment of contrast and brightness) using Photoshop software. DNA 
sequence analysis was carried out online at the Sequence Manipulation Suite 
(http://www.bioinformatics.org/sms/). Sequence alignments were performed using 
the Multalin software, publicly available online, using default parameters  
(http://multalin.toulouse.inra.fr/multalin/multalin.html) (Corpet, 1988). Alignment 
figures in this thesis were produced in JalView 2.4 (Clamp et al., 2004). Finally, for 
prediction of mRNA secondary structure the publicly available Sfold software was 




3 Chapter 3: Identification of regulatory regions that 





Gene expression in trypanosomes is controlled almost entirely post-transcriptionally, 
such that developmental changes in gene expression are controlled largely by mRNA 
abundance and translation. Genes that are up-regulated in stumpy forms must 
therefore be repressed during the slender life-stage and must escape translational 
repression during the stumpy life-stage. So far, regulatory signals controlling 
expression of a stumpy-specific transcript have not been identified, although 
bioinformatic analysis has revealed two motifs enriched in the 3’UTR of stumpy-
specific transcripts (Kabani et al., 2009). Although linear motifs clearly play an 
important role in the control of gene expression, RNA molecules are three 
dimensional molecules with potentially dynamic secondary structures (Clayton, 
2002). These structures can form regulatory signals, recognised by RNA binding 
proteins, and control gene expression (section 1.10). As such, it is unlikely that 
bioinformatic analysis alone will reveal the mechanisms of stumpy-specific gene 
regulation.    
 
PAD1 expression is up-regulated at both the mRNA and protein level in stumpy form 
cells compared to slender forms (Dean et al., 2009). As such, analysis of the control 
of expression of PAD1 may reveal mechanisms by which trypanosomes suppress 
expression of stumpy-specific transcripts during the slender stage of the life-cycle. 
Additionally, many transcripts are translationally repressed during the stumpy life-
stage, and understanding how PAD1 escapes this translational repression could 
inform understanding of stumpy-specific gene expression more generally.  
 
As we know that stumpy-specific regulation will require suppression of expression 
during the slender stage, here monomorphic slender reporter cell lines were used to 
identify regions in the PAD1 3’UTR that prevent expression in proliferative slender 







3.2 Sites of polyadenylation in the PAD1 3’UTR 
The intergenic region between the PAD1 gene and the downstream PAD2 gene is 
966nt long. In order to identify any regulatory regions in the PAD1 3’UTR it was 
first necessary to know the polyadenylation site. This defines the length of the 
mRNA and as such provides limits in which to study the 3’UTR.  
 
The polyadenylation sites of almost 6000 genes have recently been identified in 
slender and procyclic forms (Siegel et al., 2010). For PAD1, three polyadenylation 
sites were found in the procyclic forms, and none in slender forms, likely due to the 
lack of expression in this life-stage. In procyclic forms the three sites identified were 
at position 428nt, 572nt and 835nt (Siegel et al., 2010). As these polyadenylation 
sites were identified in procyclic forms rather than stumpy forms, and there may be 
stage-specific differences in choice of polyadenylation site (Clement and Koslowsky, 
2001; Erondu and Donelson, 1992), it was still necessary to confirm the sites used in 
stumpy forms. 
 
3.2.1 Identifying the PAD1 3’UTR polyadenylation site by BLAST 
Initially, to identify the PAD1 3’UTR polyadenylation site, a nucleotide BLAST 
search was carried out. The entire 966nt intergenic region between PAD1 and PAD 2 
was used to search in the “Non-human, non mouse ESTs” database on NCBI BLAST 
(http://www.ncbi.nlm.nih.gov/). The most significant alignment was a 273nt 
sequence (accession number W00184) from a Trypanosoma brucei rhodesiense 
cDNA library. This sequence aligned from position 437 to position 709 in the 
intergenic region downstream of PAD1 (Figure 3.1). This suggested that the PAD1 
3’UTR polyadenylation site is located at position 709. However, as bases 707-710 
are all adenine it was not possible to distinguish the exact polyadenylation site from 
these. As this is only a short fragment of sequence which does not include the PAD1 
ORF and did not contain a stretch of adenine residues indicative of a polyadenylation 






Figure 3.1 Alignment between the 966nt PAD1 to PAD2 intergenic region and a 273nt sequence 
from a Trypanosoma brucei rhodesiense cDNA library.  The intergenic region between PAD1 and 
PAD2 (Pad1-2/1-966) was used to carry out a nucleotide BLAST search. The closest matching 
sequence (EST/1-273) was a 273nt sequence (accession number W00184) from a Trypanosoma brucei 
rhodesiense cDNA library. Coloured nucleotides represent identity between the two sequences. This 






3.2.2 Identification of the PAD1 3’UTR polyadenylation sites by 
RT-PCR  
To map the PAD1 polyadenylation site experimentally, RT-PCR was carried out on 
stumpy form trypanosome RNA using the method and primers as described in 
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Figure 3.2 Mapping the PAD1 3’UTR polyadenylation site by RT-PCR. (A) A schematic diagram 
of the primers (shown as arrows) used to map the polyadenylation sites. An RT-PCR reaction was 
carried out using the ADAPT dT15 primer to produce cDNA. The ADAPT dT15 primer contains a 
unique sequence as denoted in red. A nested PCR reaction was carried out using the AUAP primer 
specific to the unique sequence in the ADAPT dT15 primer with primers specific for the targets. 
Diagram not drawn to scale. (B) Round 1 and round 2 PCR products resolved on an agarose gel 
stained with ethidium bromide and visualised using UV light. The prominent band from the round 2 
PCR was excised, purified, cloned into pGEM-T Easy and sequenced. Also shown are the negative 





A primer complementary to the polyA tail was used to make cDNA (Figure 3.2). 
This primer, ADAPT dT15, contains an additional unique sequence at the 5’end. The 
cDNA was then used as a template for a nested PCR. In the first round PCR, a primer 
complementary to the additional sequence in the ADAPT dT15 primer (AUAP) was 
coupled with a primer specific to the PAD1 mRNA (PAD PolyA Round 1). In the 
second round PCR, the AUAP primer was coupled to a second primer specific to the 
PAD1 or mRNA, but further downstream (PAD PolyA Round 2) (Figure 3.2A). The 
PCR products from both round 1 and round 2 were then resolved on an agarose gel 
(Figure 3.2). There was one prominent band, although a ‘smear’ of larger bands was 
also visible. The prominent band was excised and gel purified. The PCR product was 
then cloned into pGEM-T Easy and transformed into XL1 E.coli. Five colonies were 
selected, small scale DNA preparations were carried out and the DNA was 
sequenced. 
 
The PAD1 3’UTR polyadenylation site varied between clones (Figure 3.3). Position 
707-710 was confirmed as a polyadenylation site, however, a further site at position 
722-723 was also identified. From a combination of experimental and bioinformatic 
analysis it was possible to create a map of the polyadenylation sites (Figure 3.3). 
Given this map it was then possible to begin the study of the 3’UTRs to identify any 









Figure 3.3 A schematic map of the PAD1 3’UTR polyadenylation sites in stumpy form T.brucei. 
Sites mapped experimentally by RT-PCR in this analysis are shown by black dots. The site mapped by 
nucleotide BLAST analysis (section 3.2.1) is shown by a white dot. Genome-wide analysis in 
procyclic forms identified further polyadenylation sites at positions 428nt, 572nt and 835nt (not 






3.3 The PAD1 3’UTR does not contain known stumpy-
enriched sequence motifs 
Recent bioinformatic analyses comparing the 3’UTR of all predicted ORFs from 
chromosomes 1 and 2 with the predicted 3’UTR of transcripts enriched in stumpy 
forms, as determined by microarray analysis, have revealed two motifs enriched in 
the 3’UTR of stumpy-specific transcripts (Kabani et al., 2009). Stumpy motif 1 and 
stumpy motif 2 (SM1 and SM2) are hexanucleotide sequences (TCTTAC and 
TTCTTA respectively) with SM1 displaying positional bias, in that it is most often 
found 150-200nt downstream of the stop codon (Kabani et al., 2009). Upon analysis 
of the sequence of the PAD1 3’UTR neither SM1 nor SM2 was found to be present.  
 
3.4 Creation of reporter constructs for the functional 
analysis of the PAD1 3’UTR 
In order to functionally analyse the PAD1 3’UTR, a series of reporter cell lines were 
created. The full length 3’UTR, as well as sequential deletions, were coupled to the 
chloramphenicol acetyl transferase (CAT) reporter gene and transfected into 
monomorphic BSF trypanosomes. As PAD1 is not expressed in slender forms the 
reporter gene should also not be expressed in monomorphs. If the lack of expression 
is due to negatively acting elements repressing gene expression in slender forms, 
then as sections of the 3’UTR are deleted, the negative elements should be deleted. 
Hence, as negative elements are deleted it would be expected that there would be 
alleviation of repression of expression causing reporter gene expression to increase.  
 
Reporter constructs were based on the T.brucei CAT449 expression vector (Figure 
3.4) (Mayho et al., 2006). In this plasmid, the CAT gene was coupled to the full 
length aldolase 5’UTR and a truncated aldolase 3’UTR providing constitutive CAT 
protein expression. The construct contains a phleomycin resistance gene under the 
control of the actin 5’ and 3’UTRs and was therefore also constitutively expressed. 
The CAT449 plasmid, when digested with NotI, integrates into the -tubulin locus of 




transcribed by PolII read-through transcription so that the reporter gene is processed 





Figure 3.4 Schematic diagram of the CAT449 reporter construct.  In the CAT449 expression 
vector, the CAT reporter gene has an aldolase 5’UTR (Ald 5’UTR) and a truncated aldolase 3’UTR 
(Ald 3’UTR) providing constitutive expression in T.brucei. The construct contains a phleomycin 
resistance gene (BLE
R
) with the actin 5’ and 3’UTRs providing constitutive expression. The construct 
contains a -tubulin intergenic region targeting sequence (-tubulin IGR TS); when the plasmid is 
linearised with NotI the plasmid can integrate into the -tubulin locus. Diagram is not to scale. Figure 
modified from Mayho et al., 2006.  
 
The truncated aldolase 3’UTR can be excised from the CAT449 construct using 
BamHI and BbsI restriction enzymes which cut at the 5’ and 3’ of the UTR 
respectively (Figure 3.4). The BbsI enzyme cuts outside of the recognition sequence 
and so creates a 5’ overhang dependent on the upstream sequence. To insert the 
PAD1 3’UTR into the construct, primers were designed to the 3’UTR sequences such 
that the 5’ primer contained a BamHI site complementary to that in the vector. The 
PAD1 3’UTR contains a BbsI restriction site and thus it was not possible to use a 
BbsI site to insert the 3’UTR at the 3’ end. Therefore, the 3’ primer instead contained 
a BsmAI site which, like BbsI, cuts outside the recognition sequence. Hence, it was 
necessary to include a short sequence into the 3’ primer to create a complementary 





















































Figure 3.5 The PAD1 3’UTR was integrated into the CAT449 construct using BamHI and 
BsmAI restriction enzymes.  (A) The CAT449 vector is digested with BamHI, which recognises and 
cuts within the sequence GGATCC (shown in bold type), and with BbsI, which recognises the 
sequence GTCTTC (shown in bold type) and cuts upstream of this sequence. The resulting products 
are shown. (B) The PAD1 3’UTR is amplified from genomic DNA using primers which contain a 
BamHI site at the 5’end (shown in bold) and a BsmAI recognition site, GTCTC (shown in bold). The 
BsmAI enzyme cuts downstream of the recognition sequence. The resulting product from a digestion 
with BamHI and BsmAI is shown. (C) The resulting product of a ligation with the CAT449 vector 
(digested with BamHI and BbsI) and the PAD1 3’UTR (digested with BamHI and BsmAI). Only the 
regions of interest are shown here. A full diagram of the CAT449 vector is shown in Figure 3.3. 
Arrowheads indicate cleavage sites for restriction enzymes. Red bases represent the CAT449 vector 
and blue bases represent the PAD1 3’UTR insert. 
 
It was necessary to include additional sequence 3’ of the polyadenylation site in 
order to ensure correct processing of the polyadenylation site (Matthews et al., 
1994); therefore, for the full length PAD1 3’UTR, the entire 966nt intergenic region 




made at intervals along the 3’UTR from the 5’ end to allow for correct processing of 






Figure 3.6 A schematic diagram of the CAT449 PAD1 3’UTR deletion constructs. To create the 
CAT449 PAD1 5’UTR construct from the CAT449 original construct, the aldolase 5’UTR was 
excised and replaced by the PAD1 5’UTR using XhoI and HindIII. To create the CAT449 PAD1 
3’UTR deletion constructs for the CAT449 original construct the truncated aldolase 3’UTR was 
excised using BamHI and BbsI. This was replaced with either the full length PAD1 3’UTR or a 
truncated form created by amplifying the 3’UTR using a series of primers which progressively deleted 
regions from the 5’ end. All 5’ primers contained a BamHI site and the 3’ primer contained a BsmAI 
site with a complementary sequence to that created by the BbsI digestion in the CAT449 construct 
(Figure 3.5). The ‘A’ in the PAD1 3’UTR depicts the 707-710nt and 722-723nt polyadenylation sites. 






In order to confirm that it is the 3’UTR and not the 5’UTR that is responsible for 
PAD1 stumpy-specific expression, the 5’UTR was also integrated into the CAT449 
vector. The aldolase 5’UTR was excised via XhoI and HindIII restriction sites 
(Figure 3.4). To introduce the PAD1 5’UTR, XhoI and HindIII sites were added to 5’ 
and 3’ primers, respectively, designed to amplify the 582nt upstream of the PAD1 
start codon (Figure 3.6). It was expected that if the 3’UTR of PAD1 was indeed 
controlling stage-specific gene expression then the 5’UTR would not cause 
repression of expression in monomorphs.  
 
Once created, constructs were transformed into XL1 E.coli and a small scale 
preparation of each of the plasmids was isolated. The plasmids were sequenced over 
the regions of interest to ensure the UTR sequences had inserted correctly and then 
larger-scale midi-prep DNA was prepared. Plasmids were linearised with NotI and 
transfected into T.brucei 427 by electroporation. After 24 hours, transfectants were 
selected in 2ml selective media in 24-well plates with 0.5µg/ml phleomycin. 
Addition of the phleomycin caused cell death of non-transformed cells in 2-3 days. 
After 5-7 days, wells containing proliferating cells were considered as positive 
transfectants. Two clones were selected for each cell line and grown in 5ml selective 
media in 6-well plates, then in 10ml selective media in 25cm
2 
tissue culture flasks. 
Cell lines were stored at -80C and in liquid nitrogen. All cell lines made for the 















Construct Description of 3'UTR coupled to CAT reporter gene 
CAT449 Original Truncated aldolase 3'UTR 
  
PAD1 5'UTR Truncated aldolase 3'UTR 
 Note: aldolase 5'UTR replaced with PAD1 5'UTR 
  
Full PAD1 3'UTR Entire 966nt intergenic region between PAD1 and PAD2 
  
PAD1 3'UTR 1-21 Nucleotides 1-21 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-145 Nucleotides 1-145 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-207 Nucleotides 1-207 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-265 Nucleotides 1-265 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-354 Nucleotides 1-354 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-391 Nucleotides 1-391 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-502 Nucleotides 1-502 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-609 Nucleotides 1-609 deleted from 'Full PAD1 3'UTR' 
PAD1 3'UTR 1-776 Nucleotides 1-776 deleted from 'Full PAD1 3'UTR' 
  
PAD1 3'UTR 386-564 Nucleotides 386-564 deleted from 'Full PAD1 3'UTR' 
 and replaced by a HindIII restriction site 
PAD1 3'UTR 354-624 Nucleotides 354-624 deleted from 'Full PAD1 3'UTR' 
 and replaced by an XhoI restriction site 
  
354-624 PAD1 3'UTR Nucleotides 354-624 of PAD1 3'UTR inserted upstream  
  of the truncated aldolase 3'UTR in 'CAT449 Original' 
 
Table 3.1 All constructs created for PAD1 3’UTR functional analysis. All constructs were based 
on the CAT449 expression vector (Figure 3.4), labelled here as CAT449 Original. For the PAD1 
3’UTR 386-564 and 354-624 constructs the deleted region was replaced by a restriction site 
(section 3.8). For the 354-624 PAD1 3’UTR construct the 354-624nt region of the PAD1 3’UTR was 
PCR amplified with primers containing HindIII sites at both the 5’ and 3’end. The section was then 
inserted into the 5’end of the truncated aldolase 3’UTR at the HindIII site present between the CAT 
reporter gene and this UTR (Figure 3.4). All constructs were sequenced to ensure correct insertion. 
With the exception of the PAD1 5’UTR construct, the 5’UTR upstream of the CAT reporter gene was 





3.5 The PAD1 3’UTR controls reporter gene mRNA 
abundance in slender forms 
Once the CAT449 PAD1 3’UTR cell lines were produced (section 3.4), two 
independent clones from each cell line were analysed for CAT mRNA expression. 
Northern blots were prepared for the two clones of each cell line. A representative 
northern blot analysed by X-ray film is shown in Figure 3.7A and quantification of 
two northern blots (one from each clone) analysed by luminescence is shown in 
Figure 3.7B.  
 
First, the data demonstrated that the CAT449 original construct did provide 
constitutive CAT mRNA expression as expected (Figure 3.7). Furthermore, the 
replacement of the aldolase 5’UTR with the PAD1 5’UTR caused a 1.6 fold increase 
in mRNA abundance (Figure 3.7), thus demonstrating that the PAD1 5’UTR was not 
responsible for repression of expression in slender forms.  
  
The replacement of the truncated aldolase 3’UTR in the CAT449 original construct 
with the PAD1 3’UTR caused an approximately 3.7-fold decrease in CAT mRNA 
abundance (Figure 3.7 lane 3). Hence, the PAD1 3’UTR was sufficient for repression 
of mRNA abundance in monomorphic slender forms. This was later confirmed to be 
the case in pleomorphic reporter cell lines, where a reporter gene coupled to the 
PAD1 3’UTR exhibited low mRNA abundance in slender forms and high mRNA 
abundance in stumpy forms (Chapter 4).  
 
Progressive deletions into the PAD1 3’UTR from the 5’ end initially caused very 
little effect on mRNA abundance, indicating that first 207nt of the PAD1 3’UTR was 
not necessary for repression of expression in slender forms (Figure 3.7 lanes 3-6). 
Further deletions however, caused gradual alleviation of repression of expression 
with deletion of 1-502nt of the PAD1 3’UTR causing an approximately 8.1-fold 
increase in reporter mRNA abundance compared to the full length construct (Figure 
3.7 lane 10).  Hence, the latter section of the PAD1 3’UTR appeared to contain a 











































Figure 3.7 CAT mRNA abundance increases with sequential deletion of the PAD1 3’UTR. (A) A 
representative northern blot of the CAT449 PAD1 3’UTR deletion series shows that CAT mRNA 
abundance down-regulated by the PAD1 3’UTR compared to the CAT449 original construct. This 
repression of mRNA expression is alleviated with progressive deletions. Upper bands are processing 
intermediates, often observed when using the CAT449 construct (Mayho et al., 2006). (B) 
Quantification of the mRNA abundance in two independent clones for each cell line shows that the 
full length PAD1 3’UTR causes an almost 4-fold decrease in mRNA abundance compared to the 




The final PAD1 3’UTR deletion construct (1-776nt) removed the polyadenylation 
sites mapped experimentally in section 3.2.2. Indeed, by northern blot analysis, it 
was observed that the progressive deletions of the full length PAD1 3’UTR caused 
progressive decreases in transcript size until the PAD1 3’UTR 1-776 construct, 
where there was a size increase compared to the previous deletion (Figure 3.7A lane 
12). It is likely that with the loss of the preferred polyadenylation site, an alternate 
location is used. This indicated that the polyadenylation sites mapped in stumpy 
forms (section 3.2.2) are also the polyadenylation sites used in monomorphic slender 
forms. The sites mapped by Siegel and colleagues in procyclic forms, at positions 
428, 572 and 835nt (Siegel et al., 2010) are not major sites of polyadenylation in 
these cell lines, as the associated changes in transcript size that would be expected 
are not observed by northern blot analysis (Figure 3.7A).  
 
3.6 The PAD1 3’UTR controls reporter gene protein 
expression in slender forms 
The preceding section demonstrated that the PAD1 3’UTR caused repression of 
reporter mRNA abundance in slender forms. To assess regulation at the protein level, 
the level of CAT protein expression was measured in the CAT449 PAD1 3’UTR cell 
lines. In all cases, two independent clones were analysed for each cell line, with each 
clone tested in at least two CAT ELISAs and the results were consistent between 
clones (Figure 3.8).  
 
As expected, the CAT449 original construct provided good levels of CAT protein 
expression (Figure 3.8). Replacement of the aldolase 5’UTR with the PAD1 5’UTR 
caused an approximately 1.6-fold increase in CAT protein expression (Figure 3.8) 
precisely correlating with the 1.6-fold increase in mRNA abundance observed in 
section 3.5. Hence, it appears that the role of the PAD1 5’UTR in controlling gene 
expression in this context is probably entirely controlled at the level of mRNA 
abundance and has no discernable effect on translation efficiency. There is, 
alternatively, the possibility that, as the levels of expression are compared relative to 




compared to the mRNA are masked by equivalent difference in the CAT449 
construct. It seems that this would be rather unlikely given such a close correlation 
between relative mRNA and protein expression yet cannot be ruled out. The high 
levels of protein expression in the PAD1 5’UTR cell line reveals, again, that the 
PAD1 5’UTR is not responsible for repression of expression in slender forms.  
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Figure 3.8 CAT protein increases with sequential deletion of the PAD1 3’UTR.  Analysis of the 
level of CAT protein expression relative to the CAT449 original construct shows that CAT protein 
expression is down-regulated by the PAD1 3’UTR to a greater degree than that observed at the mRNA 
level. This repression of protein expression is alleviated with progressive deletions, particularly at the 






In contrast, CAT protein was almost undetectable when the truncated aldolase 
3’UTR of the original CAT449 construct was replaced by the full-length PAD1 
3’UTR (Figure 3.8). There was almost a 4-fold decrease in mRNA expression but an 
almost 180-fold decrease in protein expression, in the PAD1 3’UTR construct 
compared to the CAT449 construct. This demonstrates that the PAD1 3’UTR is 
repressed at both the level of mRNA abundance (section 3.5) and protein expression.  
 
Deletion of the first 207nt of the PAD1 3’UTR had been demonstrated to have no 
effect on the mRNA levels compared to the full length UTR (section 3.5). Likewise, 
deletion of these bases caused no discernable effect on reporter protein expression 
compared to the full length PAD1 3’UTR (Figure 3.8). Hence, it appears that the first 
207nt is not necessary for repression of mRNA abundance or protein expression in 
slender forms. Further deletions did cause alleviation of repression of expression, 
however (Figure 3.8). Deletion of 1-354nt, although showing alleviation of 
repression of expression compared to the full length transcript, still demonstrated a 
low level of CAT protein expression compared to the CAT49 original construct. It 
may be that deletion of sections of the UTR not directly involved in repression of 
expression cause disruption of the secondary structure of other parts of the molecule 
(section 3.7). In the case of the PAD1 3’UTR 1-265 and 1-354 constructs, the 
small rise in CAT protein expression may, speculatively, represent a small disruption 
in the folding of the downstream region of the UTR which reduces the efficiency of 
binding to an RNA binding protein, for instance.   
 
Deletion beyond 354nt caused a large rise in CAT protein expression, up to over a 
300-fold increase in protein expression in the PAD1 3’UTR 1-609nt construct 
compared to the full length UTR, suggesting that there was specific deletion of some 
element causing repression of protein expression in slender forms (Figure 3.8). Thus, 
the PAD1 3’UTR contains one or more slender form repression elements at the distal 
end of the 3’UTR which cause repressed mRNA abundance and repressed protein 
expression. It is also worth noting that the PAD1 coding sequence is clearly not 
necessary for stumpy-specific gene expression, although this does not exclude a 




3.7 The secondary structure of the PAD1 3’UTR 
In trypanosomes it is often the 3’UTR of a gene that is responsible for the control of 
expression via the action of regulatory RNA binding proteins. These proteins 
recognise and bind to the three-dimensional RNA molecule and can either promote 
or repress expression (section 1.10). Although linear regulatory motifs have been 
identified, any interaction will be dependent on the structure of the RNA molecule; 
even linear motifs can fold into specific loops (Mayho et al., 2006) that may dictate 
association with the RNA binding protein.  
 
The secondary structure of an RNA molecule can be predicted using algorithms, such 
as Sfold and Mfold, that are publicly available online (http://sfold.wadsworth.org and 
http://mfold.bioinfo.rpi.edu/ respectively) (Ding et al., 2005; Ding and Lawrence, 
2003; Mathews et al., 1999; Zuker, 2003). Mfold predicts secondary structure based 
on minimising the free energy of a particular mRNA, such that the molecule folds 
into the lowest possible energy state (Mathews et al., 1999; Zuker, 2003). In contrast, 
Sfold predicts a sample of 1000 possible secondary structures, within which, 
structural features will recur (Ding and Lawrence, 2003). The resulting optimum 
predicted structure, known as the ensemble centroid, is the structure which is the 
most similar to all the other predicted structures (Ding et al., 2005). For the analysis 
described here, the Sfold program was utilised as it was demonstrated to be less 
prone to error (Ding et al., 2005). Although such algorithms provide models of the 
potential structure into which an RNA molecule may fold, these are still very much 
predictions. However, they do provide a framework for directing further 




































Figure 3.9 Structural features of the PAD1 3’UTR as predicted by Sfold. (A) The predicted 
secondary structure of the full length PAD1 3’UTR using position 710nt as the polyadenylation site. 
The nucleotide positions indicated correlate with the position of the deletions made in the PAD1 
3’UTR deletion series produced in section 3.4. (B) There are various stem-loops and bulges in the 
PAD1 3’UTR, some of which have been indicated by numbered boxes. This is not an exhaustive 





Using Sfold analysis (http://sfold.wadsworth.org) (Ding et al., 2005; Ding and 
Lawrence, 2003), the secondary structure of the PAD1 3’UTR was predicted (Figure 
3.9A), using position 710nt as the polyadenylation site (see section 3.2). The PAD1 
3’UTR is fairly long, compared to the median 3’UTR length in trypanosomes of 
400nt (Siegel et al., 2010), and has various potential structural features, which may 
or may not have a functional relevance. Some of these potential features have been 
highlighted in Figure 3.9B. It appears that the secondary structure clusters into either 
the proximal (structures I and II) or distal (structures IV-VII) end of the molecule 
spatially separated by a ‘linker’ region (containing element III). 
 
In order to determine if any of the potential structural features of the 3’UTR can be 
implicated in the stumpy-specific expression of PAD1, the predicted secondary 
structure of each of the deletion constructs was produced (Appendix B). As the 1-
776nt deletion construct deletes beyond the polyadenylation site it was not 
considered in this analysis. Table 3.2 indicates both the sequences and potential 
structures that are disrupted in each deletion. With the aim of identifying potentially 
important structures in the control of stumpy-specific gene expression, the presence 
or absence of structures was compared to CAT protein expression in the various cell 
lines. 
 
Alleviation of repression of CAT protein expression in slender forms was first seen 
to some degree in deletion 1-354nt and more so with, 1-391nt (Figure 3.8). This 
correlates with the loss of structures IVb and V (Table 3.2). The most marked 
increase in CAT protein expression was with deletions 1-502nt and 1-609nt (Figure 
3.8) which correlate with the additional loss of structures VI and VIIa (Table 3.2). 
These structures, IVb-VIIa, are clustered at the distal end of the predicted secondary 
structure (Figure 3.9). Evidently this region of the molecule plays a role in repression 
of expression in slender forms. It may not be any one of these structures in particular 
that are involved in stumpy-specific gene expression, but rather the configuration of 







Table 3.2 The features predicted to be present or absent in the PAD1 3’UTR deletion series.  The 
presence (white squares) or absence (dark grey squares) of the sequence (Seq) and secondary structure 
(Str) of each of the structural features highlighted in Figure 3.9B, in each of the 3’UTR deletions, are 
indicated. For four of the deletion constructs structure VIIb was still present but in a somewhat 
disrupted form (see Appendix B) and this is indicated by light grey squares in the table.  
 
3.8 Internal deletions of the PAD1 3’UTR  
From the experimental and structural analysis of the PAD1 3’UTR deletion series, it 
appeared that the distal region of the mRNA plays a role in stumpy-specific gene 
expression. However, in the initial analysis the deletions created were from the 5’ 
end of the molecule, such that a large portion of the 3’UTR had been deleted before 
alleviation of repression was observed. As such, it was not clear if deletion of this 
region alone would be adequate for the loss of repression in slender forms. To further 















Figure 3.10 Strategy for the production of internal deletion constructs of the PAD1 3’UTR.  The 
full length PAD1 3’UTR (grey box) is amplified in two halves, without the section to be deleted 
(hatched box); with primers containing restriction enzyme sites (RE denotes either HindIII or XhoI 
restriction sites). These sections can then be digested and joined by ligation before being integrated 
into the CAT449 vector (as section 3.4) using the BamHI and BsmAI restriction sites.  
 
Two deletion constructs were made which delete the 386-564nt and 354-624nt 
internal sections of the PAD1 3’UTR (Table 3.1). This was achieved by amplifying 
the remaining sections of the 3’UTR independently with the introduction of a 
restriction site in order that the two sections could then be digested and joined by 
ligation (Figure 3.10). These inserts were then introduced into the CAT449 
expression vector as for the previous inserts (section 3.4). The constructs were 
designed so as to only minimally disrupt the remainder of the mRNA structure, as 
predicted by Sfold (Figure 3.11). Indeed, structures I and II at the proximal end of 
the molecule, as well as structure III in the ‘linker’ region, remain intact in both 





























Figure 3.11 Predicted structures of the PAD1 3’UTR internal deletions. The predicted secondary 
structure of (A) the full length PAD1 3’UTR compared to the 386-564nt internal PAD1 3’UTR 
deletion and (B) the full length PAD1 3’UTR compared to the 354-624nt internal PAD1 3’UTR 
deletion using position 710nt as the polyadenylation site. Boxes on full length structures indicate the 
structures that are deleted. Boxes on deletion constructs indicate approximate location of deleted 





Two clones per construct were created and the level of CAT mRNA and protein was 
determined (Figure 3.12). The PAD1 3’UTR 386-564 construct had no discernable 
effect on the level of CAT mRNA or protein levels compared to the full length PAD1 
3’UTR, with no alleviation of repression observed. This demonstrated that loss of the 
386-564nt region of the PAD1 3’UTR was not sufficient for alleviation of repression 
of expression in monomorphic slender forms and hence this region is not necessary 
for repression of expression.  
 
On the contrary, the PAD1 3’UTR 354-624 construct demonstrated an 
approximately 2-fold increase in CAT mRNA abundance compared to the full length 
PAD1 3’UTR (Figure 3.12A and B) but still remains below the level of mRNA 
abundance in the CAT449 original construct and therefore does not alleviate 
repression of mRNA abundance to the same degree as was observed for the deletions 
made from the 5’ end of the molecule (compare with the alleviation of mRNA 
repression observed in Figure 3.7). Additionally, the PAD1 3’UTR 354-624 
construct caused no difference in CAT protein expression compared to the full length 
PAD1 3’UTR (Figure 3.12C). This suggested that the 354-624nt region of the PAD1 
3’UTR was not necessary for the repression of expression in monomorphic slender 
cells. The partial alleviation of repression of mRNA abundance may indicate that 
part of this region is responsible, at least to an extent, for PAD1 mRNA abundance. 
Alternatively, it may be that deletion of this region is not at all sufficient for 
alleviation of repression, and some more proximal region is acting as a dominant 
control region at the level of both mRNA abundance and protein expression. The 
alleviation of repression of mRNA abundance in the PAD1 3’UTR 354-624 may in 
this case simply represent some disruption to the remainder of the molecule rather 


































































































Figure 3.12 Repression of CAT protein expression is not alleviated when internal elements of the 
PAD1 3’UTR are deleted, but there is some effect on CAT mRNA.  (A) A representative northern 
blot of one clone per construct is shown. (B) Quantification of the mRNA abundance in two 
independent clones for each cell line. As previously observed (Figure 3.7) the full length PAD1 
3’UTR causes repression of mRNA abundance compared to the CAT449 original construct. The 
PAD1 3’UTR 387-564 construct causes no change in the level of mRNA abundance compared to the 
full length construct demonstrating that the 387-564nt region of the molecule is not necessary for 
repression of mRNA abundance. Deletion of the 354-624nt region of the PAD1 3’UTR did cause 
some alleviation of repression of mRNA abundance. (C) Neither the PAD1 3’UTR 387-564 nor the 
PAD1 3’UTR 354-624 construct caused alleviation of repression of CAT protein expression in 






3.9 Section 354-624nt of the PAD1 3’UTR can act 
independently to repress reporter gene expression 
It had been demonstrated that the loss of the 354-624nt region of the PAD1 3’UTR 
had not been sufficient to cause complete alleviation of repression of reporter gene 
mRNA abundance or any alleviation of repression of reporter protein expression 
(section 3.8). However, in sections 3.5 and 3.6, it was demonstrated that deletion up 
to position 354 of the PAD1 3’UTR had also not been sufficient for complete 
alleviation of reporter gene expression, with full alleviation of repression not 
observed until deletions beyond this position (Figure 3.7 and Figure 3.8). This 
indicated that there were at least two, complementary, elements in the PAD1 3’UTR 
responsible for stumpy-specific gene expression and deletion of either alone was not 
sufficient for full alleviation of repression of expression. If the 354-624nt region of 
the PAD1 3’UTR did indeed contain one of two (or more) stumpy-specific control 
regions, then insertion of this region alone into another 3’UTR should cause at least 
some repression of expression in slender forms.  
 
In order to investigate this, the 354-624nt region was inserted into the truncated 
aldolase 3’UTR of the CAT449 original construct (Table 3.1). In the CAT449 
construct, there is a HindIII restriction site between the CAT reporter gene and the 
truncated aldolase 3’UTR (Figure 3.4). The 354-624nt region of the PAD1 3’UTR 
was therefore amplified using primers with the addition of HindIII restriction sites at 
both the 5’ and 3’ ends. The amplicon was then digested with HindIII and ligated 
into the CAT449 construct which had also been digested with HindIII. To ensure that 
only one copy of the 354-624nt region has inserted into the construct, and that this 
section was in the correct orientation, the region was sequenced before use.  
 
Two clones containing this construct were created and were analysed for CAT 
mRNA and protein expression (Figure 3.13). Firstly, by northern blot it can be 
observed that the insertion of the 354-624nt region of the PAD1 3’UTR into the 
truncated aldolase 3’UTR of the CAT449 original construct caused a size-shift of the 
processed mRNA (Figure 3.13A) indicating that the normal aldolase polyadenylation 




mRNA abundance in slender forms compared to the CAT449 original construct 
where mRNA (Figure 3.13A and B). This repression, was not however, to the same 
extent as the full length PAD1 3’UTR where much greater repression is observed 
(Figure 3.13A and B). The same is true for CAT protein expression, where the insert 
causes 3-fold, but not complete, repression of protein expression. This suggests, that 
either the 354-624nt region is not sufficient for complete repression of gene 
expression in slender forms or that the region is unable to fold correctly out of 
context of the remainder of the PAD1 3’UTR or in the presence of the truncated 
aldolase 3’UTR. The ability of the element to cause some repression of both mRNA 
and protein expression, however, suggests that the element is able to fold into a 
somewhat functional conformation, suggesting incorrect folding may not be 
completely responsible for the incomplete repression. These data, along with the 
observation that deletion of this region in the context of the full length PAD1 3’UTR 
was not sufficient to cause alleviation of repression indicates that there is some other 
element in the 3’UTR controlling stumpy-specific gene expression, yet this region 
does contribute.  
 
It would be of interest to create a further cell line where an unrelated sequence, of a 
similar size, is inserted into the truncated aldolase 3’UTR in the CAT449 construct 
in order to ensure that the repression of expression observed here was not a non-
specific effect whereby the presence of an additional sequence is interfering with 
















































































































Figure 3.13 Insertion of the 354-624nt region of the PAD1 3’UTR into the truncated aldolase 
3’UTR in CAT449 causes some repression of expression in slender forms.  (A) A representative 
northern blot of one clone per construct is shown. (B) Quantification of the mRNA abundance in two 
independent clones for each cell line. As previously observed (Figure 3.7) the full length PAD1 
3’UTR causes repression of mRNA abundance compared to the CAT449 original construct. Insertion 
of the 354-624nt region into the truncated aldolase 3’UTR of the CAT449 construct caused a decrease 
in the level of mRNA abundance compared to the CAT449 original construct but not to the same 
extent as the full length PAD1 3’UTR demonstrating that the 354-624nt region of the molecule does 
contribute to repression of mRNA abundance. (C) Insertion of the 354-624nt region into the truncated 
aldolase 3’UTR of the CAT449 construct caused a decrease in CAT protein expression compared to 





3.10  Treatment of the PAD1 3’UTR reporter cell lines with a 
stumpy-inducing compound 
It had been established that the PAD1 3’UTR causes repression of expression in 
slender forms. However, during the slender to stumpy transition the repression of 
expression must be relieved such that the PAD1 is expressed during the stumpy-life 
stage. There are numerous possibilities for how this may occur. It may be that the 
trans-acting factors responsible for repression in slender forms are stage-specific and 
therefore absent in stumpy forms. Otherwise they may associate with different 
proteins and machinery such that they promote rather than repress expression in the 
stumpy life stage. Instead, a stumpy-specific RNA-binding protein could potentially 
out-compete a slender-specific protein for the same region of the 3’UTR. Or 
alternatively, it may be that cis-acting signals other than the slender repression 
element are responsible for the promotion of expression in stumpy forms. Of course, 
it could be that a combination of these suggestions act together to provide the 
developmental regulation of gene expression observed for PAD1. 
 
A deletion series of the PAD1 3’UTR had been created in monomorphic slender cells 
(section 3.4). With the large number of transfections required to create the number of 
cell lines in Table 3.1, it was not practical to create the deletion series in a 
pleomorphic cell line given the low transfection efficiency of the pleomorphic cell 
lines available. Therefore in order to examine reporter gene expression in stumpy 
forms, the monomorphic cell lines were induced to differentiate to ‘stumpy-like’ 
forms by the use of the hydrolysable analog of cAMP, 8pCPT-2’-O-Me-cAMP. This 
drug has been reported to cause ‘stumpy-like’ formation in monomorphic cell lines 
(Laxman et al., 2006) and is analysed in Chapter 4 of this thesis. It is worth noting at 
this point that although 8pCPT-2’-O-Me-cAMP causes some of the changes 
associated with stumpy formation it does not appear to create ‘true’ stumpy forms as 
would be observed in natural infections. This is perhaps unsurprising given that they 
are derived from culture adapted monomorphic cells which, after serial passage in 
the laboratory, may have acquired various mutations. The treated cells do however 
show decreased cell growth and an increased capacity for differentiation to the 




The truncated aldolase 3’UTR in the CAT449 original construct conveys constitutive 
CAT protein expression. It was therefore expected that, as cells are induced to 
differentiate to the stumpy life stage, the CAT reporter gene expression would either 
remain the same as in slender forms, or if any change is observed, it would be a 
decrease in protein expression, as there is a global decrease in protein synthesis 
during the stumpy life-stage (Brecht and Parsons, 1998). Treatment of cells 
containing the CAT449 original construct with 10µM 8pCPT-2’-O-Me-cAMP did 
indeed cause a small decrease in CAT protein expression (Figure 3.14). However, the 
replacement of the aldolase 5’UTR with the PAD1 5’UTR caused this small decrease 
in protein expression to be lost. Thus, it may be that the PAD1 5’UTR is playing a 
minor role in stabilising the transcript, or assisting translation, during the stumpy 
life-stage.  
 
The PAD1 3’UTR causes repression of reporter gene expression in slender forms and 
upon induction to differentiate to stumpy forms would be expected to cause an 
increase in CAT reporter gene expression. Indeed, treatment of cells containing the 
full length PAD1 3’UTR with 8pCPT-2’-O-Me-cAMP causes alleviation of 
repression of reporter gene protein expression (Figure 3.14). This indicates that the 
8pCPT-2’-O-Me-cAMP is indeed inducing ‘stumpy’ or ‘stumpy-like’ formation in 
monomorphic slender cells and that the PAD1 3’UTR is sufficient for stumpy-
specific gene expression. Due to very low levels of CAT protein for many of the 
constructs in the slender forms, it is not possible to accurately measure the fold 
increase in CAT protein expression in slender forms compared to stumpy forms in all 
cell lines, but the increase in CAT protein expression upon stumpy induction is 
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Figure 3.14 8pCPT-2’-O-Me-cAMP causes alleviation of repression of the PAD1 3’UTR in 
monomorphs and this alleviation is lost with progressive deletions of the UTR.  Upon chemical 
induction to the stumpy life-stage, cells containing the CAT449 Original construct show a small 
decrease in reporter protein expression. Conversely, stumpy induction in cells containing the full 
length PAD1 3’UTR causes alleviation of repression of expression. Thus, the PAD1 3’UTR is 
sufficient for up-regulation of expression during the stumpy life stage. Progressive deletions into the 






Deletion of the even the first 21nt of the PAD1 3’UTR reduced the increase in total 
CAT protein expression upon stumpy induction (Figure 3.14) and was continued to 
be reduced with progressive deletions. However, it appeared that the fold increase 
upon stumpy-induction was actually increased with the first three deletions (1-21, 
1-145 and 1-207) due to the very low CAT protein expression in the DMSO-
treated cell lines. Hence, it is not possible to ascertain if deletion up to position 207nt 
caused an increase or decrease in protein expression in response to stumpy-
formation. Deletions beyond position 265nt caused a measurable decrease in fold-
increase upon stumpy induction; only an 11-fold increase in CAT protein expression 
was measured in the 1-265 cell lines upon stumpy-induction and a 3- and 2-fold 
increase in the 1-354 and 1-391 cell lines respectively. Deletion beyond position 
502nt actually caused decreased protein expression upon stumpy formation 
indicating that at this point responsiveness to stumpy induction had been completely 
lost. These data indicate that the element(s) responsible for up-regulation of protein 
expression upon stumpy induction is located 5’ to position 502nt.  
 
Endogenous PAD1 is up-regulated at both the level of mRNA abundance and protein 
expression in stumpy forms compared to slender forms (Dean et al., 2009). Although 
numerous attempts were made it was not possible to determine the effect of 8pCPT-
2’-O-Me-cAMP on mRNA levels. Repeated northern analyses produced inconsistent 
and non-reproducible results (data not shown). There was not a clear or consistent 
up-regulation of CAT mRNA levels upon stumpy formation despite the consistent 
up-regulation of protein expression. Indeed, when monomorphic slender cells were 
treated with 8pCPT-2’-O-Me-cAMP no up-regulation of PAD1 mRNA was observed 
(Dean and Matthews, unpublished data), although PAD1 protein levels were not 
measured. This may indicate that the stumpy-like cells produced by this drug are not 
‘true’ stumpy forms as would be found in pleomorphic populations (Chapter 4). Due 
to this, any conclusions made regarding stumpy-specific gene expression after 
treatment with 8pCPT-2’-O-Me-cAMP would ideally be validated in pleomorphic 
cell lines. However, given the difficulty in creating transgenic pleomorphic cell lines, 
drug-induced stumpy formation still provides a useful primary analysis to direct 




3.11  Discussion 
3.11.1 The PAD1 3’UTR utilises more than one 
polyadenylation site 
From genome-wide analysis, the PAD1 3’UTR polyadenylation site used during the 
procyclic life-stage had been mapped to positions 428, 572 and 835nt (Siegel et al., 
2010). For the purposes of the analysis of the PAD1 3’UTR in bloodstream forms, 
the polyadenylation site was determined both experimentally (section 3.2.2) and by 
database searching (section 3.2.1) and was shown to be at positions 707-710nt and 
722-723nt in stumpy forms.  
 
When a deletion series of the PAD1 3’UTR, from the 5’ to 3’ end, was created 
(section 3.4), it was observed that progressive deletions caused a decrease in 
transcript length, as determined by northern blot (Figure 3.7). However, the 
exception to this was a construct which deleted up to position 776nt and therefore 
beyond the polyadenylation site as determined in this thesis. In this case, the size of 
the transcript appeared to increase relative to the previous deletion suggesting that at 
this point an alternative polyadenylation site was being utilised. By contrast, if 
positions 428 or 572nt were polyadenylation sites in bloodstream forms then it would 
be expected that deletions beyond these positions would have a similar effect on 
transcript length, which was not observed. Further, if position 835nt was a 
polyadenylation site used in bloodstream forms, the deletion up to position 776nt 
would not be expected to have caused the relative increase in transcript length 
compared to the previous deletion. These data help to confirm positions 707-710nt 
and 722-723nt as the polyadenylation sites used in bloodstream forms.  
 
The discrepancy between the polyadenylation sites mapped in this analysis and those 
mapped by Siegel et al may be due the different life stages in which the analysis was 
carried out as differential use of polyadenylation sites during different life stages has 
been observed in trypanosomes (Clement and Koslowsky, 2001; Erondu and 
Donelson, 1992). Given that position 707-710nt or 722-723nt were not identified at 




sites may used during different life stages. In order to determine if this is indeed the 
case, the same experimental analysis carried out here with RNA harvested from 
stumpy form cells could be carried out on RNA harvested from procyclic form cells. 
 
3.11.2 The PAD1 3’UTR is sufficient for stumpy-specific gene 
expression 
As discussed in section 1.10, trypanosomes control their gene expression almost 
entirely post-transcriptionally (Clayton, 2002). As such, it is often the 3’UTR of a 
gene that is responsible for gene expression. Although stumpy-specific motifs have 
been identified by bioinformatic analysis (Kabani et al., 2009), no stumpy-specific 
gene has been experimentally analysed for the control of gene expression. Here the 
PAD1 3’UTR was coupled to a reporter gene and transfected into monomorphic 
slender cells. It was hypothesised that if the PAD1 3’UTR is sufficient for stumpy 
specific gene expression, that this would cause repression of expression of the 
reporter gene in slender cells. Indeed, this was the case (section 3.5 and 3.6), with the 
PAD1 3’UTR causing a 3.7-fold decrease in reporter mRNA abundance and almost 
180-fold decrease in reporter protein expression compared to a constitutive control. 
Due to the very low levels of both mRNA and particularly protein caused by the 
PAD1 3’UTR all measurements were given relative to the constitutively expressing 
CAT449 original construct which is essentially an arbitrary measurement, but allows 
comparison between cell lines which would otherwise not be possible.   
 
In this chapter, all analysis of the PAD1 3’UTR was carried out in monomorphic 
cells which do not naturally produce stumpy forms. Chemical induction of stumpy of 
stumpy-like formation in these monomorphic cells (section 3.10) resulted in 
alleviation of reporter gene protein expression under the control of the PAD1 3’UTR 
further demonstrating that the 3’UTR is sufficient for stumpy-specific gene 
expression.  However, chemical induction of stumpy formation may not produce 
fully differentiated cells, as seen in pleomorphic cell lines, and so the sufficiency of 




naturally derived stumpy forms from an in vivo infection was later confirmed in 
pleomorphic reporter cell lines, as will be discussed in Chapter 4.  
 
3.11.3 The PAD1 5’UTR does not contribute to repression of 
gene expression in slender forms 
It was established that the PAD1 5’UTR does not contribute to repression of gene 
expression in slender forms, in fact causing an up-regulation of reporter gene 
expression compared to the control construct during this life-stage (section 3.5 and 
3.6). A 1.6-fold increase in both reporter gene mRNA abundance and protein 
expression compared to the control construct implies that effect of the PAD1 5’UTR 
on protein expression is completely accountable by the increase in mRNA 
abundance.  
 
When induced to differentiate to the stumpy-life stage by 8pCPT-2’-O-Me-cAMP, 
the control construct demonstrated a small decrease in reporter gene protein 
expression. The presence of the 5’UTR however, caused this small decrease to 
disappear. Thus, the PAD1 5’UTR may be playing a minor role in stabilising the 
transcript, or assisting translation, during the stumpy life-stage. In order to confirm if 
the PAD1 5’UTR does contribute to gene expression during the stumpy life stage, a 
reporter construct with both the PAD1 5’ and 3’UTR could be created. If the 5’UTR 
does contribute to increased gene expression in stumpy forms, it would be expected 
that this new construct would have greater reporter mRNA abundance and protein 
expression than with the PAD1 3’UTR alone and if it has no effect, then no 
difference would be observed. Either way, the data here demonstrates that the PAD1 
5’UTR is not necessary for either down-regulation of gene expression during the 






3.11.4 Progressive deletions of the PAD1 3’UTR cause 
alleviation of repression of gene expression in slender 
forms 
Having established that the PAD1 3’UTR was indeed sufficient for repression of 
gene expression during the slender life stage it was hypothesised that deletion of any 
repressive element in the 3’UTR should cause alleviation of repression in slender 
forms. Therefore, a deletion series of the PAD1 3’UTR was created in monomorphic 
slender cells, where deletions where made from the 5’end of the UTR (section 3.4). It 
was observed that progressive deletions into the UTR did cause alleviation of 
repression of both reporter mRNA abundance and protein expression. Based on the 
predicted secondary structure of the molecule, the 3’UTR can be divided into various 
structures and these structures are essentially clustered into the proximal and distal 
end of the molecule (Figure 3.9 and Table 3.2). Deletion of the proximal end, up to 
position 265nt, of the molecule had little effect on mRNA abundance and no 
discernable effect on protein expression. Thus, the proximal end of the molecule is 
not necessary for repression of expression in slender forms. This did not discount a 
role for the proximal end of the molecule (as will be discussed in section 3.11.6), but 
did demonstrate that there was at least one repressive element in the PAD1 3’UTR at 
the distal element of the molecule. 
 
The progressive deletions into the 3’UTR caused alleviation of repression of both 
mRNA abundance and protein expression, although the repression of mRNA 
abundance was not enough to account for the repression of protein expression, 
indicating that PAD1 is controlled at both levels. However, the pattern of loss of 
repression of mRNA abundance correlated with the pattern of loss of repression of 






3.11.5 There is more than one repressive element in the 
PAD1 3’UTR 
Having established the proximal end of the PAD1 3’UTR was not required for 
repression of gene expression in slender forms, two internal deletions of the UTR 
were made, deleting sections 386-564nt and 354-624nt (section 3.8). Having shown 
that deletion of these regions from the 5’end caused alleviation of repression, it was 
expected that these internal deletions may have a similar effect. However, the 386-
564nt deletion had no effect on reporter gene expression and 354-624nt deletion had 
only a small effect on mRNA abundance and no effect on protein expression. Thus, 
having demonstrated that the proximal end of the molecule was not necessary for 
stumpy-specific expression (section 3.5 and 3.6), it was then shown that the distal 
end of the transcript was also not necessary (section 3.8). This suggests that there are 
at least two complementary elements controlling repression of expression in slender 
forms, each of which can act independently of one another.  
 
Given the hypothesis that there are two elements involved in the control of stumpy 
specific gene expression in the PAD1 3’UTR, the 354-624nt section was then 
inserted into the 5’end of the truncated aldolase 3’UTR in the CAT449 construct 
(section 3.9). It was expected that if this region was a repressive element in slender 
forms, that a decrease in reporter gene expression would be observed compared to 
the original construct. Indeed, a decrease in both reporter mRNA abundance and 
protein expression was observed. The repression was not complete however, in that 
there was still greater reporter expression than observed with the full length PAD1 
3’UTR. Thus, it may be that the structure of this section was disrupted out of the 
context of the remainder of the PAD1 3’UTR or that this section is not sufficient for 
complete repression of expression in slender forms. Indeed, deletion up to position 
354nt from the 5’end (section 3.5 and 3.6) caused some alleviation of repression of 
expression, correlating with this hypothesis. Regardless of the extent of repression of 
expression, the insertion of the 354-624nt segment of the PAD1 3’UTR into the 
truncated aldolase 3’UTR did cause some repression of expression, demonstrating 
that the sequence does contain a repressive element. Given that deletion of this 




alleviation of repression, this correlates with the hypothesis that there must be more 
than one repressive element in the UTR preventing expression in slender forms.  
 
3.11.6 A model for the PAD1 3’UTR 
Analysis of the PAD1 3’UTR has revealed that there are at least two repressive 
elements controlling repression of expression in slender forms. The data generated in 
this thesis suggests that one element resides at the proximal end of the molecule and 
the other at the distal end, correlating with the two predicted clusters of secondary 
structures (section 3.7), and that these two elements are complementary and can act 
independently. A schematic model of the mechanism by which the full length PAD1 
3’UTR causes repression of expression in slender forms, along with the various 
deletion constructs produced in this thesis is shown in Figure 3.15.  
 
In this model, the PAD1 3’UTR has two areas which contain elements responsible 
for repression of expression in slender forms, one at the proximal end of the 
molecule, the other at the distal end of the molecule (Figure 3.15A). These elements 
may act through trans-acting factors such as RNA-binding proteins (depicted in 
Figure 3.15 by red and blue circles), which may function though a variety of methods 
(discussed in section 3.11.8) 
 
From the analysis of the PAD1 3’UTR deletion series, it is clear that the proximal 
end of the molecule is not necessary for repression of expression in the presence of 
the distal element and therefore that the distal end must be sufficient for at least some 
degree of repression at both the level of mRNA abundance and protein expression. In 
the model, this correlates to loss of the first element, but maintenance of the second 
repressive element (Figure 3.15B). In all cases, deletions made from the 5’end of the 
molecule may disrupt surrounding structures resulting in less effective repression of 
the element(s) still present. Deletions into the distal end of the molecule, from the 
5’end, results in loss of both elements (Figure 3.15C) and therefore complete 






Figure 3.15 A model of the PAD1 3’UTR. The structure of the PAD1 3’UTR is represented by the 
black stick diagram and is based on the predicted secondary structure of the 3’UTR as shown in 
Figure 3.9. Solid black lines represent the presence of the structure; dotted black lines represent the 
absence of the structure. The circles represent possible RNA-binding proteins or protein complexes 
(section 3.11.8). The blue circle represents association with the proximal end of the molecule; the red 
circle represents association with the distal end of the molecule. Solid lines around circles represent an 
ability to associate with the 3’UTR, dashed lines represent a reduced capacity for association and 
dotted lines represent an inability to associate with the UTR. In (A) the full length PAD1 3’UTR 
contains two repression elements which can be bound by two sets of trans-acting factors. (B) Deletion 
of the proximal end of the molecule by deletions from the 5’end results in loss of the proximal 
element without complete loss of the repression of expression. (C) Deletion of both the proximal and 
distal elements results in loss of both elements and therefore loss of repression. (D) Internal deletion 
of the 387-564nt and (E) 354-624nt regions disrupts the distal element without loss of repression due 
to the remaining proximal element. (F) The 354-624nt section, containing the distal element, into the 




Deletion of the internal 387-564nt region may not be sufficient for complete loss of 
the distal element (Figure 3.15D) and with the proximal element still functional in 
isolation there is no alleviation of repression. Internal deletion of the 354-624nt 
region may cause complete loss of the distal element resulting in a small increase in 
reporter mRNA abundance observed (Figure 3.12). Alternatively, loss of both 
regions may result in complete loss of the distal element. In this case, the small 
increase in mRNA abundance caused by the 354-624nt deletion and not in the 387-
546nt deletion could be explained by a disruption to the secondary structure in the 
remainder of the molecule, slightly reducing the efficiency of the proximal element. 
Insertion of the 354-624nt segment of the PAD1 3’UTR, containing the distal 
element, into the truncated aldolase 3’UTR is sufficient for at least some repression 
of reporter gene expression. The data is consistent with either a reduced capacity for 
repression out with the context of the remainder of the PAD1 3’UTR (as shown in 
Figure 3.15F) or with the distal element not being sufficient alone to cause complete 
repression of expression in slender forms.  
 
The up-regulation of reporter protein expression in response to chemical induction of 
stumpy formation in the monomorphic cell lines was reduced by deletion beyond 
position 265 and lost by deletion beyond position 502nt of the PAD1 3’UTR. This 
implies that both the proximal and distal elements of the PAD1 3’UTR may play a 
role in the positive regulation of gene expression in stumpy forms. Furthermore, the 
effect of 8pCPT-2’-O-Me-cAMP was clear and consistent at the protein level but 
difficult to characterise at the mRNA level. This implies that the key level of 
regulation upon stumpy induction is at that of the level of translation efficiency 
rather than mRNA abundance. It is not clear however to what extent this drug 
induces stumpy formation in these culture adapted monomorphic cell lines and 
therefore, for future examination of up-regulation in stumpy forms, analyses would 





3.11.7 Further characterisation of the PAD1 3’UTR 
Having established that there are at least two repressive elements in the PAD1 
3’UTR, and having proposed a model which accounts for the data generated in this 
thesis (section 3.11.6), the UTR could be studied further by creation of additional 
constructs in order to identify more defined control regions and to test the model. For 
instance, larger internal deletions could be created that move further towards the 
5’end of the molecule. This may help to define a minimal sequence which is still 
capable of complete repression of expression which could then be used to attempt to 
identify trans-acting factors (section 3.11.8). Then, having defined a minimal 
sequence, specific deletions could be made that disrupt particular structures which 
may help to very specifically define a region of importance. Additionally, the 
proximal end of the molecule could be inserted into the truncated aldolase 3’UTR to 
determine if this conveys complete repression of expression out of context of the 
remainder of the PAD1 3’UTR, and responsiveness to chemical inducers of stumpy 
formation.   
 
To further characterised the responsiveness of the PAD1 3’UTR to stumpy 
formation, cells containing the PAD1 3’UTR 386-564, PAD1 3’UTR 354-624 and 
354-624 PAD1 3'UTR constructs (Table 3.1) could be treated with 8pCPT-2’-O-Me-
cAMP. The most ideal way in which to test if a given element is stumpy-responsive 
however, would be to create constructs for the insertion into a pleomorphic cell line. 
Pleomorphic transfections are difficult and time-consuming and could not be used 
effectively to identify candidate regions, but given preliminary analysis in 
monomorphic cell lines with chemical induction of stumpy formation, confirmation 
of results with selected constructs would be possible.  
 
The PAD1 3’UTR has been shown here to be responsible for repression of mRNA 
abundance in slender forms. It is most likely that this is through mRNA stability 
(rather than regulation of mRNA processing), although this was not demonstrated 
here. To confirm that it is indeed decreased mRNA stability that causes decreased 
mRNA abundance an experiment could be carried out whereby transcription is 




over time by northern blot in order to determine the estimated half-life of the 
molecule. A rapid turn-over of mRNA would confirm that low mRNA abundance 
was due to mRNA instability. The same experiment could be carried out on other 
constructs from the deletion series to determine if the increase in mRNA abundance 
is due to increased mRNA stability.  
 
3.11.8 Trans-acting factors controlling PAD1 expression 
In trypanosomes, the cis-acting elements in the 3’UTRs of differentially regulated 
mRNAs act through trans-acting factors, such as RNA binding proteins which affect 
mRNA stability and protein translation (section 1.10). In this thesis, only cis-acting 
elements of the PAD1 3’UTR have been investigated, but discovery of the RNA-
binding proteins or complexes that are responsible for stumpy-specific expression 
would be of interest given that although there are a large number of potential RNA-
binding proteins in the trypanosome genome (De Gaudenzi et al., 2005), relatively 
few have been characterised (Archer et al., 2009; Estevez, 2008; Paterou et al., 
2006), and no stumpy-specific mechanisms of control of gene expression have been 
reported.  
 
The mechanism by which RNA-binding proteins could be causing repression of 
expression in slender forms and alleviation of repression in stumpy forms could be 
occurring by a variety of methods. For example, for each element there may be one 
RNA-binding protein complex which is repressive, which is present in slender forms 
but absent in stumpy forms. Alternatively, the complex could have differential 
associations between slender and stumpy forms such that it is repressive in slender 
forms but promotes expression in stumpy forms. Further, it could be that two 
complexes compete for each element, with a repressive complex being dominant in 
slender forms and a positive complex being dominant in stumpy forms. Indeed, given 
that there are at least two elements controlling gene expression in the PAD1 3’UTR it 
may be that one acts via one of the above mechanisms and the other acts by another. 
Identification of proteins which are able to bind the PAD1 3’UTR and analysis of the 




identification of other proteins to which they bind could elucidate the mechanism of 
stumpy-specific gene expression used by PAD1.  
 
In previous analysis, cis-acting elements have been used as bait in RNA-affinity 
purification in order to identify proteins able to bind that element (Estevez, 2008). 
With further characterisation of the PAD1 3’UTR (section 3.11.7) a more defined 
region of the UTR involved in stumpy specific gene expression could be used in such 
a method to identify interacting proteins. Alternatively, known RNA-binding 
proteins could be analysed for their ability to bind the PAD1 mRNA. For example, 
PAD6 was identified as a potential target of TbDRBD3 as depletion of this protein by 
RNAi causes down-regulation of PAD6 mRNA (Estevez, 2008) and it has since been 
shown that this protein can associate with PAD1 mRNA (Estevez, unpublished data, 
personal communication). The effect of TbDRBD3 depletion on PAD1 mRNA 
abundance could be determined by northern blot or quantitative RT-PCR of PAD1 
mRNA in the TbDRBD3 RNAi cell line. If an effect was observed, this would 
implicate TbDRBD3 as a regulator of PAD1 expression. 
  
3.11.9 The PAD1 coding sequence may still play a role in 
stumpy-specific expression  
In this analysis the PAD1 3’UTR was sufficient to convey stumpy-specific gene 
expression onto the CAT reporter gene. In Chapter 4 the same effect is observed with 
another reporter gene, GUS, demonstrating that this effect is not sequence specific. 
However, in analysis of the control of procyclin gene expression it was demonstrated 
that although the 3’UTR was sufficient for stage-specific regulation in the context of 
a reporter gene, the coding sequence itself also played a role in preventing expression 
during the inappropriate life-stage even in the absence of the 3’UTR control elements 
(Schurch et al., 1997). Here, the PAD1 coding sequence was not investigated and so 
it remains a possibility that despite the 3’UTR being sufficient for stage-specific 





3.11.10 The PAD1 3’UTR provides a tool for the creation of 
reporter cell lines for the stumpy life stage 
It has been shown in this chapter that the PAD1 3’UTR is sufficient for control of 
stumpy-specific gene expression of a reporter gene. This provides a valuable tool for 
the analysis of stumpy formation in vitro by the creation of reporter cell lines 
coupled to the PAD1 3’UTR. Previous analyses on stumpy formation have relied on 
morphological analysis, which is time-consuming and subjective, or analysis of 
increased capacity for differentiation to the procyclic life-stage or mitochondrial 
activation (Breidbach et al., 2002; Denninger et al., 2007; Laxman et al., 2006; 
Reuner et al., 1997; Tyler et al., 1997). The use of reporter cell lines to identify 
stumpy forms would provide a high-throughput method of analysis for stumpy 
formation in vitro, which would allow for further analysis of chemical inducers of 
stumpy formation, such as 8pCPT-2’-O-Me-cAMP, as well as potentially providing a 
method for identification of SIF. The use of the PAD1 3’UTR in both pleomorphic 
and monomorphic reporter cell lines for stumpy formation was therefore investigated 




















4 Chapter 4: Monomorphic and pleomorphic reporter 







Study of the slender to stumpy transition has been hindered by a lack of molecular 
marker for the stumpy life stage. The PAD1 3’UTR is sufficient for stumpy-specific 
gene expression, as demonstrated in Chapter 3. Therefore it should be possible to 
create stumpy-specific reporter cell lines that couple the PAD1 3’UTR with reporter 
genes. This would provide a method to study stumpy formation in vitro.  
 
Most laboratory trypanosome strains are monomorphic, that is, they have lost the 
ability to differentiate into stumpy forms due to serial passage. Although 
monomorphs do not differentiate in response to cell density this does not exclude 
their use to study stumpy formation. The inability of monomorphs to differentiate 
may be due to an inability to detect SIF, for instance, and by targeting downstream 
effectors of the SIF pathway, stumpy formation could potentially be induced. 
Therefore, reporter cell lines for the analysis of stumpy formation in monomorphs 
were created.  
 
Although monomorphic cells are a useful tool for studying the downstream effectors 
of SIF signalling, a pleomorphic cell line is required for the analysis of the, as yet 
unidentified, SIF itself. For this purpose, a pleomorphic reporter cell line was 
therefore created for the analysis of the effects of conditioned media, containing SIF, 
on pleomorphic cells.  
 
4.2 Production of monomorphic reporter cell lines for 
analysis of stumpy formation 
A series of reporter constructs were created for the purpose of analysing stumpy 
formation in monomorphs (Table 4.1). All constructs created were based on the 
plasmid pHD617 (Biebinger et al., 1997) which integrates into the ribosomal spacer 
region and uses PolI transcription (Figure 4.1). The pHD617 vector originally 
contained a hygromycin resistance cassette (HygroR). For the purpose of inserting 




resistance cassette (PuroR) was also used, which had previously been generated in 
the laboratory (S.Dean, unpublished). Reporter genes were coupled either to the 
PAD1 3’UTR for stumpy-specific expression or to the Actin 3’UTR for constitutive 
expression. Both enzymatic (CAT and GUS) and fluorescent (GFP and CFP) 
reporters genes were used. Reporter constructs were transfected into trypanosomes 
either alone, or in combination with another construct with complementary drug 





Figure 4.1 The pHD617 vector. The reporter gene (CAT, GUS, CFP or GFP) is controlled by 
either a constitutive Actin 3’UTR or a stumpy-specific PAD1 3’UTR. The construct contains either 
a puromycin or hygromycin resistance gene which is under the control of the Actin 3’UTR. After 
linearisation with NotI, the vector integrates into the ribosomal spacer locus via a ribosomal 
integration site sequence (RITS). As such, transcription is via PolI and uses the EP2 promoter (pEP2) 









427 GFP-PAD1 3’UTR/ 
CFP-Actin 3’UTR 
pHD617 GFP-PAD1 3’UTR puroR 
pHD617 CFP-Actin 3’UTR hygroR 
CFP GFP 
427 GFP-Actin 3’UTR 
 
pHD617 GFP-Actin 3’UTR hygroR GFP None 
427 CAT-PAD1 3’UTR/ 
GUS-Actin 3’UTR 
pHD617 CAT-PAD1 3’UTR puroR 
pHD617 GUS-Actin 3’UTR hygroR 
GUS CAT 
427 GUS-PAD1 3’UTR 
 
pHD617 GUS-PAD1 3’UTR puroR None GUS 
Table 4.1 Cell lines created for the study of stumpy formation in monomorphs. All cell lines arise 





4.2.1 Validation of fluorescent cell lines 
The 427 GFP-PAD1 3’UTR/CFP-Actin 3’UTR cell line was expected to express CFP 
protein in monomorphic cells, but express little, if any, GFP protein (Table 4.1). In 
order to determine if the cells were indeed constitutively expressing CFP, cells were 
analysed via flow cytometry. Figure 4.2 shows that 427 GFP-PAD1 3’UTR/CFP-
Actin 3’UTR cells did show a small increase in CFP expression, although most of the 
cells were still considered negative for CFP expression. This indicates that there was 
very low constitutive expression of this reporter. Cells were not expected to be 
positive for GFP expression as cells were monomorphic slender and thus would not 
express PAD1. However, treatment of the 427 GFP-PAD1 3’UTR/CFP-Actin 3’UTR 
cell line with stumpy-inducing drugs (as discussed in section 4.3) never resulted in 
cells positive for GFP expression (data not shown). Hence, this cell line was not 
considered useful for monitoring stumpy formation. 
 


















































































































































Figure 4.2 427 GFP-PAD1 3’UTR/CFP-Actin 3’UTR cells have a small increase in CFP signal 
compared to parental cells. A) Parental 427 cells are negative for CFP and GFP B) GFP-PAD1 
3’UTR/CFP-Actin 3’UTR cells have an increase in CFP signal, yet the shift is largely not out-with the 
negative range. There is also a small increase in GFP positive cells. This increase in CFP expression is 
not high enough to clearly distinguish between positive and negative populations. The lower left-hand 
quadrant in each graph represents cells negative for CFP and GFP expression. The upper left-hand 
quadrant represents cells positive for GFP and negative for CFP. The lower right-hand quadrant 
represents cells positive for CFP and negative for GFP. Finally, the upper right-hand quadrant 
represents cells positive for both GFP and CFP expression. Values within each quadrant represent the 




Nine independent clones of the 427 GFP-Actin 3’UTR cell line have been produced. 
Of these, none expressed detectable GFP protein, as determined by flow cytometry 
(data not shown). This suggested that there is a fundamental difficulty with free 
fluorescent protein expression in these bloodstream cells. As attempts to produce 
fluorescent reporter cell lines were unsuccessful, enzymatic reporter genes were then 
tested.  
 
4.2.2 Validation of enzymatic cell line 427 CAT-PAD1 3’UTR/GUS-
Actin 3’UTR 
The 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR cell line was expected to express 
GUS protein in monomorphic cells, but express little, if any, CAT protein. To 
quantify CAT protein levels a Roche CAT ELISA kit was used as described in 
Chapter 2. As expected CAT protein expression was low in untreated 427 CAT-
PAD1 3’UTR/GUS-Actin 3’UTR cells, but increased in response to stumpy-inducing 
drugs, as will be demonstrated in section 4.3. This demonstrated the validity of this 
reporter system in monomorphic cells.  
 
Previously, transgenic trypanosome cell lines have been produced which replaced a 
procyclin gene with the GUS gene as a marker for differentiation from bloodstream 
to procyclic forms (Sbicego et al., 1999). GUS activity was then assayed via a colour 
change reaction which was quantified by an absorbance reading (Sbicego et al., 
1999). Here a similar method was used to evaluate the 427 CAT-PAD1 3’UTR/GUS-
Actin 3’UTR cell line where 4-Methylumbelliferyl--D-glucopyranosiduronic acid 
(MUG) is used as a fluorescent substrate for the GUS enzyme (as recommended by 
Prof. I. Roditi, University of Bern). The substrate was added to the trypanosome 
culture in 96-well plates and absorbance measured after 2 hours, with an excitation 
wavelength of 355nm and emission wavelength of 460nm, as detailed in Chapter 2. 
The 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR cell line was shown to express GUS 
using this method (Figure 4.3), thus confirming successful transfection and GUS 
expression from the cell line. Supporting this, no GUS activity was detected in 




Although CAT proved an effective reporter, for high throughput screens the GUS 
reporter was considered a more cost effective reporter system. Therefore, as 
described in section 4.4, a cell line coupling the GUS gene with the PAD1 3’UTR 
was also created (Table 4.1).  
 
GUS Activity












Figure 4.3 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR did express GUS protein, whereas 
parental 427 cells did not. 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR (transfectants), 427 parental 
cells and media only were tested for GUS activity using the 4-Methylumbelliferyl--D-
glucopyranosiduronic acid fluorescent substrate. The solution was excited at 355nm and emission read 
at 460nm after 2 hours incubation at 37

C. The media was tested to ensure the coloured pH indicator 
in the media did not affect the colour-based assay, which it did not. 
 
4.3 Previously studied inducers of stumpy formation in 
monomorphs 
Monomorphic slender cells, by very definition, do not differentiate into stumpy 
forms in response to high cell density. However, it appears that monomorphic cells 
have not lost the capacity to differentiate per se, as various drugs have been reported 
in the literature to cause stumpy or stumpy-like formation (section 1.7.3). In order to 
demonstrate that the 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR cell line could be 
used to detect stumpy formation in vitro, these cells were treated with three of the 
reported stumpy-inducing drugs: 8pCPT-cAMP, 8pCPT-2’O-Me-cAMP and 




Vassella et al., 1997). In each case the concentration of drug used was based on 
effective concentrations in previous studies. After drug treatment, samples were 
collected at 0 hours, 24 hours and 48 hours in order to measure cell proliferation, 
CAT reporter gene expression and GUS reporter gene expression. After 48 hours of 
drug treatment, the cells were induced to differentiate to the procyclic life stage and 
differentiation capacity was measured.  
 
4.3.1 8pCPT-cAMP causes monomorphic slender cells to 
differentiate to stumpy-like cells 
Despite years of study, the cAMP signalling pathway in trypanosomes is not yet 
understood. However, cAMP signalling has been implicated in playing a role in 
trypanosome proliferation and differentiation (Breidbach et al., 2002; Mancini and 
Patton, 1981; Rolin et al., 1993; Vassella et al., 1997). For instance, cell permeable 
cAMP has been shown to mimic SIF in pleomorphic cells (Vassella et al., 1997) as 
well as in monomorphic forms (Breidbach et al., 2002). Furthermore, treatment with 
low concentrations (1-2µM) of the phospodiesterase inhibitor, etazolate, also 
mimicked SIF activity.  It was therefore hypothesised that SIF acts via the cAMP 
signalling pathway. However, high concentrations of cAMP are required, with 
previous studies using 250µM in pleomorphs and 1mM in monomorphs. Here the 
monomorphic reporter cell line was treated with a lower concentration of 100µM 
8pCPT-cAMP, freshly dissolved in dH2O after it was shown in preliminary 
experiments that this concentration was sufficient to cause up-regulation of reporter 
gene expression (data not shown). 
 
After 24 hours drug treatment there was a clear decrease in cell proliferation 
compared to control cells as would be expected if proliferative slender cells are 
differentiating to cell-cycle arrested stumpy forms (Figure 4.4A). There was also an 
approximately 24-fold increase in stumpy-specific reporter gene expression after 24 
hours, rising to an over 36-fold increase after 48 hours (Figure 4.4B). Contrasting 
with this, there was small decrease in constitutive reporter gene expression after 48 




forms are repressed in translation (Brecht and Parsons, 1998). To further confirm that 
cells had differentiated to stumpy-like forms, cells treated with drug for 48 hours 
were then induced to differentiate to the procyclic life stage by the addition of cis-
aconitate and a decrease in temperature. After only 6 hours, approximately 75% of 
drug-treated cells had differentiated to the procyclic life stage compared to less than 
2% of the control cells (Figure 4.4D), as assessed by the expression of EP procyclin. 
This indicated that the drug treated cells had an increased capacity for differentiation 
to the procyclic life stage, as would be expected of a stumpy population.  
 
Despite the various indications that cells had differentiated to the stumpy life stage, 
cells treated with drug did not develop a truly stumpy morphology (Figure 4.4E) 
unlike previous reports (Breidbach et al., 2002). In this study, 10 times less drug was 
used than that required to induce stumpy-like morphology in monomorphs 
previously (Breidbach et al., 2002). It may be that at the lower concentration the drug 
was causing some, but not all, of the molecular changes that are required for full 
differentiation to the stumpy forms. Alternatively, it may be that there is a 
requirement for a further differentiation trigger, or that the monomorphic cells are 
not capable of morphological differentiation. This does, however, indicate that 
morphological change is not the initial step in the process of differentiation, as 

















































































































































































Figure 4.4 100µM 8pCPT-cAMP causes monomorphic slender cells to differentiate to stumpy-
like forms.  Treatment of 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR monomorphic slender cells with 
100µM 8pCPT-cAMP causes (A) a decrease in cell proliferation, (B) an increase in stumpy-specific 
CAT reporter gene expression, normalised to cell number and (C) a decrease in constitutive GUS 
reporter gene expression, normalised to cell number. (D) After 48 hours of 8pCPT-cAMP treatment, 
cells were induced to differentiate to the procyclic life stage with the addition of 6mM cis-aconitate 




C. 8pCPT-cAMP treated cells had higher EP procyclin 
expression compared to controls. (E) After 24 and 48 hours of 8pCPT-cAMP treatment, the cell 
morphology had not changed in comparison to dH20-treated controls and therefore the cells had not 




4.3.2 8pCPT-2’O-Me-cAMP causes monomorphic slender cells to 
differentiate to stumpy-like cells 
The cAMP signalling pathway is not understood in kinetoplastids and may differ 
significantly from other eukaryotes (section 1.7.3). Although the cAMP pathway has 
been implicated as the mechanism by which SIF acts (Vassella et al., 1997), recent 
data has suggested that it is actually the hydrolysis products of cAMP that are 
inducing stumpy formation (Laxman et al., 2006). Therefore, the effect of 10µM 
8pCPT-2’O-Me-cAMP freshly dissolved in DMSO on the monomorphic reporter cell 
line was also analysed (Figure 4.5). Control cells were treated with DMSO alone. 
 
After 24 hours drug treatment there was again a decrease in cell proliferation 
compared to control cells (Figure 4.5A). There was also an over 18-fold increase in 
CAT reporter expression after 24 hours, rising to an over 41-fold increase after 48 
hours (Figure 4.5B). There was a small decrease in constitutive reporter gene 
expression after 48 hours of drug treatment (Figure 4.5C). Again, to further confirm 
that cells had differentiated to stumpy-like forms, cells treated with drug for 48 hours 
were then induced to differentiate to the procyclic life stage by the addition of cis-
acconitate and a decrease in temperature. After 6 hours, approximately 83% of drug-
treated cells had differentiated to the procyclic life stage compared to less than 2% of 
the control cells as monitored by EP procyclin expression (Figure 4.5D). This 
indicates that the 8pCPT-2’O-Me-cAMP treated cells had an increased capacity for 
























































































































































































Figure 4.5 10µM 8pCPT-2’-O-Me-cAMP causes monomorphic slender cells to differentiate to 
stumpy-like forms.  Treatment of 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR monomorphic slender 
cells with 10µM pCPT-2-O-Me-cAMP caused (A) a decrease in cell proliferation, (B) an increase in 
stumpy-specific CAT reporter gene expression normalised to cell number and (C) no change in 
constitutive GUS reporter gene expression, normalised to cell number. (D) After 48 hours of pCPT-2-
O-Me-cAMP treatment, cells were induced to differentiate to the procyclic life stage with the addition 




C. 8pCPT-2-O-Me-cAMP treated 
cells had higher EP procyclin expression compared to controls. (E) After 24 of 8pCPT-cAMP 
treatments, the cell morphology had not changed in comparison to DMSO-treated cells, however, after 




Unlike the cells treated with 8pCPT-cAMP (Figure 4.4E), those treated with 8pCPT-
2’O-Me-cAMP did have an altered morphology after 48 hours with cells beginning 
to appear ‘stumpy-like’ (Figure 4.5E). However, monomorphic slender forms can 
look more morphologically intermediate than true slender forms from a pleomorphic 
population (compare dH2O-treated monomorphic control cells in Figure 4.4 with 
pleomorphic slender cells from day 4 of an in vivo infection in Figure 5.9). This 
makes analysis of morphological changes very subjective. However, as a 
morphological change was observed with 8pCPT-2’O-Me-cAMP treatment and not 
with 8pCPT-cAMP treatment, along with the lower dosage required, it may be that 
the 8pCPT-2’O-Me-cAMP could elicit more of the molecular changes that are 
required for full differentiation to the stumpy-life stage. 
 
4.3.3 Troglitazone does not cause monomorphic slender cells to 
differentiate to stumpy-like cells 
Having analysed the effect of cell permeable cAMP and a hydrolysable cAMP 
analogue, the effect of a distinct drug was tested. Troglitazone is a thiazolidinedione 
and has been reported to induce stumpy formation in monomorphic trypanosomes at 
a concentration of 5µM (Denninger et al., 2007). Therefore, the effect of 5µM 
Troglitazone freshly dissolved in DMSO on the monomorphic reporter cell line was 
analysed (Figure 4.6). Control cells were treated with DMSO alone.  
 
After 48 hours of treatment with Troglitazone there was no effect on cell 
proliferation compared to control cells (Figure 4.6A). There was no detectable 
increase in stumpy-specific reporter gene expression (Figure 4.6B) and no change in 
constitutive reporter gene expression (Figure 4.6C) after the 48 hours. Thus, it 
















































































































































          



























Figure 4.6 5µM Troglitazone does not cause monomorphic slender cells to differentiate to 
stumpy-like forms.  Treatment of 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR monomorphic slender 
cells with 5µM Troglitazone caused no effect on (A) cell proliferation, (B) stumpy-specific CAT 
reporter gene expression, normalised to cell number and (C) constitutive GUS reporter gene 
expression, normalised to cell number. (D) After 48 hours of troglitazone treatment, cells were 
induced to differentiate to the procyclic life stage with the addition of 6mM cis-acconitate and a drop 




C. Troglitazone treatment had no effect on EP procyclin expression 
compared to controls. (E) After 24 and 48 hours of 8pCPT-cAMP treatments, the cell morphology had 
not changed in comparison to DMSO-treated controls and did not therefore turn stumpy in 




To further confirm that cells had not differentiated to stumpy-like forms, cells treated 
with drug for 48 hours were then induced to differentiate to the procyclic life stage 
by the addition of cis-acconitate and a decrease in temperature. Even after 24 hours, 
cells had not differentiated to the procyclic life stage any more efficiently than 
compared to control cells, as determined by EP procyclin expression (Figure 4.6D). 
This indicates that the Troglitazone treated cells had not differentiated to the stumpy 
life stage. Morphological analysis also revealed no change in Troglitazone treated 
cells compared to control cells (Figure 4.6E).   
 
The discrepancy between the results shown here and previously published data 
(Denninger et al., 2007) may be due to differences between the monomorphic strains 
used. The cells in each laboratory will have very different passage histories and 
therefore there are likely to be numerous differences between strains. This does 
however indicate that Troglitazone may not be a biologically significant inducer of 
stumpy formation, potentially unlike cAMP and its hydrolysis products. 
 
4.4 High-throughout screening for pharmaceutical inducers 
of stumpy formation 
Treatment of the 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR cell line with stumpy-
inducing drugs caused an increase in CAT reporter gene expression. This ability to 
monitor stumpy induction provided the opportunity to develop a high throughput 
assay for compounds that accelerate stumpy formation at abnormally low parasite 
density. This reporter line could provide a simple assay for enhanced stumpy 
formation accessible to screening with small molecule or natural product libraries. If 
administrable compounds were identified that are able to force the irreversible 
differentiation of slender forms to stumpy forms at low levels of parasitaemia then 
this could have potential therapeutic consequences. For example, by inducing 
stumpy-formation at low parasitaemia the potential for parasite transmission may be 
reduced (Figure 4.7). In order to examine this further, and establish a high-
throughput method of analysis, a collaboration was established with the Drug 






Figure 4.7 Accelerated parasite development as a route to limiting transmission and 
parasitaemia. In the normal course of infection slender cells generate stumpy forms once parasite 
numbers are sufficient to ensure transmission if taken up during a tsetse blood meal. By accelerating 
stumpy formation at a lower parasitaemia, the parasite load in the host would be reduced, potentially 
reducing pathogenicity. Furthermore, the consequent limitation in parasite numbers could reduce the 
potential for parasite transmission during a tsetse blood-meal. Figure from (MacGregor and Matthews, 
2010). 
 
4.4.1 The 427 GUS-PAD1 3’UTR reporter cell line can act as a 
marker cell line for stumpy formation 
Although the detection of the CAT reporter expression was straightforward, 
involving a simple ELISA protocol, this could not be incorporated into a high 
throughput screen as it is expensive, labour-intensive and time-consuming. 
Therefore, the CAT reporter gene was replaced with the GUS reporter gene to 
produce the 427 GUS-PAD1 3’UTR reporter cell line (Table 4.1). Detection of the 
GUS enzyme involves incubating drug treated cells with lysis buffer containing a 
substrate of the enzyme and detection by the resulting fluorescence. Thus, this fast, 
cheap assay could be utilised in high-throughput analysis.  
 
Having replaced the reporter gene, it was necessary to confirm that GUS activity did 
increase in stumpy forms as expected. Therefore, 427 GUS-PAD1 3’UTR cells were 
treated with 10µM 8pCPT-2’-O-Me-cAMP, which had caused an increase in stumpy 
specific CAT reporter gene expression in 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR 
cells (section 4.3.2).  When GUS activity was normalised to cell number there was a 
clear increase in GUS activity after treatment with 10µM 8pCPT-2’-O-Me-cAMP 




marker cell line for stumpy formation. This increase was, however, detected without 
adjusting the relative fluorescence units reading for cell number (Figure 4.8). This 
was because the decreased cell proliferation caused by the drug generates fewer cells 
with greater GUS gene expression in drug treated cells compared to the large number 
of cells with low GUS gene expression in untreated cells. Hence, cell number 
adjustment was appropriate to measure the increase in reporter activity.  
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Figure 4.8 427 GUS-PAD1 3’UTR cell line responds to 10µM 8pCPT-2’-O-Me-cAMP. Treatment 
of 427 GUS-PAD1 3’UTR monomorphic slender cells with 10µM pCPT-2-O-Me-cAMP caused an 
increase in GUS activity which was detectable when the data are adjusted for cell number but was not 
detectable when not adjusted for cell number. Error bars represent s.e.m, n = 3. 
 
4.4.2 Modification of the assay for high-throughput analysis 
Because it appeared that monitoring total cell number was important to evaluate the 
GUS activity results, use of the Alamar Blue
®
 assay was investigated to incorporate 
some measure of cell number into a high-throughput analysis (Raz et al., 1997; Sykes 
and Avery, 2009), although it is important to note that the Alamar Blue
®
 assay 
measures metabolic activity rather than absolute cell number. Additionally, the initial 
protocol involved: culturing cells in a volume of 10ml in 25cm
2
 flasks at a starting 
concentration of 1 x 10
5
 cells/ml; incubating with drug for 48 hours; measuring cell 
number; and then carrying out the GUS assay. However, for high-throughput 
analysis the entire method required to be carried out in 96-well plates. To this end, 
cells were seeded at 1 x 10
5
, 5 x 10
5 
and 1 x 10
6
 cells/ml in 100µl volumes in 96-well 




stumpy formation in monomorphic slender cells (section 4.3.1) and incubated for 48 
hours. At 44 hours, 10% v/v Alamar Blue
®
 was, or was not, added to the cells and 
incubated for 4 hours. At 48 hours (4 hours post addition of Alamar Blue
®
) 
fluorescence was measured at 540nm and 595nm for the Alamar Blue
®
 assay. 
Immediately subsequent to the alamar fluorescent reading, 100µl of MUG substrate 
was added to all cells and incubated for 2 hours at 37C. All combinations of 
treatments were performed in triplicate. 
 
After 48 hours in culture, all cells seeded at 1 x 10
6
 cells/ml had become very dense 
and died (data not shown). In cells seeded at 1 x 10
5
 cells/ml or 5 x 10
5
 cells/ml, 
however, the presence of Alamar Blue
®
 had no effect on the measurement of GUS 
activity with or without drug (Figure 4.9A). Therefore, it was clear that the Alamar 
Blue
®
 assay could be used in combination with the GUS assay without interference, 
although the GUS assay was required to be the latter of the two assays performed, as 
the MUG substrate lyses the cells.  
 
At a starting concentration of 1 x 10
5
 cells/ml, a 1.9-fold increase in GUS activity 
was observed upon incubation with 100µM 8pCPT-cAMP compared to untreated 
cells (Figure 4.9B). As determined by the Alamar Blue
®
 assay, the growth of cells 
treated with the drug was 55.2% that of untreated cells. Although this cannot provide 
an accurate measure of total cell number it can provide an estimate of population 
growth. More specifically, we can estimate that for every 100 hundred cells in the 
untreated populations, there are only 55.2 cells in the drug treated populations. When 
the difference in estimated cell number is taken into account, a 3.1-fold increase in 
GUS activity could be observed (Figure 4.9B). 
 
At a starting concentration of 5 x 10
5
 cells/ml, a 4.1-fold increase in GUS activity 
was observed upon incubation with 100µM 8pCPT-cAMP compared to untreated 
cells (Figure 4.9C). As determined by the Alamar Blue
®
 assay, the growth of cells 
treated with the drug was 71.6% that of untreated cells. When the difference in 
estimated cell number was taken into account, a 7.6-fold increase in GUS activity in 
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Figure 4.9 The Alamar Blue
®
 assay can be used to provide an estimate of cell number for the 
GUS assay.  Cells were seeded at 1 x 10
5
 or 5 x 10
5
 cells/ml and incubated with 100µm 8pCPT-
cAMP for 48 hours. At 48 hours GUS activity was measured. (A) GUS activity was unaffected by the 
presence/absence of Alamar Blue
®
 (added at 44 hours) with or without drug, in cells seeded at 1 x 10
5
 
cells/ml or 5 x 10
5
 cells/ml. Therefore the Alamar Blue
®
 assay could be used in combination with the 
GUS assay without interference. (B) At a starting concentration of 1 x 10
5
 cells/ml, a 1.9-fold increase 
in GUS activity was observed upon incubation with the drug compared to untreated cells. When the 
difference in estimated cell number, using the Alamar Blue
®
 assay, was taken into account, a 3.1-fold 
increase could be observed. (C) At a starting concentration of 5 x 10
5
 cells/ml, a 4.1-fold increase in 
GUS activity was observed upon incubation with the drug compared to untreated cells. A 7.6-fold 
increase in GUS activity in response to drug treatment was observed when the difference in estimated 





The aim of the inclusion of the Alamar Blue
®
 assay was to better observe a clear 
distinction between cells treated with drugs that are inducing stumpy formation and 
untreated cells. The Alamar Blue
®
 assay does provide this clearer distinction (Figure 
4.9B and C) without interfering with the GUS assay. Additionally, it could easily be 
incorporated into the 96-well plate format as required for high-throughput screening.  
 
Cells seeded at a concentration of 5 x 10
5
 cells/ml provided a better assay than those 
seeded at 1 x 10
5
 cells/ml. It may be that cells seeded at 1 x 10
5
 cells/ml have not 
reached a high enough cell number in the 96-well plates for positive GUS expression 
to clearly be distinguished from background GUS activity. Although a starting 
concentration of 1 x 10
6
 cells/ml was also tested, all untreated cells had grown dense 
and stopped growing within the 48 hour incubation period. Therefore in the 96-well 
format a starting concentration of 5 x 10
5
 cells/ml was considered the most 
appropriate.  
 
Taking the above observations into account, the 96-well format assay outlined in 
Figure 4.10A was provided to the Drug Discovery Unit at the University of Dundee. 
The protocol was then subject to further assay development at the Drug Discovery 






Seed cells at 5 x 105
cells/ml in 100l in 
96-well plates
Incubate with drug 
for 48 hours
Add 10% v/v Alamar
Blue after 44 hours
Measure 
fluorescence for 
Alamar Blue assay 
Add 100l MUG 
substrate at 48 hours
Incubate with Alamar
Blue for 4 hours







Figure 4.10 Flow diagram of the 96-well format assay. The 96-well format assay provided to the 
Drug Discovery Unit operated by seeding cells at a density of 5 x 10
5
 cells/ml in 100µl in 96-well 
plates. Cells are then incubated at 37C with the drug of interest for 48 hours. At 44 hours post 
addition of the drug, 10% v/v Alamar Blue
®
 is added to the cells and incubated for 4 hours at 37C. 
Fluorescence is read at 540nm and 595nm for the Alamar Blue
®
 assay and difference in cell growth 
between untreated and drug treated cells is calculated (Chapter 2). At 48 hours post addition of the 
drug, 100µl MUG substrate is added and incubated at 37C. After 2 hours, GUS activity is quantified 





4.4.3 Kinase inhibitors will be screened for ability to induce 
stumpy formation  
Having established a method for the high-throughput screening of compounds able to 
induce stumpy formation, it remained to select an appropriate group of compounds to 
test. It was decided that a library of 6708 kinase inhibitors would be an appropriate 
set of compounds. These were chosen for two key reasons: firstly, kinases play an 
important role in many cell processes and there is evidence that they are involved in 
the stumpy induction pathway (Domenicali Pfister et al., 2006; Vassella et al., 
2001b) (section 1.7.3); secondly, kinases are thought to be potential drug targets in 
trypanosomes (Doerig, 2004; Naula et al., 2005; Parsons et al., 2005) and therefore 
they have therapeutic potential.  
  
At the time of production of this thesis, assay development and compound screening 
were still underway at the Drug Discovery Unit at the University of Dundee. The 
screen will include a primary single point screen at 16.6µM, repeats and potency 
testing of positive results. Any compounds identified from the screen as inducers of 
stumpy formation will be subject to further analysis, including monitoring the ability 
for compounds to cause an increased capacity for differentiation to the procyclic life 
stage (section 4.6.7).  
 
4.5 Production of a pleomorphic reporter cell line for 
analysis of stumpy formation 
Monomorphic reporter cell lines for the analysis of stumpy formation in vitro have 
successfully been produced. However, for the analysis of SIF, the use of a 
pleomorphic reporter cell line was required. Serial passage of bloodstream 
trypanosomes in culture selects for monomorphism: cells which respond to SIF and 
differentiate to the stumpy-life stage die and are lost from the population, whereas 
any slender forms which do not respond to SIF will continue to proliferate and take 
over the culture (see section 4.6.5). As such, pleomorphic cell lines are less 




density and the difficulty in successfully culturing and genetically manipulating these 
cells.  
 
However, over recent years, advancements have been made in developing methods to 
culture pleomorphic cells (McCulloch et al., 2004; Vassella and Boshart, 1996). In 
particular, the addition of methyl cellulose to the media (McCulloch et al., 2004) aids 
pleomorphic cell growth. Additionally, a pleomorphic cell line, AnTat1.1 90:13, 
which has been culture adapted and transfected to enable tetracycline-inducible gene 
expression or RNAi, is available (Engstler and Boshart, 2004).  
 
The original pHD617 CAT-PAD1 3’UTR construct (Table 4.1) contained a 
tetracycline-repressor binding site upstream of the CAT reporter gene. If transfected 
into the AnTat1.1. 90:13 cell line, which expresses the tetracycline repressor protein, 
this construct would require addition of tetracycline for expression of the construct. 
The tetracycline-repressor binding site was therefore removed from the construct 
before transfection into AnTat1.1 90:13 cells. After numerous attempts, a transgenic 
pleomorphic reporter cell line, AnTat1.1 90:13 CAT-PAD1 3’UTR, was successfully 
created for the analysis of the effects of conditioned media, containing SIF, in vitro.  
 
4.5.1 Validation of the AnTat1.1 90:13 CAT-PAD1 3’UTR reporter 
cell line in vivo 
In order to determine if the AnTat1.1 90:13 CAT-PAD1 3’UTR reporter cell line 
exhibited the expected pattern of CAT mRNA and protein expression, two mice were 
infected with the cell line. Trypanosomes were harvested from one mouse on day 
three post infection when the population was predominantly slender. Trypanosomes 
were harvested from the second mouse on day 6 post infection when the population 
was predominantly stumpy. Slender form AnTat1.1 90:13 CAT-PAD1 3’UTR cells 
express very little CAT protein or mRNA (Figure 4.11). Stumpy forms, however, 
express a large amount of CAT protein and mRNA compared to the slender forms 
(Figure 4.11). Therefore the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line can act as a 




of the reporter gene under control of the PAD1 3’UTR confirms the conclusions of 
Chapter 3, that the PAD1 3’UTR is responsible for the stumpy-specific gene 

























































































Figure 4.11 The AnTat1.1 90:13 CAT-PAD1 3’UTR expresses the CAT reporter gene in stumpy 
forms. Slender and stumpy populations of the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line were 
isolated from mice infections. (A) The slender population expresses little CAT protein whereas the 
stumpy population expresses comparatively high levels of CAT protein (B) The slender population 
expresses little CAT mRNA whereas the stumpy forms express comparatively high levels of CAT 
mRNA. Parental cells express no CAT mRNA, as expected.  
 
4.5.2 Culturing the reporter cell line in vitro 
Having established that the pleomorphic reporter cell line expressed the reporter gene 
appropriately in vivo, the cell line was then analysed in vitro. To grow the 
pleomorphic cell line in vitro for the purpose of transfection, media containing 
methyl cellulose had been used. However, the inclusion of methyl cellulose in the 
media prevents counting of the cells by the use of a coulter counter and instead 
requires the use of a haemocytometer. As the CAT reporter assay requires that an 
accurate cell count is taken for analysis, it was decided that the use of methyl 






As this cell line had previously been cultured in the presence of methyl cellulose, it 
was initially thought that the trypanosomes may need to adapt to media without 
methyl cellulose. For that reason, cells were grown for up to one week without 
methyl cellulose in order to attempt to further culture-adapt the cells before the start 
of any experiment. However, as cell density had to be maintained at very low 
densities to prevent stumpy formation, it was difficult to obtain enough cells to start 
an experiment. For example, for an experiment to compare only two factors, each in 
triplicate, in 10ml flasks at a starting concentration of 1 x 10
5 
cells/ml, a total of 6 x 
10
6
 cells are required. From a culture of cells maintained at no greater than 5 x 10
4
 
cells/ml to prevent stumpy formation, a minimum of 120ml of culture is required. 
Additionally, cells did not reliably grow at such low densities and as such, would 
often die. The cell death was not a result of growth in culture per se, as cells could be 
grown reliably in culture at a higher density (for example, see Figure 4.12B).  
 
Despite being unable to maintain a slender population in vitro, it was discovered that 
slender forms of the pleomorphic reporter cell line harvested from a mouse infection 
could be grown in culture without the use of methyl cellulose, at least over a 72 hour 
time frame (for example, see Figure 4.12B) without any further prior adaptation to 
culture. Therefore, all cells used for experimentation were obtained from mice three 
days post infection when the population is predominantly slender. Cells were 
purified from the blood and incubated in pre-warmed media without methyl 
cellulose.  
 
4.5.3 Characterisation of the pleomorphic reporter cell line in vitro  
To establish if the AnTat1.1 90:13 CAT-PAD1 3’UTR reporter cell line was 
expressing the reporter gene appropriately in vitro, slender cells were harvested from 




 cells/ml in triplicate. Cell density and CAT 
protein expression was measured every 24 hours for 72 hours (Figure 4.12).  Cells 
seeded at 10
5
 cells/ml showed an increase of the CAT protein expression over time 
(Figure 4.12A) as the population density increased slowly (Figure 4.12B). In 
contrast, cells seeded at 10
6




lack of proliferation was not due to an inability of these cells to survive in culture as 
they were from the same starting populations as the cells seeded at 10
5
 cells/ml 
(Figure 4.12B). These cells did, however, show increased reporter gene expression 
over the first 48 hours, reaching expression levels almost as high as an in vivo-
derived stumpy population (Figure 4.12A) indicating that the population, although 
not growing well, was able to differentiate to stumpy forms. Indeed the lack of 
growth may be due to rapid cell cycle arrest of the population. At 72 hours, the cells 
seeded at 10
6
 cells/ml had reduced CAT expression compared to 48 hours, which 
may represent senescence of the stumpy population. Additionally, the decrease in 
CAT protein expression in the population between 48 and 72 hours suggested that 
the protein is being turned over and that the increase in protein expression over time 




 cells/ml is an increase in CAT protein 
production and not simply accumulation of the protein.  
 
The reduced increase in CAT expression in cells seeded at 10
5
 cells/ml compared to 
cells seeded at 10
6
 cells/ml, demonstrates that the AnTat1.1 90:13 CAT-PAD1 
3’UTR reporter cell line is responding to cell density (Figure 4.12). That is, those 
cells at a lower density have lower reporter gene expression. This would be expected 
from a stumpy-specific marker as cells differentiate in a density dependent manner 
(Vassella et al., 1997). These results demonstrate that the pleomorphic reporter cell 
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Figure 4.12 The AnTat1.1 90:13 CAT-PAD1 3’UTR responds to cell density. Slender AnTat1.1 
90:13 CAT-PAD1 3’UTR cells were harvested from a mouse infection and transferred into culture 




 cells/ml in triplicate. (A) CAT protein 
expression was monitored every 24 hours. The cell line showed an increase in CAT reporter 
expression over time (normalised to cell number) in culture in a density dependent manner. The CAT 
reporter gene expression of a stumpy population from a mouse infection is shown for comparison. (B) 
Cells seeded at 10
5
 cells/ml grew slowly over the 72 hour time period. (C) Cells seeded at 10
6
 cells/ml 
did not grow well over the 72 hour time period. As these cells were from the same starting population 
as those seeded at 10
5
 cells/ml, the lack of growth is not due to a general inability to grow in culture. 






4.5.4 The pleomorphic reporter cell line does not respond to 
monomorphic or pleomorphic conditioned media in vitro 
The AnTat1.1 90:13 CAT-PAD1 3’UTR reporter cell line provides a method to study 
stumpy formation in pleomorphic cells in vitro and hence may be used to further 
characterise the putative density-signalling factor, SIF. Although the identity of SIF 
is unknown, there are numerous characteristics of this factor that have been 
determined (section 1.7.3). SIF is produced by the parasite and is sufficient to induce 
the slender to stumpy transition without the requirement for host processes (Reuner 
et al., 1997; Vassella et al., 1997). The factor, which may be a combination of 
chemical inducers, is small enough to pass through a filter with a 500Da cut-off and 
therefore is thought to potentially be a small metabolite. The factor is stable in vitro 
and can be maintained at 37C for up to 27 days and can be heated to 90C for 15 
minutes without loss of activity (Vassella et al., 1997), but has been proposed 
through mathematical modelling to have a half-life of 1.4 hours in vivo (Savill and 
Seed, 2004). Further, it has been demonstrated that both pleomorphic and 
monomorphic conditioned media is able to induce stumpy formation in pleomorphic 
cells with similar kinetics (Vassella et al., 1997). Thus, it appears that monomorphic 
cells produce SIF at the same rate as pleomorphic cells, supporting the proposal that 
SIF may be a metabolite.  
 
Given that conditioned media contains SIF, it would be expected that treatment of 
the AnTat1.1 90:13 CAT-PAD1 3’UTR reporter cell line with conditioned media 
from both monomorphic and pleomorphic reporter cell lines would cause the cells to 
differentiate to the stumpy form and that the CAT reporter expression would 
consequently increase. If this were the case, the cell line would provide a method to 
track SIF activity. It follows that different conditioned media could be analysed by 
both ability to induce stumpy formation and composition by mass spectrometry: by 
comparing the results, it may help to identify SIF. 
 
To prepare monomorphic conditioned media, 427 cells were seeded at 1 x 10
5
 




of 7.8 x 10
6
 cells/ml. The culture was then centrifuged to pellet the cells and the 
supernatant was collected. The conditioned media was then filter sterilised through 
an 20µm filter, which should not cause loss of the SIF, given that it can pass through 
a filter with a 500Da cut-off (Vassella et al., 1997). In case there was any effect of 
keeping media at 37C with 5% CO2, ‘untreated’ media without cells was also kept 
as a control in the incubator and was also filter sterilised before use.  
 
As pleomorphic cells did not grow well at high density (Figure 4.12C), to prepare 
pleomorphic conditioned media, AnTat1.1 90:13 cells were grown in culture, 
maintained at a density less than 1 x 10
6
 cells/ml. Cells were passaged daily and the 
remaining culture media was collected and pooled. As such, the density of the 
pleomorphic culture was not particularly high and SIF was not allowed to 
accumulate over time. Despite this, there should still be a small amount of SIF 
compared to fresh media which will not contain SIF. The pleomorphic conditioned 
media was also filter sterilised through a 20µm filter. 
 
To treat AnTat1.1 90:13 CAT-PAD1 3’UTR cells with conditioned media, slender 
cells were harvested from a mouse infection and transferred to pre-warmed culture 
media at a density of 1 x 10
5
 cells/ml. Cells were incubated in media composed of 
50% fresh media and 50% monomorphic or pleomorphic conditioned media, or 
untreated media, which had been incubated at 37C but contained no trypanosomes. 
Cells were then incubated for 48 hours, with cell density and CAT reporter 
expression measured at 10, 24 and 48 hours (Figure 4.13).  
 
Cells incubated in conditioned media grew less well than those incubated in 
untreated media (Figure 4.13A). Disappointingly however, cells treated with either 
pleomorphic or monomorphic conditioned media showed decreased CAT reporter 
gene expression compared to those maintained in untreated media after 48 hours 
(Figure 4.13B). Hence, under these conditions, the AnTat1.1 90:13 CAT-PAD1 
3’UTR reporter cell line did not respond to either pleomorphic or monomorphic 
























































































Figure 4.13 The AnTat1.1 90:13 CAT-PAD1 3’UTR does not respond to pleomorphic or 
monomorphic conditioned media.  Slender AnTat1.1 90:13 CAT-PAD1 3’UTR cells were harvested 
from a mouse infection and transferred into culture medium composed of 50% fresh media and 50% 
monomorphic or pleomorphic conditioned media or untreated media. (A) Cells grown in conditioned 
media grew less well than those grown in untreated media after the first 10 hours. (B) Cells grown in 
untreated media showed the greatest increase in CAT reporter gene expression, normalised to cell 





Although the conditioned media was diluted 50:50 with fresh media, it is likely that 
the conditioned media had reduced nutritional capacity compared to untreated media. 
It would not be expected that this would be a limiting factor for growth given the low 
cell density of the culture (starting at 1 x 10
5
 cells/ml) and the addition of fresh 
media. However, this may possibly account for the decrease in cell proliferation 
observed (Figure 4.13).  
 
The difference in cell density between the three groups of cells may account for the 
observed differences in CAT expression as the AnTat1.1 90:13 CAT-PAD1 3’UTR 
cell line responds to population density (section 4.5.3). Biologically, it is likely that it 
is not cell density at a given time point that is relevant but rather the total number of 
cells producing SIF over the duration of the experiment. For example, imagine two 
populations, A and B, starting at 1 x 10
5
 cells/ml. Population A grows to 5 x 10
5
 
cells/ml in 24 hours and then grows no further in the following 24 hours whereas 
population B does not grow for the first 24 hours, but in the following 24 hours 
grows to 5 x 10
5
 cells/ml. Both populations will have a final density at 48 hours of 5 
x 10
5
 cells/ml, but population A will have had 24 hours at maximum population 
density to accumulate SIF, compared to population B which will have a lower 
accumulation of SIF. Of course, this may be complicated further by the rate of 
turnover of SIF, and if this is dependent on cell density, which is unknown. 
Additionally, it is not known if cells which are committed to stumpy formation 
produce SIF and as such inequalities in SIF production relative to the growth phase 
are unknown, but could also complicate analysis.  
 
Regardless of the reason for the decrease in CAT protein in cells treated with 
conditioned media compared to untreated media, the most notable outcome of this 
experiment was that there was no increase in CAT expression in response to 
conditioned media under these conditions. As previously mentioned, one of the 
possible explanations for the lack of response of the reporter cell line to conditioned 
media is that the media was no longer optimised for cell growth. It is unlikely that at 
such low cell density the media, which is composed of 50% fresh media, would have 




trypanosomes had a detrimental effect. Trypanosomes, and indeed all cell types, 
must regulate their internal pH in order to maintain the correct pH for intracellular 
processes. As a result, culture media is prepared at a pH of 7.5 but growth of the 
trypanosomes in the media causes a decrease in the pH, making the conditioned 
media more acidic. Although trypanosomes are able to regulate their internal pH it 
has been shown that an external pH of 5.5 can induce bloodstream to procyclic 
differentiation in the absence of CCA (Rolin et al., 1998) and slender forms are 
particularly sensitive to pH stress compared to stumpy forms (Nolan et al., 2000). 
The pH of the conditioned media was not as low as 5.5 (actual pH unknown) but if it 
were causing differentiation to the procyclic form it would be expected that actually 
this would also cause an increase in CAT reporter gene expression. Despite this, it is 
still possible that more acidic pH of the conditioned media affected the 
differentiation processes or growth of the cells. Indeed, Vassella et al., prepared 
conditioned media by readjusting the pH to 7.5 and supplementing the cells with 
additional FCS. Thus, this was examined by treating the AnTat1.1 90:13 CAT-PAD1 
3’UTR cells with modified conditioned media (Vassella et al., 1997). To achieve 
this, monomorphic conditioned media was prepared by seeding 427 cells at a density 
of 5 x 10
5
 cells/ml and incubating them for 48 hours without passage such that cells 
reached a density of 8.7 x 10
6
 cells/ml. The culture was centrifuged to pellet the cells 
and the supernatant was collected. To modify the conditioned media, the pH was 
readjusted to 7.5 by the addition of NaOH and 20% FCS was added. The medium 
was then filter sterilised through a 20µm filter. Unmodified media and untreated 
media were also included as controls. 
 
To treat AnTat1.1 90:13 CAT-PAD1 3’UTR cells with modified conditioned media, 
slender cells were harvested from a mouse infection and transferred to pre-warmed 
culture media at a density of 1 x 10
5
 cells/ml. Cells were incubated in media 
composed of 50% fresh media and 50% monomorphic conditioned media or 
untreated media which had either been unmodified, or modified as detailed above. 
Cells were then incubated for 24 hours, with cell density and CAT reporter gene 
expression measured at 10 and 24 hours (Figure 4.14). Each treatment was 




For cells grown in untreated media, there was an initial increase in cell proliferation 
in modified media compared to unmodified media, which then reversed after 24 
hours (Figure 4.14A). This may have represented the cell line proliferating at a 
greater rate initially, and then responding to the increased cell density and starting to 
exit the cell cycle as they differentiated to stumpy forms. Indeed this correlates with 
the increase in CAT expression observed in cells incubated in modified media 
compared to unmodified media after 24 hours (Figure 4.14B). Cells grown in 
conditioned media, both modified and unmodified, had decreased proliferation 
compared to untreated media (Figure 4.14A). Modified conditioned media caused a 
greater decrease in cell proliferation than unmodified conditioned media, suggestive 
that the modified conditioned media was perhaps causing cell cycle arrest and 
stumpy formation. However, there was no increase in CAT reporter expression in 
cells treated with either modified or unmodified conditioned media compared to 
those treated with control media (Figure 4.14B). Although this analysis only 
considered effects up to 24 hours, further analysis with modified media, up to 72 
hours (see section 4.5.5) confirmed this observation. Thus, under these conditions the 
reporter cell line did not respond to monomorphic conditioned media. Further, this 
























































































Figure 4.14 Adjusting the pH and addition of FCS to monomorphic conditioned media does not 
cause a response in AnTat1.1 90:13 CAT-PAD1 3’UTR cells.  Slender AnTat1.1 90:13 CAT-PAD1 
3’UTR cells were harvested from a mouse infection and transferred into culture medium composed of 
50% fresh media and 50% monomorphic conditioned media or untreated media which had either been 
unmodified, or modified by the addition of 20% FCS and adjusted to pH 7.5. (A) Cells grown in 
conditioned media grew less well than those grown in untreated media. After 24 hours, cells grown in 
modified media grew less well than those in unmodified media (B) All cells increased CAT reporter 
expression over time in culture, normalised to cell number. However, after 24 hours, there was no 
difference between cells grown in modified conditioned media compared to unmodified media. Error 




4.5.5 Maintaining low cell density can prevent increased reporter 
gene expression in the pleomorphic reporter cell line 
The AnTat1.1 90:13 CAT-PAD1 3’UTR cell line had not responded to conditioned 
media, with or without modification of that media. Nonetheless, the population of 
cells will themselves be producing SIF in culture. As the half-life of SIF is unknown, 
although it has been shown to be stable over a 27 day period, it may be that the 
conditioned media used had lost some activity.  As such, it was possible that the SIF 
accumulated in the population will have a greater effect than SIF from conditioned 
media and, given the difference in cell proliferation between cells grown in 
conditioned media versus control media, this may have confounded the analysis.  
 
If the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line could be maintained at low cell 
density this should prevent the increase in CAT reporter gene expression over time in 
culture. Moreover, the addition of conditioned media to cells maintained at low cell 
density should allow the observation of an effect of conditioned media, as there 
should be only a low amount of the SIF produced by the population. 
 
To test these hypotheses, monomorphic conditioned media was prepared by seeding 
427 cells at 1 x 10
5
 cells/ml and incubating them for 72 hours without passage such 
that cells reached a density of 6.7 x 10
6
 cells/ml. The culture was centrifuged to 
pellet the cells and the supernatant was collected. Despite the modification of the 
conditioned media not causing an increase in CAT reporter expression (section 
4.5.4), the pH was again readjusted to 7.5 and 20% FCS was added. The media was 
then filter sterilised through a 20µm filter.  
 
To maintain AnTat1.1 90:13 CAT-PAD1 3’UTR cells at low density with and 
without conditioned media, slender cells were harvested from a mouse infection and 
transferred to pre-warmed culture media at a density of 1 x 10
5
 cells/ml. Cells were 
then incubated in media composed of 50% fresh media and 50% monomorphic 
conditioned media or untreated media. Cells were then incubated for 72 hours, with 
cell density being measured every 12 hours after the first 24 hours. Every 12 hours 




50% monomorphic conditioned media or untreated media. A control group of cells 
were not split during the experiment. In each case, CAT reporter expression was 
measured every 24 hours (Figure 4.15) and all treatments were performed in 
triplicate.   
 
Figure 4.15 shows that it was possible to maintain low CAT expression in the 
AnTat1.1 90:13 CAT-PAD1 3’UTR cell line by maintaining the cells at a low 
density. This confirms that the reporter cell line responds to cell density as shown 
previously in section 4.5.3. At the 24 hour time point all cells had been treated 
equally (as no samples were diluted until this time). Therefore, the differences in 
CAT expression observed at 24 hours did not reflect an effect of treatment and the 
cause of these differences in unknown.  
 
Figure 4.15A shows that whilst there may have been a small effect of monomorphic 
conditioned media on cell growth at 48 and 72 hours, no effect on CAT reporter gene 
expression was seen compared to those cells diluted with untreated media (Figure 
4.15). This indicates that the lack of observed effect of monomorphic conditioned 
media on the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line was not due to cell 
density, via the action of the population’s own SIF, confounding the effect.  
 
With more time it would be possible to explore the numerous possible reasons that 
the cell line does not respond to conditioned media, as will be discussed in section 
4.6.3. Despite the lack of response to conditioned media under these conditions, the 
AnTat1.1 90:13 CAT-PAD1 3’UTR pleomorphic reporter cell line did however 
display appropriate reporter gene expression in vivo (section 4.5.1) and did respond 
to population density in vitro (section 4.5.3) Hence, it still provides an invaluable 
tool for the analysis of stumpy formation and potentially for the characterisation of 












































































Figure 4.15 CAT reporter expression could be kept low by maintaining the AnTat1.1 90:13 
CAT-PAD1 3’UTR cells at a low cell density. Slender AnTat1.1 90:13 CAT-PAD1 3’UTR cells 
were harvested from a mouse infection and transferred into culture medium composed of 50% fresh 
media and 50% monomorphic conditioned media or untreated media. Cells were diluted to a starting 
concentration of 1 x 10
5
 cells/ml every 12 hours. A control group of cells were not passaged. (A) Cells 
grown in conditioned media as well as those than grown in untreated media. (B) Cells which had not 
been diluted showed increased CAT reporter expression, normalised to cell number, over time in 
culture. Cells diluted into fresh or conditioned media both showed reduced CAT reporter gene 
expression compared to undiluted cells. There was no difference between CAT reporter gene 
expression in cells diluted with fresh or conditioned media. CM = conditioned media. Error bars 




4.6 Discussion  
4.6.1 Monomorphic and pleomorphic reporter cell lines have been 
produced for analysis of stumpy formation in vitro. 
The identity of the parasite-derived density sensing molecule, SIF, remains unknown, 
despite being proposed over 10 years ago (Vassella et al., 1997). Additionally, little 
is known about the signalling pathway through which SIF acts. This is largely due to 
a lack of efficient tools for the analysis of stumpy formation both in vivo and in vitro. 
The discovery of the stumpy-specific surface protein, PAD1 (Dean et al., 2009), 
provided a molecular marker for the stumpy life stage. It was demonstrated in 
Chapter 3 that the 3’UTR of the PAD1 gene is sufficient for stumpy-specific gene 
expression and, as such, this could be utilised for the production of reporter cell lines 
for the stumpy life stage. Here, both monomorphic and pleomorphic reporter cell 
lines have been created which allow the analysis of stumpy formation in vitro. The 
monomorphic cell lines were used for rapid and objective analysis of chemical 
inducers of stumpy formation, which may aid in the characterisation of the stumpy 
induction pathway and allow for identification of compounds with potential 
therapeutic uses. The pleomorphic cell line has the potential for the characterisation 
and, potentially, the identification of SIF. So far, however, this reporter system has 
not demonstrated stumpy inducing activity in conditioned media.   
 
4.6.2 The AnTat1.1 90:13 CAT-PAD1 3’UTR cell line responds to 
cell density in vivo and in vitro 
It was confirmed that in the AnTat1.1 90:13 CAT-PAD1 3’UTR pleomorphic 
reporter cell line, both the CAT mRNA and protein are developmentally regulated in 
vivo (section 4.5.1). Hence, the cell line is pleomorphic, as expected, and the PAD1 
3’UTR is confirmed as sufficient for stumpy-specific gene expression.  
 
In culture, the reporter cell line responded to high cell density (section 4.5.3) and 
reporter expression could be maintained at a low level by maintaining a low 




for the analysis of stumpy formation (see section 4.6.4). Despite the appropriate 
expression of the cell line in response to the population’s own cell density, the cell 
line has, so far, failed to respond to conditioned media however. 
 
4.6.3 The AnTat1.1 90:13 CAT-PAD1 3’UTR cell line does not 
respond to conditioned media 
SIF is the density-sensing signal produced by the parasite, which induces the slender 
to stumpy transition. As the parasite produces SIF it is released into the culture media 
such that conditioned media from a dense parasite population contains SIF activity 
and can be used to induce stumpy formation at low cell density (Vassella et al., 
1997). Therefore, the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line was treated with 
conditioned media and reporter gene expression was monitored (section 4.5.4 and 
4.5.5). It was expected that the addition of conditioned media would result in an 
increase in reporter expression compared to control media due to the presence of SIF. 
However, despite numerous attempts, not all of which are shown here, this was never 
observed. As we have no positive control, interpretation of these negative results 
becomes difficult. Indeed it had been expected that perhaps conditioned media would 
act as a positive control for further experimentation given that it is proposed to 
contain SIF.  
 
There are numerous possible reasons for the lack of response of the cell line to 
conditioned media. The two broad possibilities are that (a) the conditioned media 
does not support stumpy formation or (b) that the cell line is unable to respond to 
SIF. Firstly, the possibility that the conditioned media does not support stumpy 
formation shall be considered.  
 
It could be that there is no SIF in the conditioned media. For the pleomorphic 
conditioned media, a low density of cells were used and SIF was not allowed to 
accumulate over time. Although, it may be expected that even a small amount of SIF 
would result in an increase in reporter expression compared to control media it may 




this cannot be ruled out as a possible explanation for the lack of response to 
pleomorphic conditioned media. For the monomorphic conditioned media, cell 
density was high (always above 6.5 x 10
6
 cells/ml) and SIF was allowed to 
accumulate for at least 48 hours. These conditions should definitely cause the 
conditioned media to contain SIF, unless the monomorphic cell line was not 
producing SIF at all. This is highly unlikely. A monomorphic cell line, related to the 
one used here, was shown to produce SIF at approximately the same rate as two 
different pleomorphic cell lines (Vassella et al., 1997), which would concur with the 
hypothesis that SIF is a small metabolite. Additionally, it is unlikely that 
monomorphic cell lines are monomorphic due to an inability to produce SIF; rather 
they would be predicted to be unable to perceive the signal (see section 4.6.5). 
Although unlikely, however, it cannot be excluded that our monomorphic cells do 
not produce SIF. Hence, it would be appropriate to repeat the attempts at inducing 
stumpy formation via the action of pleomorphic conditioned media which had been 
allowed to accumulate SIF to a greater extent than carried out here. Alternatively, the 
cell line used by Vassella et al., could be evaluated. 
 
Another explanation is that the conditioned medium may have lost SIF activity. This 
would be unexpected given that Vassella et al., were able to store the conditioned 
media for up to 27 days, heat it to 90C, and filter through a 500Da cut-off without 
loss of SIF activity (Vassella et al., 1997). Indeed our, conditioned medium was 
stored for less than one week and was only filtered through a 20µM filter to remove 
any potentially remaining trypanosomes. To establish if loss of SIF activity during 
storage is indeed a problem, however, the pleomorphic reporter cell line could 
potentially be grown in a transwell system along with a high density of pleomorphic 
or monomorphic cells. This would result in the cell line being exposed directly to 
fresh conditioned media without the requirement for processing or storage of that 
media.  
 
Given that all conditioned media used by Vassella et al., was ultra-filtered, it could 
be speculated that there is an inhibitory factor preventing stumpy formation in the 




(Vassella et al., 1997). This seems unlikely, as it would require complex dynamics 
between a positive and negative stumpy induction factor, for which there is no 
evidence. It also seems unlikely that the conditioned media is having some toxic 
effect on the cells, which then prevents stumpy formation, as cell growth is still 
observed (Figure 4.13, Figure 4.14 and Figure 4.15). Also, those cells which do grow 
would presumably still be capable of responding to the high concentration of SIF 
expected to exist in the monomorphic conditioned media.  
 
Perhaps it would be appropriate to attempt to induce stumpy formation via the action 
of stumpy inducing chemicals such as cell permeable cAMP ((Vassella et al., 1997) 
and see section 4.3). Should the cell line respond to chemical induction this would 
indicate that indeed the conditioned media does lack stumpy inducing activity and 
that the cell line is capable of responding to triggers of stumpy formation under these 
conditions. However, if the cAMP was unable to induce stumpy formation, the 
results would imply that the cell line is unable to respond to stumpy inducing signals 
under these conditions. 
 
It is not the case that our reporter line is unable to differentiate to stumpy forms at 
all, as it has been shown that it responds to its own cell density both in vivo and in 
vitro. Therefore, the possibility that the cell line is simply unable to differentiate can 
be excluded. Nonetheless, it may be that under the conditions used in this study the 
cell line is unable to respond to SIF. A fundamental difference in the conditions used 
is that here cells are grown in liquid culture, whereas Vassella et al., use semi-solid 
agarose plates for cell culture. It was decided not to use semi-solid agarose plates at 
the start of this study due to the tendency for cells to form localised clusters of cells 
which may create regions of high local density on an otherwise low density plate 
(Reuner et al., 1997). This has two implications; the first being that it may create 
high local concentrations of SIF which would confound analysis of SIF. 
Alternatively, however, it may provide cells with a high degree of cell-to-cell contact 
in a local area. Perhaps, to induce stumpy formation two factors are required: the 
diffusible stumpy induction factor and cell-to-cell contact. It was concluded in the 




was achieved at low cell density (Vassella et al., 1997). However, if the local cell 
density in a cluster of cells on a semi-solid agarose plate was sufficient to fulfil this 
requirement, but the local SIF concentration is not, then this would result in the same 
positive response to conditioned media as if SIF is required alone. If this were the 
case, it may be that the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line does not 
respond to SIF due to a lack of cell-to-cell contact in a homogenous liquid culture. 
To test if this is the case, it would be appropriate to replicate the conditions used by 
Vassella et al., to grow the reporter cell line on semi-solid agarose plates and 
determine if there is any observed effect of conditioned media. If there was, this 
would confirm that the conditioned media contains SIF, but also opens up the 
possibility that SIF is not the only factor required.  
 
Indeed, there is the potential for many further experiments to ascertain the reason for 
the lack of response of the pleomorphic reporter cell line to conditioned media which 
will then allow use of the cell line for the characterisation of SIF. Also, 
understanding the reason why the cell line does not respond might in itself help to 
further characterise the stumpy induction pathway.  
 
4.6.4 The AnTat1.1 90:13 CAT-PAD1 3’UTR cell line could provide 
a method for the identification of SIF 
Although the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line has not responded to 
conditioned media, this problem may be resolved with further analysis, as has been 
discussed (section 4.6.3). If this can be resolved, the cell line provides a valuable tool 
for the characterisation and perhaps identification of SIF. For instance, the cell line 
could be used to track SIF activity in conditioned media. The media could potentially 
be fractionated and SIF activity tracked to specific fractions. Those fractions with 
SIF activity could then be subject to mass spectrometry which may identify the 
chemical identity of SIF. Alternatively, different conditioned media produced and 
treated in different ways, such as different durations of SIF accumulation or filtration 
of the media could be compared for both SIF activity and composition by mass 




Considering the identity of SIF has remained elusive for so long, there is a huge 
requirement for a method to track stumpy formation in order to identify this factor. 
The developed cell line will provide a key reagent for this, albeit one requiring 
further optimisation.  
 
4.6.5 The 427 CAT-PAD1 3’UTR cell line further demonstrates that 
monomorphic cells are not incapable of stumpy-formation 
per se 
It was confirmed in the 427 CAT-PAD1 3’UTR monomorphic reporter cell line, that 
both CAT mRNA and protein increase in response to stumpy-inducing compounds. 
This confirms that the cell line is a suitable tool for the analysis of stumpy formation 
in monomorphs and that monomorphs are capable of, at least partially, undergoing 
some steps in the progression to the stumpy form.  
 
Monomorphic cells are essentially artefacts of cell culture procedures. In a natural 
infection, only stumpy cells are capable of transmission. As such, the capacity for 
perception of population density and differentiation to the stumpy-life stage is 
maintained by cyclical transmission. Conversely, in the laboratory there is a selective 
advantage for any mutation that prevents an individual cell from perceiving, or 
responding to, increased population density, as stumpy cells are exited from the cell 
cycle and, in culture, will die. The resulting monomorphic cells are most commonly 
studied in the laboratory because they proliferate well and show low levels of 
antigenic variation. The latter phenomenon, in particular, has greatly aided the 
molecular understanding of VSG switching mechanisms.  
 
In a whole population, a mutation in a single cell that prevents the production of SIF 
would not prevent the differentiation of that individual cell given that the rest of the 
population would continue to make SIF. As such, it is unlikely that monomorphic 
cells arose from a mutation in the production of SIF. It is not impossible, however, 
that after some initial mutation, monomorphs subsequently lost the capacity to 




hypothesised to be a small metabolite (Vassella et al., 1997) and monomorphic 
conditioned media has been shown to be capable of inducing stumpy formation as 
well as pleomorphic conditioned media (Vassella et al., 1997), but until the identity 
of SIF is exposed, it is not possible to be certain. Moreover, different passage 
histories of even the same monomorphic lines in different laboratories may generate 
different phenotypes through independent mutations after the populations diverged. 
 
It remains, therefore, that monomorphs are either unable to perceive or unable to 
respond to SIF. As monomorphic cells are able to generate stumpy or stumpy-like 
cells in response to analogues of cAMP ((Laxman et al., 2006; Vassella et al., 1997) 
and section 4.3), they are not incapable of differentiating to stumpy forms per se. 
Nonetheless, these compounds do not appear to induce full differentiation to the 
stumpy life stage (see section 4.6.6 for further discussion) and one of the possible 
explanations for this is that monomorphic cells have a reduced capacity for 
transmission of the SIF signal.  
 
It seems that the most likely initial mutation in monomorphic cells is in the reception 
of SIF. If SIF is transmitted through a single receptor then a single mutation could 
prevent stumpy formation. In this case, induction of stumpy formation by compounds 
such as cAMP analogues, would act by by-passing the reception mutation by 
inducing downstream effectors of the stumpy induction pathway.  
 
As detailed above, monomorphs generated at different times in different laboratories 
could also have different initial mutations. Moreover, it is certain that monomorphic 
cell lines will have acquired numerous additional mutations during long term cell 
culture that may or may not impact on the stumpy induction pathway and that will 
vary between laboratories. Differences between the cell lines in different laboratories 
may account for differences in the effects of drugs on different monomorphic cell 
lines. For instance, it was observed that Troglitazone was able to induce stumpy-like 





A large-scale analysis of the differences between monomorphic and pleomorphic 
cells, either by genome sequencing or by microarray analysis, may identify mutations 
in the stumpy induction pathway or potentially reveal the SIF receptor. However, it is 
likely that many mutations irrelevant to the stumpy induction pathway between cell 
lines would also be observed. Perhaps the comparison between a newly created 
monomorphic cell line and its parental pleomorphic line would reduce the number of 
differences, making for less complicated analysis. Alternatively, the comparison of 
numerous pleomorphic lines with numerous monomorphic lines may identify 
recurring mutations between the two groups which may pinpoint genes of interest in 
this pathway. 
 
4.6.6 cAMP signalling in the stumpy induction pathway 
cAMP signalling has been implicated in the differentiation of trypanosomes since it 
was discovered that there are changes in the intracellular cAMP concentration during 
the slender to stumpy differentiation (Mancini and Patton, 1981) and during the 
bloodstream to procyclic differentiation (Rolin et al., 1993). When it was first 
recognized that the slender to stumpy transition was induced by the unidentified SIF, 
it was shown that cell permeable cAMP was able to mimic the actions of SIF in 
monomorphic and pleomorphic cell lines (Breidbach et al., 2002; Vassella et al., 
1997). It therefore seemed likely that cAMP is playing some role in the stumpy 
induction pathway. However, little is known about the mechanisms by which cAMP 
signalling act in kinetoplastids (section 1.7.3). Generally, in eukaryotes, cAMP 
transmits a signal via protein kinase A which phosphorylates transcription factors 
and causes changes in gene expression. This is clearly unlikely to be the mechanism 
that cAMP works in trypanosomes given the broad lack of regulation at the 
transcriptional level (section 1.10). Although PKA-like proteins have been identified, 
these often lack the cAMP-binding domain essential for cAMP-dependence (Seebeck 
et al., 2001). Proteins predicted to bind cAMP have been identified (Laxman and 
Beavo, 2007; Seebeck et al., 2001), but as yet, no protein has been shown to be an 
effector of cAMP in trypanosomes. When it was demonstrated that the hydrolysis 




monomorphic cells, this implied that a cAMP-type signalling pathway was unlikely 
to be acting during induction of stumpy formation (Laxman et al., 2006).  
 
Here, both 8pCPT-cAMP and 8pCPT-2’-O-Me-cAMP were used to validate reporter 
cell lines which act as molecular markers for the stumpy life stage. Both drugs 
caused increased stumpy-specific reporter gene expression as well as decreased cell 
proliferation and increased capacity for differentiation to the procyclic life-stage, all 
characteristics of stumpy cells. However, 8pCPT-cAMP did not cause any 
morphological change and although 8pCPT-2’-O-Me-cAMP did cause some 
morphological change, these cells did not look like true stumpy forms from a 
pleomorphic population (compare Figure 4.5E with Figure 5.9 and 5.13). As the 
drugs did not induce a full morphological change, this suggests that these drugs are 
not causing complete differentiation of slender to stumpy cells, but rather they are 
becoming ‘stumpy-like’. It is possible that this is due to a decreased capacity for 
culture-adapted monomorphic cells to differentiate to the stumpy life-stage, even 
after by-passing a perception mutation (see section 4.6.5). Alternatively, it may be 
that SIF has more than one downstream effector pathway and that the cAMP 
analogues are only targeting one of these pathways. The analysis of additional 
compounds able to induce stumpy formation may indicate if this is a likely 
explanation. A final possibility is that the addition of cAMP has other unknown 
effects on the cells which confound analysis.  
 
4.6.7 The 427 GUS-PAD1 3’UTR cell line provides a method for the 
identification of pharmaceutical inducers of stumpy 
formation 
The identification of a molecular marker that distinguishes the non-proliferative 
stumpy form provides the ability to develop high throughput screens for compounds 
that accelerate stumpy formation at abnormally low parasite density. The 427 GUS-
PAD1 3’UTR cell line provides a fast, simple assay for enhanced stumpy formation 




Each of the compounds identified by the 427 GUS-PAD1 3’UTR cell line will be 
validated initially by testing their action on the 427 CAT-PAD1 3’UTR/GUS-Actin 
3’UTR cell line. This will determine if the response seen in a high-throughput screen 
can be mimicked on a smaller-scale in the laboratory. The use of the constitutive 
reporter in the 427 CAT-PAD1 3’UTR/GUS-Actin 3’UTR cell line will ensure that 
there is not a global up-regulation of protein in response to the drug. Additionally, 
the testing for the capacity for differentiation to the procyclic life stage will ensure 
that the compounds cause the cells to become functionally stumpy. Having 
established that these compounds are able to cause stumpy formation in 
monomorphs, it will then remain to test the compounds on pleomorphic cells, 
potentially on the AnTat1.1 90:13 CAT-PAD1 3’UTR cell line to further confirm 
that they are inducing stumpy formation.  
 
The identification of these compounds has two potential rewards: their use as 
therapeutic compounds for the acceleration of parasite development; and potentially 
in the elucidation of the stumpy induction pathway.  
 
4.6.8 Further elucidation of the SIF pathway  
The compounds used in the screen for ability to induce stumpy formation were from 
a library of kinase inhibitors. There are approximately 176 putative protein kinases in 
the T.brucei genome (Parsons et al., 2005) and they likely play a role in the cell cycle 
and differentiation events (Naula et al., 2005). Given that kinases play an important 
role in many cell processes, it is likely that they also play a role in stumpy formation. 
Indeed, knock-out of two different kinases, ZFK and TbMAPK5, have both been 
shown to cause increased stumpy formation, suggesting a role in the stumpy 
induction pathway (Domenicali Pfister et al., 2006; Vassella et al., 2001b).   
 
By identifying kinase inhibitors that cause stumpy formation we may be able to 
identify kinases that act in the stumpy induction pathway. The targets of the kinase 
inhibitors could potentially be identified by a technique created by Cellzome which 




Kinobeads™ to select for those proteins and mass spectrometry for their 
identification (Bantscheff et al., 2007). This would then identify candidate proteins 
involved in stumpy formation that could then be studied further. This may provide 
key insights into the production of stumpy forms and the signalling pathways 
involved. 
 
4.6.9 Accelerated parasite development as a therapeutic tool 
If compounds are identified that are able to force the differentiation of slender forms 
to stumpy forms at low parasitaemia then this may have potential therapeutic 
consequences. Firstly, as trypanosome infections last from months to years, each 
infected individual can act as a reservoir for the disease for a considerable period of 
time. The degree of periodicity in their transmission capacity is poorly understood 
but potentially vital in a context where tsetse bites are rare or show seasonality 
(Baylis, 1997). During the chronic stage of a T.brucei infection in cattle, the 
parasitaemia fluctuates such that there are periods when the parasitaemia is 
sufficiently low to prevent the infection of tsetse flies feeding on the host (Van den 
Bossche et al., 2005). Therefore, differentiation of the population to the cell-cycle 
arrested stumpy form specifically at these points of very low parasitaemia could 
cause decreased transmissibility.  
 
Although accelerated parasite development has the potential to reduce host 
parasitaemia it also has the potential to increase the transmission potential of the 
population through increasing the proportion of stumpy forms. The extent of this risk 
depends on several factors: the density of parasites in the bloodstream, the number of 
parasites required to infect a tsetse fly and the efficiency of accelerated development. 
Assuming a typical parasitaemia in cattle of 10
5
 parasites/ml (Van den Bossche et al., 
2005) and an infective dose to tsetse under optimal conditions of 1 trypanosome 
(Maudlin and Welburn, 1989), then a reduction in parasite numbers of at least three 
orders of magnitude would be required to minimise the probability of parasite 
transmission in a tsetse blood meal. However, in the field chronic infections of cattle 




transmission, suggesting that the parasites may be on the threshold of 
transmissibility, particularly when compounded by seasonal effects. This might make 
transmission-blocking feasible.  
 
Moreover, if stumpy formation could be driven to 100% efficiency then the 
irreversible division arrest of these forms would ensure complete parasite elimination 
through cell senescence within only a few days, limiting the risks of enhanced 
transmission and providing a curative regime. Clearly, without better understanding 
of the transmission biology of trypanosomes in the field the prospects for a 
transmission blocking approach are difficult to assess and a more thorough 
understanding of the within-host dynamics would be required to predict the outcome 
of such a treatment.  This does, however, offer great potential for disrupting normal 
life-cycle progression and thereby restricting both pathogenicity and transmissibility 
of the parasite. 
  
It is satisfying, that the identification of the stumpy marker gene, PAD1 offers the 
ability to both screen for new drugs to accelerate stumpy formation, as described in 
this chapter, and to refine the transmission models required to optimise their potential 

















5 Chapter 5: Monitoring within-host dynamics of 





Trypanosome infections are characterised by periodic fluctuations in parasitaemia 
(Ross and Thomson, 1910). These fluctuations are caused by a combination of the 
slender to stumpy transition and antigenic variation (section 1.7). However, within-
host dynamics are not as well characterised due to the technical difficulty of 
quantifying slender and stumpy forms by microscopy, especially given the presence 
of cells with an intermediate morphology, which are in the transition process.  
 
As trypanosome infections last from months to years, each infected individual can 
act as a reservoir for the disease for a considerable period of time. However, the 
degree of periodicity in their transmission capacity is poorly understood but 
potentially vital in a context where tsetse bites are rare or show seasonality (Baylis, 
1997). Furthermore, through mathematic modelling it has been predicted that the 
production of stumpy forms is a key contributor to the ordered expression of distinct 
antigenic variants that sustain chronic trypanosome infections (Lythgoe et al., 2007). 
This, combined with the likelihood of co-infection with different trypanosome strains 
(Balmer and Caccone, 2008), generates the potential for complex infection dynamics 
with important possible implications for disease progression and transmission in 
endemic areas. Quantitative models for the dynamics of slender and stumpy parasites 
and fluctuating parasitaemia could allow the consequences of potential therapeutic 
strategies, such as those discussed in Chapter 4, to be predicted.  
 
PAD1 is a marker for transmission competence in individual cells (Dean et al., 
2009). Monitoring PAD1 expression provides a route to analyse the proportions of 
slender and stumpy forms during infections and to understand how the dynamics of 
these change throughout the course of a classical chronic infection.  Here, the use of 
PAD1 as a marker for the transmission stage during in vivo infection is investigated 





5.2 Establishing chronic trypanosome infections in mice 
In order to monitor within-host infection dynamics, it was first necessary to 
determine if it was possible to establish chronic infections in the mouse model 
system and, further, if characteristic fluctuations of the parasitaemia could be 
observed. As chronic infections had not previously been established in this 
laboratory there was the potential that either the trypanosome infection would 
overwhelm and kill the mouse, or that the mouse would be able to control infection 
after the first peak of parasitaemia. To investigate this, three male MF1 mice were 
infected with approximately 500 AnTat1.1 pleomorphic trypanosomes and the 
parasitaemia was monitored by microscopy over a 32 day period (Figure 5.1) using 
the rapid matching method for the quantification of parasitaemia (Herbert and 
Lumsden, 1976).  
 
Parasitaemia



























Figure 5.1 Chronic trypanosome infections in MF1 mice. Three MF1 mice were injected I.P. with 
500 AnTat1.1 pleomorphic trypanosomes at day 0. Parasitaemia was monitored by microscopy over a 
32-day period. Each “” represents a point at which the parasitaemia was measured. Error bars 
represent standard error of the mean. 
 
In all three mice a trypanosome infection was established, with the parasitaemia 
peaking twice at a density of approximately 10
7
 parasites/ml blood, as determined by 
microscopy. This demonstrated that not only is it possible to establish a chronic 
infection in this model system, but that fluctuations in parasitaemia could be 





5.3 RNA extraction, DNase treatment and cDNA production 
of trypanosome mRNA from whole-blood samples 
In order to track disease progression it was necessary to examine constitutive 
transcript levels in order to monitor parasitaemia (section 5.4) and relative stumpy-
specific transcript levels to monitor transmissibility (section 5.5) throughout an 
infection. Hence, it was necessary to establish a method of collection and processing 
of whole-blood samples for qRT-PCR. This had already been established for the 
analysis of gamete production during rodent malaria infection (Wargo et al., 2006) 
and so a similar protocol was utilised here. 
 
In order to acquire blood samples from mice daily, 10µl capillary tubes were used to 
draw blood from a small tail snip. The 10µl samples were transferred immediately 
into 30µl of lysis mix (Chapter 2).  RNA was extracted from whole blood samples 
using an ABI Prism 6100 Nucleic Acid PrepStation (Chapter 2) (Wargo et al., 2006). 
 
Although a DNase treatment step was included in the RNA extraction protocol, it 
was discovered that this did not remove all contaminating DNA from the samples 
which caused a high degree of background signal in “no reverse transcriptase” 
(NoRT) controls (Figure 5.2). Hence, it was necessary to add a further DNase 
treatment step into the protocol after RNA extraction, but before cDNA production, 
using the Ambion TURBO DNase kit (Chapter 2). This reduced the DNA 
contamination of the samples (Figure 5.2) and was therefore used in the treatment of 
all samples.  
 
The Ambion Turbo DNase treatment was carried out in a buffer which, in high 
concentrations, can inhibit the reverse transcriptase reaction and this was observed to 
be the case here (data not shown). Therefore the DNase-treated RNA samples were 
diluted 
1
/10 before cDNA production. Reverse transcription was carried out using the 
ABI High-Capacity cDNA Reverse Transcription kit (Chapter 2). The cDNA 
produced was diluted 
1
/10 before the qRT-PCR reaction so as to prevent cDNA-
inhibition. Unfortunately, the necessity to dilute the sample at various steps along the 




in a limitation of detection of target transcripts (section 5.4 and section 5.5), reducing 
the overall sensitivity of the assay. 
 
 
Figure 5.2 TURBO DNase treatment removes contaminating DNA from the reaction. Shown in 
dark green are samples without the additional Turbo DNase treatment after RNA extraction. Although 
a positive signal was detected in the untreated samples, there was a large signal in the ‘NoRT’ control 
samples. Shown in light green are the Turbo DNase treated samples. There was a small decrease in the 
signal of the DNase treated samples compared to the untreated samples, due to loss of the 
contaminating DNA and because the sample was diluted into a buffer. Importantly, there was a large 
decrease in the signal in the DNase treated ‘NoRT’ control samples compared to the untreated ‘No 
RT’ control samples demonstrating that the Turbo DNase treatment was effective. Each sample was 
run in duplicate. Rn is the fluorescent signal of the sample relative to the ROX passive reference dye. 
Rn is the Rn minus the baseline, where the baseline is the background fluorescent signal in all 
samples.   
 
5.4 Determining parasitaemia of chronic trypanosome 
infections in mice 
In order to measure parasitaemia using qRT-PCR it was necessary to identify a target 
transcript that is constitutively expressed in bloodstream trypanosomes. TbZFP3 was 




throughout the slender, stumpy and procyclic stages of the trypanosome lifecycle 
(Paterou et al., 2006). Thus, it was expected that TbZFP3 expression levels would be 
the same in all samples for any given concentration regardless of cell morphology. 
 
5.4.1 Production of slender and stumpy standards curves  
In order to measure parasitaemia using TbZFP3 as a target, it was necessary to create 
a standard curve from a sample of known parasitaemia. To do this, slender and 
stumpy trypanosomes were harvested from mice infections, purified and counted. A 
known number of parasites were then used to inoculate a known volume of fresh 
whole blood. This blood was then divided into 10µl aliquots and added to 30µl lysis 
mix, as is the procedure for experimental samples (section 5.3). These control 
samples were then processed with experimental samples and used to create the 
standard curve.  
 
5.4.2 TbZFP3 is an appropriate target for the quantification of 
parasitaemia in chronic trypanosome infections in mice  
To test that TbZFP3 expression levels are indeed equal in slender and stumpy 
trypanosome RNA samples, three slender and three stumpy standard curves were 
produced by processing these samples simultaneously (section 5.4.1). A semi-log 
regression line was calculated for the slender samples and the stumpy samples 
(Figure 5.3A). Neither the slope nor the intercept of the regression lines of the 
slender and stumpy samples were significantly different (F1,25= 0.048, p= 0.8276 and 
F1,26= 0.004, p= 0.9493, respectively) and therefore the data could be combined 
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Figure 5.3 TbZFP3 is constitutively expressed between slender and stumpy forms. (A) Three 
slender form and three stumpy form standard curves were used to calculate a semi-log regression line 
for each cell type (y= 53.07 – 3.289x, r
2
= 0.9926 and y= 53.24 – 3.312x, r
2
= 0.9949, respectively). 
The slope and intercept of the slender and stumpy semi-log regression lines are not significantly 
different from one another (F1,25= 0.048, p= 0.8276 and F1,26= 0.004, p= 0.9493, respectively). (B) 
Combining the slender and stumpy data produces a semi-log regression line of y= 53.15 – 3.299x, r
2
 = 
0.9937 which can be used to calculate estimated PCR efficiency of 100.92%. Error bars represent 
s.e.m.  
 
Importantly, this demonstrates that TbZFP3 is indeed constitutively expressed 
between slender and stumpy forms. This has been tested over an approximately 




 trypanosomes/ml mouse 
blood. Additionally, given that the six samples were processed and standard curves 
produced simultaneously, this demonstrates that there is very little error in the 
procedure. Furthermore, the efficiency of the PCR can be estimated using the 
following calculation: 
 
PCR Efficiency = (10
-1/slope
-1) x 100 
 
From the combined slender and stumpy TbZFP3 data (Figure 5.3B), the estimated 
PCR efficiency is 100.92% indicating excellent PCR performance. Overall therefore, 
TbZFP3 can be used as a target in qRT-PCR to measure parasitaemia. TbZFP3 is also 
an appropriate endogenous control for the CT method of calculation of relative 




5.5 Measuring stumpy formation in chronic trypanosome 
infections in mice 
As PAD1 mRNA is differentially expressed in slender and stumpy forms, relative 
PAD1 expression could potentially be used as a stumpy-specific target transcript in 
qRT-PCR during an in vivo infection. For this the CT method of relative 
quantification of PAD1 expression was used: the CT method uses an endogenous 
control (in this case, TbZFP3) in order to calculate the expression of PAD1 
normalised to the total number of cells in the population and relative to a reference 
sample (such as a given day during an in vivo infection).  
 
5.5.1 Design of PAD1-specific RT-PCR primers 
PAD1 is a member of an eight gene family and so care had to be taken to ensure that 
PAD1 alone was detected. Although other possible primer pairs were tested (data not 
shown), only one target location was identified that allowed specific amplification of 
PAD1 and not the other PAD gene family members without contaminating primer 
dimers. These primers spanned both the protein coding region of the gene and the 











Figure 5.4 Alignment of PAD array coding sequence and 3’UTRs showing the location of the 
PAD1 specific primers. As the polyadenylation site of most of the PAD genes is unknown only the 
first 200bp of the 3’UTR of each gene is shown. Filled red boxes indicate the stop codons. Unfilled 
red boxes indicate the locations of the sequences targeted by the PAD1 specific primers at position 





5.5.2 Validation test for use of PAD1 in the CT method 
calculation  
For the CT method calculation to be valid, it was necessary to show that both the 
endogenous control, TbZFP3, and the target of interest, PAD1, had approximately 
equal amplification efficiencies. This was to ensure that for any dilution of a sample, 
within the range of the assay, the calculation would give consistent results and 
therefore that it was appropriate to compare samples of different concentrations.   
 
If the amplification efficiencies of the control and target gene are approximately 
equal then the CT, i.e. (CTPAD1 – CTZFP3) should not vary with dilution of a given 
sample. To test this, a standard curve for both PAD1 and TbZFP3 was produced from 
the same stumpy trypanosome RNA sample (section 5.4.1) and the CT was 





trypanosomes/ml mouse blood (Figure 5.5). The slope of the semi-log regression line 
in this test was 0.023. A slope of less than ±0.1 is considered to be acceptable for use 
of the CT method. Thus, this experiment was a suitable validation that the PCR 
efficiencies of PAD1 and TbZFP3 were approximately equal and do meet the 
requirements for use of the CT method.  
 
Although a further dilution to approximately 1.5x10
6
 /ml mouse blood was included, 
this was below the limit of detection of PAD1 in this assay. Therefore when PAD1 is 
not detectable at low parasitaemia this may not necessarily reflect a lack of PAD1 
expression. Although attempts were made to increase the sensitivity of the assay, the 
limitations of the small initial sample size (10µl) and the various dilutions required 






























Figure 5.5 Validation test for the CT method calculation. Stumpy trypanosome RNA extracted 
from whole blood was used to produce a standard curve for both PAD1 and TbZFP3 ranging from 7.3 
x 10
6
 to 9 x 10
 8
 cells/ml using 1/5 serial dilutions with three replications per dilution. The CT 
(CTPAD1 – CTZFP3) was calculated for each dilution and plotted against the log of the input cell 
concentration. A semi-log regression line was calculated for the data. As the slope of the semi-log 
regression line was 0.023, this demonstrated that it was appropriate to use the CT method 
calculation. Error bars represent s.e.m. 
 
5.6 Analysis of chronic trypanosome infections in mice 
using qRT-PCR 
Having developed a qRT-PCR approach that could be used to monitor stumpy 
formation and parasitaemia during an infection, six male MF1 mice were infected 
I.P. with approximately 1000 AnTat1.1 pleomorphic trypanosomes from a donor 
mouse. Every day, for 30 days, samples were taken for qRT-PCR (section 5.3) and 
for measurement of parasitaemia by microscopy using the rapid matching method 
(Herbert and Lumsden, 1976). Further, from day 4-9 microscope slides were 
prepared in order to monitor morphology, VSG expression and cell cycle status such 
that the temporal order of events during the first slender to stumpy transition could 





Figure 5.6 The experimental procedure for analysis of within-host dynamics during chronic 
mouse infections. A donor mouse was infected with an unknown quantity of AnTat1.1 pleomorphic 
trypanosomes on day -3. On day 0, the donor mouse had a detectable parasitaemia composed of 
slender cells. Whole blood was collected from the donor mouse by cardiac puncture and trypanosomes 
were purified (Chapter 2) and counted. Approximately 1000 trypanosomes were then injected I.P. into 
each of 6 experimental male MF1 mice. Infection was allowed to progress for 30 days post infection 
(dpi). Every day samples were collected for qRT-PCR and for determining parasitaemia by 
microscopy. On days 4-9 microscope slides were prepared for the analysis of cell cycle status, 




5.6.1 Parasitaemia fluctuates throughout the infection 
Every day throughout the infection samples were collected for qRT-PCR to 
determine parasitaemia, as well as relative PAD1 expression (section 5.4 and 5.5). 
Additionally, microscope slides were prepared for the purpose of analysis of 
parasitaemia by microscopy. By both microscopy and qRT-PCR, it was observed that 
in all mice, infection followed a similar pattern of progression during the first 12 
days post infection (dpi), where the parasitaemia rose from below detection on 2dpi 
to an initial peak of parasitaemia on 5-7dpi. In all cases, the parasitaemia then fell 
dramatically over 9-12dpi before fluctuating, with individual variability, for the 
remainder of the infection (Figure 5.7).  
 
By comparing the estimated parasitaemia as determined by microscopy with the 
calculated parasitaemia as determined by qRT-PCR, there was found to be a good 
correlation with the patterns of parasitaemia in most cases (for example, see mouse 2, 
23-30dpi), but a less good correlation between exact cell numbers, particularly 
during the first peak of parasitaemia. This indicates that the estimation of 
parasitaemia by microscopy in this case is not particularly accurate, especially at 
very high parasitaemia. The microscopy method used requires that a wet film of 
blood is analysed and the approximate number of parasites per field is translated into 
parasites/ml (Herbert and Lumsden, 1976). It may be that at very high density, 
parasitaemia was being underestimated. In very occasional cases, the microscopy 
data and the qRT-PCR data appear to differ in the pattern of change in parasitaemia. 
For example, in mouse 3, 20-25dpi a large fall and then rise in parasitaemia was 
observed through qRT-PCR which was not detected by microscopy. Given that the 
qRT-PCR data shows a gradual change over time this indicates that this is not likely 
an error in the qRT-PCR data, although it is possible, and is perhaps more likely due 
to human error. Although there are a few discrepancies with the qRT-PCR and the 
microscopy method for analysis of the parasitaemia, the qRT-PCR method, using 
TbZFP3 as a constitutively expressed transcript, provides a valuable technique for 
the accurate determination of parasitaemia throughout the course of an infection. 
Expansion of this method for use in other organisms, such as cattle, could provide a 











































































































































Figure 5.7 Comparison of parasitaemia as determined by microscopy and qRT-PCR. 
Throughout the infection parasitaemia was monitored daily by both microscopy and qRT-PCR. After 
an initial peak and fall in parasitaemia (measured in cells per ml mouse blood) the parasitaemia 
fluctuates throughout infection. Generally, the patterns of parasitaemia are equivalent as determined 
by both experimental methods, although differences are observed in absolute parasitaemia, likely due 




As already mentioned, the parasitaemia in all six mice fluctuates throughout the 30 
day infection. During the chronic stage (day 12 onwards) the parasitaemia and 
fluctuations in parasitaemia vary greatly between the six mice. For instance, in mice 
1-3 and 5-6 parasitaemia recovers well between 12-16dpi from the dramatic fall after 
the first peak. In mouse 4, however, the parasitaemia does not recover well and rises 
to a peak of only 3.5 x 10
6
 cells/ml on 15dpi before falling again. Interestingly, the 
parasitaemia then does increase to a maximum parasitaemia of 1.8 x 10
7
 cells/ml, 
which is similar to levels of parasitaemia observed in other mice.  
 
5.6.2 The within-host dynamics of parasitaemia and stumpy 
formation during chronic infection 
As well as measuring parasitaemia, the relative expression of PAD1 was monitored 
throughout infection (Figure 5.8). The expression of PAD1 is displayed relative to 
the parasitaemia to account for differences in cell number and in all cases is 
normalised to mouse 5, 4dpi which has been given an arbitrary value of 1. The first 
observation to note is that the PAD1 expression of the population did fluctuate 
throughout infection, corresponding to fluctuations in parasitaemia (Figure 5.8). 
Initially the PAD1 expression was very low, or below detection, at 3dpi when the 
parasitaemia was first detected in most cases, correlating with the day 3 population 
being composed of predominantly slender forms, but rose between 4-6dpi as the 
parasitaemia continued to rise. The delay between a rise in parasitaemia and a rise in 
PAD1 expression correlates with the concept that the slender cells proliferate, and as 
the density increases, produce SIF, which in turn causes stumpy formation. Although 
there was individual variation between the mouse infections, generally the 
parasitaemia began to fall at 7-10dpi whereas the relative PAD1 expression remained 
high. This is indicative of the loss of proliferative cells by differentiation and 
immune killing, with the cells that are persisting at this stage being differentiated 
forms and therefore expressing PAD1 mRNA. It is indeed known that stumpy forms 
are more resistant to immune killing than slender forms and persist therefore for 


































































































































































































































































Figure 5.8 Parasitaemia and stumpy formation in chronic infections over 30 days. Parasitaemia, 
as determined by qRT-PCR for TbZFP3, is denoted by the red line, using the left y-axis. Where qRT-
PCR data points are missing, a cross (x) represents the parasitaemia as measured by microscopy for 
that day. PAD1 expression, denoted by a blue line using the right y-axis, is given normalised to the 
parasitaemia and relative to the expression in mouse 5, 4dpi, which has been given an arbitrary value 
of 1. Relative PAD1 expression is a measure of the total PAD1 expression of a population of cells 




Throughout the chronic stage of infection the level of PAD1 expression fluctuated 
somewhat with fluctuating parasitaemia but generally remained high. This 
demonstrates that at all times during the chronic stage of infection the parasitaemia 
contained transmission competent differentiated forms. Indeed, even at low 
parasitaemia, such as observed in mouse 4, 13-19dpi (Figure 5.8), the relative PAD1 
expression remained high, indicating that the few cells that did make up the 
parasitaemia were stumpy forms. This is logical given that if the cells were 
predominantly slender forms it would be expected that the parasitaemia would rise 
and not remain at this low level. Indeed, when parasitaemia did begin to rise on 
19dpi (Figure 5.8), this was accompanied by a drop in the relative PAD1 expression, 
due to the increasing proportion of slender forms.  
 
The maintenance of a high proportion of stumpy forms throughout infection, even 
during periods of low parasitaemia, could have important implications on infection 
transmissibility (section 5.8.5). Additionally, during an infection trypanosomes 
periodically switch their surface coat in order to evade the host immune system. Only 
slender forms can functionally switch their VSG coat and so if the population 
contains a relatively low number of slender forms, then this could prolong antigen 
chronicity by reducing the number of antigenic variants used in a given time frame 
compared to a population with a higher proportion of slender forms. Therefore the 
maintenance of low slender density throughout infection could contribute to low 
antigen variant usage as well high transmission capacity.   
 
5.6.3 The temporal order of events during the slender to stumpy 
transition (within a population) 
Only during the first wave of parasitaemia in a new infection can the temporal order 
of events during stumpy formation be monitored at a population level in vivo. 
Therefore, during this first peak of parasitaemia, microscope slides were prepared for 






Figure 5.9 Representative microscope images of the morphology of cells at 4-9dpi in 6 mice. For 
all six mice, at 4-9dpi, slides were prepared from blood from a tail snip. Slides were fixed and stored 
in 100% methanol at -20ºC. Slides were stained with DAPI to visualise the nucleus and kinetoplast to 
aid in the identification of cell type. Dividing cells were always classified as slender forms. Scale bars 
represent 10µm. 
 
The analysis of cell type by morphology can be somewhat subjective and is rather 
time-consuming. Morphological change is, however, the main way by which stumpy 
forms have been distinguished previously (Breidbach et al., 2002; Denninger et al., 
2007; Laxman et al., 2006; Reuner et al., 1997; Savill and Seed, 2004; Tyler et al., 
1997). By comparing morphological cell cycle data with the qRT-PCR data, this 
allows the traditional methods to be compared to the protocol developed here. 




not all coincide temporally during the slender to stumpy transition and comparing the 
data will allow for dissection of the order of events.  
 
Firstly, 250 cells per mouse per day (4-9dpi) were scored as slender, intermediate or 
stumpy forms. Slender forms are longer and thinner than stumpy forms with a larger 
distance between the nucleus and the kinetoplast (section 1.6, figure 1.6). 
Additionally, all dividing cells were classified as slender which presumes that cell 
cycle arrest occurs before or concurrently with morphological change (section 5.7.6). 
Stumpy forms are wider with a shorter distance between the nucleus and the 
kinetoplast (section 1.6, figure 1.6). Those cells which could not definitively be 
classified as either slender or stumpy were classified as intermediate forms. Due to 
the subjective nature of the analysis it is possible that some early intermediate cells 
could be scored as morphologically slender or that late intermediates could be scored 
as morphologically stumpy. Figure 5.9 shows a panel of representative images over 
the six day period in the six mice and Figure 5.10 shows the quantitative analysis. In 
all mice, the trypanosome population at 4-5dpi was predominantly slender in 
morphology. At 6dpi there was a peak of intermediate forms and the first fully 
stumpy forms became visible. At 7-9dpi the majority of cells were stumpy in 
morphology, with very few remaining slender forms. The combined data from all six 
mice can be seen in Figure 5.12.  
 
Next, 250 cells per mouse per day (4-9dpi) were scored for their position in the cell 
cycle (section 1.5). Cells were classified as 1K1N, 2K1N or 2K2N according to the 
number of nuclei and kinetoplasts present in the cell, with 2K1N and 2K2N cells 
representing proliferating cells and 1K1N cells representing cells in G1 or G0 (or 
early S phase) of the cell cycle. It was observed that at 4dpi approximately 25% of 
the population was 2K1N or 2K2N, representing a typical proliferative population. 
This correlated with the predominantly slender morphology observed at this point in 
infection (Figure 5.10). After 4dpi, the proportion of 2K1N and 2K2N cells in the 
population decreased until 7dpi where almost the entire population was 1K1N, 
correlating with the predominantly stumpy morphology of the cells by 7dpi. The 






























































































































Figure 5.10 Cell morphology during the first peak of parasitaemia in vivo. 250 cells per mouse 
per day (4-9dpi) were scored for morphology by microscopy (see Figure 5.9 for examples of cell 
types). All mice showed a similar pattern of morphological change. In all cases, slender forms 
predominated on 4-5dpi followed by a peak of intermediate forms on 6dpi. Stumpy forms began to 
appear on 6dpi and predominated in the infection at 7-9dpi. The combined data from all six mice can 
























































































































































Figure 5.11 Population cell cycle status during the first peak of parasitaemia in vivo. 250 cells 
per mouse per day (4-9dpi) were scored for cell cycle status by microscopy (see Figure 5.9 for 
examples of 1K1N, 2K1N and 2K2N cells). All mice showed a similar pattern of cell cycle change as 
infection progressed. At 4dpi approximately 25% of the cells in the population were either 2K1N or 
2K2N. From 4dpi to 7 dpi the number of dividing cells dropped and the number of 1K1N cells 
increased such that by 7-9dpi there were very few dividing cells in the population. This decrease in 
proliferating cells correlated with the loss of slender cells from the population (Figure 5.10). The 






By combining the data from all six mice for both morphology and cell cycle status, 
and comparing this to the qRT-PCR data generated for this time period it was 
possible to observe the pattern of changes that were occurring in the population 
during the first peak of infection (Figure 5.12). After infection, the parasitaemia was 
below the limit of detection up to 2dpi, with the first detectable parasitaemia on 3dpi. 
On 4 and 5dpi, the parasitaemia rose as dividing slender forms predominated in the 
infection (99.9% ±0.1 s.e.m and 92.4% ±1.7 s.e.m respectively). As the first 
intermediate forms began to appear between 4 and 5 dpi, fewer replicating cells were 
present (with the number of 1K1N cells rising from 74% ±1.2% s.e.m to 81.9% 
±1.4% s.e.m) and the PAD1 mRNA levels rose. As PAD1 mRNA began to rise 
before the presence of a large number of intermediate and stumpy forms it may be 
that PAD1 mRNA expression is a very early marker for differentiation and mRNA 
expression rises before the onset of detectable morphological change (section 5.7.5), 
although PAD1 protein is not detected until after morphological change (Dean et al., 
2009). On 6dpi there was a peak of morphologically intermediate forms, comprising 
61% (±3.8% s.e.m) of the population, along with the peak of PAD1 mRNA. Thus, 
PAD1 was expressed in morphologically intermediate forms to a similar degree as in 
stumpy forms confirming that it is an early marker for stumpy formation. Stumpy 
forms began to emerge at 6dpi (9.6% ±3.0% s.e.m). Then, as stumpy forms 
predominated in the infection at 7-9dpi (7dpi, 74% ±3.5%; 8dpi, 70.1 ±2.1%; 9dpi, 
79% ±2.2% s.e.m), there were correspondingly few dividing cells (with 99.9% ± 
0.1% s.e.m at 7dpi being 1K1N) and the PAD1 mRNA levels plateaued. Parasitaemia 
then began to fall between 7 and 8dpi, likely due to a combination of both stumpy 
formation and immune clearance of the infecting antigen type (see section 5.7). 
Indeed, these events during the first wave of parasitaemia correspond to the 



























































































Figure 5.12 Comparison of morphology, cell cycle status, parasitaemia and PAD1 expression for 
all six mice. Comparing both the microscopy and qRT-PCR data for all six mice the temporal order of 
events during the first stage of parasitaemia could be deduced. On 4 and 5dpi, the parasitaemia rose 
and dividing slender forms predominated in the infection. On 6dpi there was a peak of 
morphologically intermediate forms correlating with a peak of PAD1 expression as PAD1 
demonstrating that PAD1 is an early marker for differentiation. Stumpy forms predominated in the 
infection at 7-9dpi and there were correspondingly few dividing cells. The PAD1 mRNA levels 
plateaued at 6-9dpi demonstrating that PAD1 is expressed equally in intermediate and stumpy forms. 




Given the consistency of data between individual mice, this temporal progression of 
stumpy formation of the population seems to be well regulated and this analysis 
provides a temporal profile of the slender to stumpy transition early in infection. 
Furthermore, the sensible correlation between cell morphology, cell cycle status, 
parasitaemia and PAD1 mRNA expression demonstrates that the qRT-PCR method 
developed here for the analysis of stumpy formation was a suitable way to monitor 
within-host dynamics. This method is less subjective than microscopy as well as less 
time-consuming, allowing large numbers of samples to be processed simultaneously. 
There are numerous future applications of this method, as will be discussed in 
section 5.8.  
 
5.6.4 The first peak of parasitaemia correlates to the expression 
of one antigen variant  
The pleomorphic strain AnTat1.1 used in this analysis is named after the infecting 
antigen variant that is expressed on its surface. Using an antibody to the AnTat1.1 
VSG, microscopy slides were analysed for loss of AnTat1.1 VSG expression, which 
would show that antigen switching had occurred (Figure 5.13).  
 
Although cells negative for AnTat1.1 staining were detected as early as 7dpi, even by 
9dpi more than 99% of the population remained positive. Due to the very low 
numbers of negative cells present, accurate estimations of the proportion of switched 
cells were not obtained. Interestingly, of the very few cells that were identified as 
being negative for AnTat1.1, both slender and stumpy morphology was observed 
(Figure 5.13, 8dpi and 7dpi respectively). Thus, either stumpy forms are capable of 
antigen variation (although this would not be a functional switch given that stumpy 
forms are cell cycle arrested and could therefore not populate the next wave of 
parasitaemia) or slender cells which have already switched antigen coat are not 






Figure 5.13 Loss of AnTat1.1 expression during infection. Microscope slides were stained for 
AnTat1.1 VSG expression. Shown are examples from the six mouse infections. From 3-6dpi no cells 
were observed that were negative for AnTat1.1 expression. From 7-9dpi the occasional cell negative 
for AnTat1.1 was observed, but this remained less than 1% of the population. Both slender and 
stumpy form cells could be identified as AnTat1.1 negative (for example, an AnTat1.1 negative 
stumpy form is shown on day 7 and a slender form on day 8). On 14dpi all cells were negative for 
AnTat1.1. Upper panels for each day are phase contrast plus DAPI staining. Lower panels for each 
day are stained for AnTat1.1 expression using a rabbit Anti-AnTat1.1 VSG primary antibody and an 
Anti-Rabbit-FITC secondary antibody. Scale bars represent 10µm.  
 
5.7 Mathematical modelling of the slender to stumpy 
transition during infection  
The slender to stumpy transition is density-dependent and controlled by a parasite-
derived factor, SIF (Vassella et al., 1997). Most of the mathematical models 
produced to describe the slender to stumpy transition have not incorporated SIF-




determine stumpy formation (Black et al., 1982; Lythgoe et al., 2007; Seed and 
Black, 1997; Seed and Black, 1999; Tyler et al., 2001). One model has been 
produced that considered SIF-induced differentiation during the slender to stumpy 
transition (Savill and Seed, 2004). This model was shown to be a good fit to existing 
data on parasitaemia over the first seven days of infection in immunocompromised 
mice and the resulting parameter estimates correlated well with previous studies 
(Savill and Seed, 2004). However, as with most models of stumpy formation 
produced thus far, this model was limited by the dependence on subjective 
morphological analysis of cell type and was considered in the absence of the immune 
system. Rather than the use of morphology to monitor stumpy formation, Tyler et al 
used increased expression of mitochondrial activity and did incorporate the host 
immune system into their model demonstrating that both the host immune system 
and density-dependent differentiation is responsible for limitation of parasitaemia, 
but that differentiation alone can account for fluctuations in parasitaemia throughout 
infection (Tyler et al., 2001). This model did, however, only quantify stumpy 
formation during the first six days of infection and did not consider SIF-induced 
differentiation.  
 
The production of accurate mathematical models is limited by the data to which the 
model is fitted. In section 5.6, data on both parasitaemia and stumpy formation had 
been generated for six mice, which were not immunocompromised, every day for 30 
days during a trypanosome infection, providing a large amount of non-subjective 
quantitative data to which a mathematical model could be fitted. Thus, this data was 
fitted to the pre-existing Savill and Seed, 2004, model which considers SIF-induced 
differentiation (Savill and Seed, 2004), but now incorporating a simple model of the 
host immune system. All mathematical modelling was carried out by Dr Nick Savill, 
University of Edinburgh. All figures produced from the data generated by the 
mathematical modelling (Figure 5.15 to Figure 5.22) were produced by Dr Savill. 
The data that was incorporated into the model was the measured parasitaemia and the 
total PAD1 expression of the population, as measured by the raw CT values from the 





5.7.1 The mathematical model  
A detailed description of the mathematical model and the equations used, written by 
Dr Savill, is shown in Appendix C. The model comprises a set of differential and 
partial differential equations describing: (1) the concentration of non-committed 
slender cells of a particular antigen variant; (2) the age distribution of cells after the 
point at which they commit to differentiate (i.e. committed slender cells, intermediate 
cells and stumpy cells); (3) the dynamics of SIF concentration and (4) the immune 
clearance rate of each antigen variant. The model was fitted to the parasitaemia and 
PAD1 expression data for each mouse and finds the most likely values for the 
parameters for each mouse. Many of the parameters are unknown, but parameter 
priors were incorporated into the model, where the expected values and distribution 
of a parameter, based on prior knowledge, was specified. Details of all the parameter 
priors are found in Appendix C, but some are also detailed below. When a parameter 
prior is described, the distribution of that parameter is specified i.e. if a parameter has 
a prior of NT(µ, ), that states that the prior has a normal distribution truncated at 
zero, with a mean of µ and a standard deviation of .  
 
There are four distinct cell types in the model: non-committed, replicating slender 
cells, committed replicating slender cells, non-replicating intermediate cells and non-
replicating stumpy cells (Figure 5.14). The concentration of non-committed slender 
cells of a particular variant is determined by the slender cell replication rate, the rate 
of switching to and from that variant, the immune clearance rate, and the rate of SIF-
induced differentiation, all of which are model parameters. The total number of non-
committed slender cells is the sum of all slender cells of all variants.  
 
Non-committed slender cells of each variant are induced to commit to differentiation 
in response to SIF. After becoming committed to differentiation, the slender cell will 
undergo further replication as a committed slender cell before cell cycle arrest. It has 
indeed been shown that commitment to differentiation occurs before cell cycle arrest 
and morphological change (Tyler et al., 1997). The cell will then become 
intermediate before becoming fully stumpy. The lifespan of each cell type through 




cells at any given time point is described by a partial differential equation. 
Committed replicating slender cells and intermediate cells of each variant are lost, 
through time, by differentiation to the next cell type as well as by immune clearance 
(Figure 5.14). Stumpy forms are lost, through time, by stumpy cell death as well as 
by immune clearance. The total concentration of cells is the sum of all cell types of 
























Figure 5.14 A model of stumpy formation in vivo. A schematic representation of the mathematical 
model used to describe stumpy formation during infection. Details of the model are discussed in the 
text.  
 
SIF is produced by non-committed slender cells, as well as by committed slender 
cells up to a certain age (section 5.7.7). Intermediate and stumpy forms do not 
produce SIF. SIF is lost by turnover or clearance in the host. SIF induces non 
committed slender cells to differentiate at a rate proportional to SIF concentration. 
This model, incorporating SIF-induced stumpy formation, was shown to better 
account for the quantitative data than the use of parasite density induced 
differentiation (section 5.7.8).  
 
PAD1 begins to be expressed as cells become committed to differentiation and is not 
expressed in non-committed slender cells. There are only two phases of change of 
PAD1 expression through differentiation. Firstly, PAD1 expression rises linearly 
until a certain age through differentiation, then PAD1 expression may remain 




section 5.6, the relative PAD1 expression per stumpy cell is approximately 10
-7
 (see 




) was set for the PAD1 
expression after the initial rise and at stumpy cell death. The change in PAD1 
expression through differentiation is discussed in section 5.7.5. 
 
At time zero (i.e. at the point of infection) the infection is composed of one variant, 
expressing the infecting VSG (in this case AnTat1.1). Later, slender cells switch 
between variants sequentially (i.e. one after another) with differential switching rates, 
such that at any given time the infection is composed of one or more variants. 
Biologically, there is a degree of ordered expression of VSGs, but rather than being 
caused by sequential switching, it is determined by differential probabilities of 
activation of each variant (Morrison et al., 2005). Indeed, differential activation rates 
combined with density-dependent stumpy formation was demonstrated to be 
sufficient for ordered antigenic variation by mathematical modelling (Lythgoe et al., 
2007). However, with the exception of analysis of the loss of the infecting variant 
(section 5.6), no data was collected regarding antigenic variation during these 
infections. As such, no data is available to model antigen switching and therefore 
associated parameters must be estimated. When producing a model, one of the aims 
is to explain the data in as few parameters as possible and when modelling a 
complicated biological system with numerous parameters, this will, at times, mean 
simplifying the system for the purposes of the model. Sequential antigenic variation 
is a simple model which reduces the number of parameters that must be estimated 
but still results in the expression of multiple variants at the same time (section 5.7.4). 
As such, the use of this model can be justified by parsimony. Furthermore, the 
number of variants expressed during the 30 day period is unknown. Therefore the 
most parsimonious situation would be for only one variant to be expressed. Thus, the 
parameter prior for the number of variants is set to 1 + NT(0,5) and hence the 
minimum number of variants in the infection is 1. Clearly more than one variant will 
be required; otherwise the immune system would have been able to clear the 
infection. Indeed the model requires more variants in order to explain the data 
(section 5.7.4), but this prior dictates that when the parameters are fitted to the 




Finally, as the data were collected in immunocompetent mice, the host immune 
system was considered. The mammalian immune system is complex and no data, 
such as the presence of antibodies against specific VSGs, was collected here. The 
model therefore incorporates a simple immune response against each variant which is 
activated by the replicating slender cells of that variant, as well as by a self-
enhancing rate. The rate of immune clearance of each type of committed cell is 
proportional, but different, to the rate of immune clearance of slender cells of that 
variant, and can be different from one another. This is to account for the differential 
efficiency of the host immune system to clear slender and stumpy forms (Engstler et 
al., 2007). There is a time delay between the initiation of infection and the activation 
of the immune response against the infecting variant, but the immune response 
against further variants is not delayed. Although this may not represent the 
complexity of the host immune system, the lack of data regarding the immune 
response limits the production of a detailed model.  
 
At time 0, i.e. the initiation of infection, all cells are assumed to be non-committed 
slender cells of the same infecting variant. The starting concentration of SIF is zero 
and the starting immune response to all variants is zero. Mice were injected with 
approximately 10
3
 cells and therefore the parameter prior for the log10 starting 
concentration of cells was set as N(3, 0.5), presuming the volume of blood per mouse 
was approximately 1ml (section 5.7.7).  
 
5.7.2 The adequacy of the fit of the model to the quantitative data 
In order to fit the quantitative data of each mouse to the model, the parameters were 
varied until the ‘best fit’ model of each mouse is found. This model then provided a 
set of estimated values for each parameter which best explained the biological data 
(section 5.7.7). To assess how well the model fitted the data, Dr Savill compared the 
position of the mean of the standardised residuals at each time point to the 95% 
predictive interval of the mean (Figure 5.15). If the model is accurate, it would be 
expected that the mean at each time point would lie within this predictive interval 




does not suitably explain that time point. Further, if there are outliers, where a 
standardised residual is more than about 3 standard deviations from zero, then this 
also indicates a poor fit of the model to the data. The model generated here had a 
very good fit to the quantitative data, with no outliers for either parasitaemia or 
PAD1 expression (Figure 5.15).  There was, however, an underestimation of 
parasitaemia on day 4, indicated by the mean of the standardised residuals being 
greater than the upper limit of the 95% predictive interval. This suggested that the 




Figure 5.15 The adequacy of the fit of the mathematical model to the quantitative data. To test 
the adequacy of fit of the model to the data, the standardised residuals of each data point from each 
mouse (blue crosses) for both parasitaemia (upper panel) and PAD1 expression (lower panel) was 
compared to the 95% predictive interval of the model (dashed lines). It would be expected that the 
mean of the data would be within that interval 95% of the time, if the model were correct. The mean 
of the standardised residuals from the six mice is shown as a solid red line. This mean lies within the 
95% predictive interval of the mean in all cases, except for the parasite concentration on day 4. 
Standardised residuals which are greater than 3 standard deviations from 0 are considered to be 
outliers. There are therefore no outliers for this model. With the exception of day 4 parasitaemia the 





5.7.3 The predicted infection dynamics 
The model fits well to quantitative data of the six mice, as determined by analysis of 
the standardised residuals from all six mice (section 5.7.2). Confirming this, the 
predicted and measured parasitaemia and PAD1 expression in individual mice were 
well correlated throughout infection in most cases (Figure 5.16). The 
underestimation of parasitaemia on day 4 can be observed in Figure 5.16B, where the 
measured parasitaemia lies above the 95% predicted interval of the model solutions 
in all mice except mouse 4 where there is a delay in the increase in parasitaemia 
compared to the other mice.   
 
In all cases, the model predicted that during the fall in parasitaemia after the first 
peak (Figure 5.16B) there was a second smaller peak, or a delay in the rate of 
decrease in parasitaemia. This could indeed be observed by the data alone in mouse 
1, 4, 5 and 6, where the parasitaemia began to fall around 6-7dpi and then that rate of 
decrease slowed around 8-9dpi in most mice. For mouse 2, it was predicted that the 
second peak was of the same approximate magnitude as the first. However, for 
mouse 2 there was no qRT-PCR data available for day 8. Thus, it may be that this 
lack of data affects the fitting of the model such that the model inaccurately predicted 
a higher parasitaemia at this point.  
 
From the model, predictions could be made regarding the dynamics of components 
of the model which were not experimentally tested, such as the dynamics of SIF 
concentration, the proportions of different cell types throughout infection, dynamics 
of antigenic variation (section 5.7.4) and PAD1 expression per cell throughout 








Figure 5.16 The fit of the mathematical model to the quantitative data for each mouse. The 
measured and predicted infection dynamics over (A) the full 30 days and (B) the first 11 days of 
infection. The measured parasitaemia (crosses) compared to the predicted parasitaemia (lines) 
according to the model is shown in upper panels. The measured log2 relative PAD1 expression 
(crosses) compared to the predicted log2 relative PAD1 expression (lines) is shown in centre panels. 
Note, that total PAD1 expression of the population, relative to mouse 5 day 4 is fitted to the model, 
and plotted here, rather than the PAD1 expression normalised to parasitaemia, as plotted in section 
5.6.  The predicted dynamics of SIF concentration is shown in lower panels. In all cases the 50% and 




Firstly, the model states that SIF induces stumpy formation at a rate proportional to 
its concentration. As the SIF concentration was unable to be measured due the lack 
of knowledge of its identity, there was no data regarding SIF that could be 
incorporated into the model, and so the predictive intervals are larger than those for 
parasitaemia and PAD1 expression (Figure 5.16). During the first peak of 
parasitaemia, SIF was predicted to rise with parasitaemia. As the parasitaemia began 
to fall after the first peak, the concentration of SIF also began to fall; reducing the 
rate of differentiation. This may be the cause of the delay in rate of parasitaemia loss 
around day 8-9. As well as the differentiation to stumpy forms, the immune response 
will also contribute to changes in parasitaemia but comparing the parasitaemia during 
the first peak to the predicted immune response against the first variant demonstrates 
that the clearance rate of the first variant rises after the initial drop in parasitaemia 
but before the second large fall after day 8-9 (section 5.7.4, Figure 5.18C). Hence, 
the initial drop in parasitaemia was predicted to be caused by SIF-induced 
differentiation and not by the immune response.  
 
The data here indicates that during the first peak of parasitaemia the SIF 
concentration rises (Figure 5.16B). The parasitaemia is then limited by SIF-induced 
differentiation to the stumpy form. As the parasitaemia begins to fall, so does the SIF 
concentration (Figure 5.16B), resulting in a reduced rate of differentiation. Thus, 
more of the remaining slender forms in the population will continue to proliferate, 
reducing the rate of loss of parasitaemia. This would predict a small rise in the 
number of slender forms (section 5.8.7) after the initial decrease in parasitaemia. 
Then as SIF concentration rises once again, and an immune response has been 
established against the first variant (section 5.7.4), the rate of loss of parasitaemia 
increases causing the low parasitaemia observed around day 10. 
 
Additionally, throughout the chronic stage of the infection SIF concentration was 
predicted to fluctuate, as would be expected from the fluctuating parasitaemia and 
PAD1 expression and fluctuations in cell types (discussed below). After the initial 
peak, the parasitaemia and PAD1 expression in mouse 5 remained high throughout 




The dynamics of the proportion of the different cell types could also be predicted 
throughout the course of infection (Figure 5.17). The model predicted that there were 
fluctuations in proportions of cell type, as would be expected, throughout infection. 
There were clear differences between different mice, where fluctuations were more 
pronounced in mouse 2 and 3 than in mouse 5 and 6, for example. After the initial 
fall in parasitaemia and proportion of slender cells there was a peak of slender forms 
in all mice as the parasitaemia is re-established. However, overall the proportion of 
slender cells tended to remain low during the chronic stage of infection, with tight 
peaks where this proportion did increase. The proportion of differentiated cells, 
however, tended to remain high although there were periodic sharp decreases 
followed by recovery of the differentiated population to a high proportion. Hence, 
during infection there was maintenance of a high level of transmissible forms, with 
no prolonged period of a low proportion of transmissible forms, implying that the 




Figure 5.17 The predicted proportion of cell types throughout infection. The proportion cell types 
fluctuate during infection, but the proportion of non committed slender forms tends to be quite low 
throughout infection (upper panel). The proportion of differentiated cells tends to remain quite high 





5.7.4 The predicted dynamics of antigenic variation throughout 
infection  
Trypanosomes have a large repertoire of VSGs which they can utilise to evade the 
host immune response throughout infection. As discussed in section 5.7.1, a simple 
model of antigen switching was used here, where switching between antigenic 
variants was sequential. Further, the parameter prior was set so that the model used 
the least number of variants possible to explain the data. The predicted dynamics of 
antigenic variation from the model are shown in Figure 5.18A. In all cases, the first 
peak of parasitaemia was predicted to be composed of the infecting variant. This 
correlates with the experimental observation in section 5.6.4 that the majority of cells 
in that first peak of infection were expressing the infecting AnTat1.1 VSG. However, 
the model does seem to underestimate the switch rate from the first to second variant. 
According to the model only approximately 1 in 10
6
 cells should have switched 
during the first peak of parasitaemia (Figure 5.18A) and it would therefore be 
unlikely to observe as many cells not expressing the AnTat1.1 VSG when counting 
only 250 cells per infection per day (section 5.6.4).  After this first peak, multiple 
variants were expressed and simultaneous expression was observed.  
 
The median predicted number of variants used by each mouse ranged from 8 to 12 
variants over the course of the 30 day infection with a mean of 10.5 ± 0.7, (section 
5.7.7, Figure 5.21). The actual number of variants used is not known. It was 
hypothesised in section 5.6.2, that the maintenance of a low number of slender cells 
during the chronic stage of infection may limit the number of variants used and 
therefore prolong antigen chronicity. Indeed, for mouse 5 and 6, where the 
parasitaemia, PAD1 expression and predicted proportion of differentiated cells 
(Figure 5.17) remained mostly high throughout infection only 8 variants were 
predicted to be used. For mouse 2, which showed the largest fluctuations in predicted 
SIF concentration (Figure 5.18) and more slender forms throughout infection than 
mice 5 and 6 (Figure 5.17), approximately 12 variants were predicted to be used. 
This correlates with the hypothesis that a low number of slender cells and high 















Figure 5.18 The dynamics of antigenic variation and immune clearance as predicted by the 
model. (A) The predicted dynamics of different antigen variant types arising through infection. The 
first wave of parasitaemia (approx days 4-11) is composed primarily of the infecting variant. Later, 
antigen switching does occur, resulting in the expression of multiple variants at once. (B) The 
predicted immune mediated clearance rates of each variant expressed. As defined by the model, there 
is a delay in the onset of the immune response to the first variant but not to subsequent variants. 
Mouse 5 has a reduced immune response compared to the other mice. (C) The predicted immune 
mediated clearance rate of the first variant compared to the predicted and measured dynamics of 
parasitaemia. Immune clearance is not predicted to rise until after the initial fall in parasitaemia 
demonstrating that the model predicts this fall was due to SIF-induced differentiation rather than 
immune clearance (see section 5.7.3). 
 
There is a variant-specific immune response that arises in response to the presence of 
each variant (Figure 5.18B). The model specifies that there is a delay in the response 
to the infecting variant but that, for the purposes of the production of a simple model, 
the response to later variants is instantaneous. The estimated mean duration before 
activation if the initial immune response was 142.2 ± 6.9 hours, or approximately 6 
days, (section 5.7.7, Figure 5.21) which is not hugely dissimilar to a previous 
estimation of  122 hours (or approximately 5 days) from infections in a different 
strain of mouse (Tyler et al., 2001). In all cases, except mouse 5, the immune-
mediated clearance of each variant, after initial activation, reached a maximum rate 
of clearance rapidly. For mouse 5, it was predicted that there was a decreased 
capacity for immune clearance (Figure 5.18B), which may reflect the health of the 
mouse. This predicted reduced immune response contributes, in the model, to the 
maintained high parasitaemia throughout infection in mouse 5 (Figure 5.16).  
 
By comparing the parasitaemia during the first peak of infection to the onset of the 
immune response, it can be observed that the initial drop in parasitaemia occurs 
before the clearance rate of the first variant reaches it maximum rate (Figure 5.18C). 
This correlates with the initial fall in parasitaemia being caused by stumpy formation 





5.7.5 The predicted dynamics of PAD1 mRNA expression per cell 
during differentiation  
In the model, cells begin to express PAD1 mRNA when they commit to 
differentiation and PAD1 expression rises for a certain time, that time being a 
parameter of the model. Then PAD1 expression can remain constant or rise or fall 
linearly from that time until stumpy cell death. Thus, in this model, committed 
slender cells were able to express PAD1. Indeed the model predicted that PAD1 
mRNA levels rose in the cell for approximately 14-15 hours (mean from six mice = 
14.4 hours ± 1.5 s.e.m) (Figure 5.19) and that the lifespan of a committed slender 
cell, before becoming the cell cycle arrested intermediate form, is also approximately 
14-15 hours (mean from six mice = 14.6 hours ± 0.7 s.e.m) (section 5.7.7). Thus, the 
model predicted that there was a rise in PAD1 mRNA expression as a cell moved 
from being non-committed slender cell to a committed slender cell and that this rise 
continued until cells became intermediate. After the initial rise in PAD1 mRNA 
expression there was no evidence in the data for any further change in expression 
until stumpy cell death.  
 
The model appears to suggest a large amount of variability between mice; however, 
there are large predictive intervals for all the mice, which for the most part overlap 
(Figure 5.19). It is expected that there will be measurement errors in both the values 
obtained for parasitaemia and PAD1 expression. To estimate the relative PAD1 
expression per cell, both parasitaemia and PAD1 expression are taken into account 
and as such the measurement errors from both data sets will be reflected in the 






Figure 5.19 Predicted PAD1 expression of differentiating cells.  The predicted dynamics of the rise 
in PAD1 mRNA expression during differentiation in individual cells is shown. The 50% and 95% 
posterior predictive intervals are shown in dark and light grey, respectively.   
 
A model where committed slender cells were not able to produce PAD1 mRNA was 
also generated, but this produced a less good fit of the model to the data (data not 
shown). This implies that cells that are differentiating, but are still slender in 
morphology, express at least a low level of PAD1 mRNA. At the protein level, PAD1 
is not expressed in cells which are morphologically slender and, as determined by 
northern blot, ex vivo populations which are predominantly slender have a very low 
level of PAD1 mRNA expression compared to predominantly stumpy populations 
(Dean et al., 2009). In Chapter 3 it was shown that PAD1 expression through the 
action of the 3’UTR is regulated at both the level of mRNA abundance and protein 
expression. It may be that this initial rise in PAD1 mRNA in cells which are in the 
very early stages of differentiation, but are still morphologically slender, is not 
reflected at the protein level and only upon transition to the intermediate life stage is 
the protein expressed. Indeed, nuclear encoded mitochondrial genes, that are up-
regulated in stumpy forms compared to slender forms, are up-regulated at the mRNA 
level before morphological change, but not at the protein level (Tyler et al., 1997). 
Thus, it may be common amongst stumpy-specific genes that the mRNA is up-
regulated in response to commitment, but that these gene remains translationally 




5.7.6 Quantitative morphological data could not be incorporated 
into the model 
In section 5.6.3 data was collected on the morphology of the cells during the first 
peak of parasitaemia. It was thought that perhaps this data could be incorporated into 
the model as had been done for parasitaemia and PAD1 expression. However, the 
predicted morphology, as determined by the model, did not fit well to the observed 
morphology, as determined by microscopy, even when intermediate and stumpy 
forms were combined (Figure 5.20). Firstly, the model predicts that the proportion of 
slender forms should fall, and the number of intermediate and stumpy form should 
rise, more rapidly than was observed by microscopy. Secondly, in section 5.7.3, it 
was shown that as parasitaemia falls, after the first peak, the model predicts that there 
is a second peak, or decrease in the rate of fall of parasitaemia (Figure 5.16). It was 
proposed that this was due to a small rise in the number of slender cells as the SIF 
concentration fell. Indeed, the model predicts that that there is a small rise in the 
proportion of non-committed and committed slender forms in the population after the 
initial fall. The measured data for mouse 1 did seem to correlate with a small rise in 
slender forms after the initial fall but there did not seem to be evidence for this in the 
other five mice (Figure 5.20).  
 
The morphological data may not fit the model predictions for a number of reasons. 
Firstly, the model states that there are four distinct cell types (non-committed 
slender, committed slender, intermediate and stumpy). The committed slender form 
is proliferative and produces SIF, but has begun the process of differentiation and 
produces PAD1 mRNA (section 5.7.5). Intermediate forms are those cells that have 
exited the cell cycle and are fully expressing PAD1 mRNA but are not yet fully 
stumpy. The transition is a complex differentiation event that comprises changes in 
gene expression, metabolism, morphology and cell cycle status. Rather than the 
existence of 4 distinct groups of cells, in reality the differentiation process is 
continuous and changes in cell cycle status, morphology and gene expression will 







Figure 5.20 Comparison of the predicted and measured morphological data during the first 
peak of parasitaemia.  The measured morphology (crosses) compared to the predicted morphology 
(lines) according to the model is shown. The 50% and 95% posterior predictive intervals are shown in 
dark and light grey, respectively. As non-committed and committed slender cells cannot be 
distinguished by microscopy the upper panel represents all slender cells. Due to the subjective nature 
of determining morphology by microscopy, the intermediate and stumpy forms were grouped to 
reduce the potential error arising from this subjectivity. A small rise in the proportion of slender forms 
in the population was predicted to occur in all mice after the initial fall.  
 
Furthermore, the assessment of morphology by microscopy is subjective: this has 
been one of the difficulties in studying stumpy formation. It may be that very early 
intermediate forms could be mistakenly scored as slender in morphology when very 
little change has occurred so far. This would account for the delay in the loss of 
slender forms in the measured data compared to the predicted data. From the 
morphology and cell cycle data collected in section 5.6.3, on day 4, where the 
population was scored as predominantly slender, 74.0% ± 1.2 s.e.m of the slender 
population in the six mice were 1K1N. On day 6, when the population was 
predominantly scored as intermediate 80.5% ± 1.5 s.e.m of the slender population 
were 1K1N. This implies that either the cell cycle is not in equilibrium, which 
certainly may be the case given the complex infection dynamics, or presuming the 
cell cycle is in equilibrium, that some of the cells which were scored as slender were 
actually cell cycle arrested. These may represent very early intermediate forms and 
this may account for the differences in the predicted and measured change in 




morphology are indeed cell cycle arrested and it is not incorrect to score proliferative 
cells as slender in morphology (as in section 5.6.3). It is worth noting that this does 
not account for the expression of PAD1 mRNA in committed slender forms (as 
discussed in section 5.7.5) as this morphological data was not incorporated into the 
model given the poor fit.  
 
5.7.7 Parameter estimation  
The model contains numerous parameters, which, when the model is produced, are 
either unknown or can be estimated based on prior knowledge (Appendix C). When 
the model was fitted to the data for each mouse these parameters were varied, until a 
set of values for each parameter were created that best explained the data. Thus, the 
model can be used to estimate the values of unknown parameters for which data was 
not collected (Figure 5.21 and Table 5.1). In cases where the estimated parameter 
distribution includes zero, there is not sufficient information in the data to provide 
information regarding this parameter.  
 
Firstly, the duration of the slender cell cycle was estimated, by the model, to be 
approximately 5 hours (Figure 5.21 and Table 5.1). Replication rates vary between 
strains (Turner et al., 1995) and estimations have varied from as low as 1.7 hours to 
as much as 9.6 hours, with most studies converging on a cell cycle duration of 
approximately 4 to 6 hours (Savill and Seed, 2004; Seed and Black, 1997; Seed and 
Black, 1999; Turner et al., 1995; Vassella et al., 1997). As the estimations of the 
mean cell cycle duration from the six mice in this case range from 4.0 – 5.5 hours, 








Figure 5.21 Predicted parameter distributions as determined by the model.  When the model is 
fitted to the data for each mouse the model parameters are varied, until a set of values for each mouse 
for each parameter are created which best explain that data. Each graph represents a probability 
distribution and as such, the area under each curve = 1. Parameters can be interdependent. In cases 
where the estimated parameter distribution includes zero, there is not sufficient information in the data 
to estimate the values of that parameter. Immune-mediated clearance rate has a minimum value of 0 








Parameter Mean (± s.e.m) 
Slender cell cycle 4.9 ± 0.2 hours 
Committed slender cell lifespan 14.6 ± 0.7 hours 
Intermediate cell lifespan 5.6 ± 0.6 hours 
Stumpy cell lifespan 49.9 ± 5.7 hours 
Total committed cell lifespan 70.0 ± 5.7 hours 
Committed slender replications 3.0 ± 0.2 
Committed cell SIF production 10.7 ± 1.2 hours 
Differentiation rate 1.6 E-09 ± 2.3 E-10 /hour 
SIF removal rate 0.30 ± 0.04 /hour 
Time of initial immune activation 142.5 ± 6.9 hours 
Duration of PAD1 rise 14.4 ± 1.5 hours 
log10 initial parasite concentration 2.3 ± 0.2 /ml  
Number of variant types 10.5 ± 0.7 
 
Table 5.1 Mean parameter estimates from all six mice. The mean parameter values from all six 
mice, as calculated from the mean parameter values of individual mice.  
 
The lifespan of a cell from the point of commitment to differentiate until stumpy cell 
death was estimated to be approximately 70 hours (Figure 5.21 and Table 5.1). This 
duration encompasses the cumulative life spans of the committed slender, 
intermediate and stumpy forms. The committed slender forms are replicating and are 
therefore clearly distinguished from intermediate forms. These committed slender 
cells were predicted to have a lifespan of approximately 14.6 hours, correlating with 
3 further replications after commitment to differentiation (Figure 5.21 and Table 
5.1). After commitment to differentiate, the level of PAD1 mRNA per cell rises for 
approximately 14.4 hours, correlating with the lifespan of a committed cell (as 
discussed in section 5.7.5). Furthermore, upon commitment to differentiate, cells 
continued to release SIF for approximately 10 hours (Figure 5.21 and Table 5.1). 
Thus, the parameter estimations suggest that a committed slender cell receives the 
signal to differentiate then begins to express PAD1 mRNA while continuing to 
proliferate for 3 further cell divisions and to produce SIF during the first two of those 
divisions, before undergoing cell cycle arrest and therefore transition into the 




would not be expected for any morphological change to begin before cell cycle 
arrest.  
 
The intermediate and stumpy forms are both cell cycle arrested and are therefore 
only distinguished, in this model, by morphology, for which no data has been 
incorporated. Therefore, although the model predicted that the stumpy lifespan is 
approximately 50 hours and the intermediate lifespan is 5 hours (Figure 5.21 and 
Table 5.1), this may not be accurate. The predicted distribution for the intermediate 
lifespan includes zero, which, as mentioned above, indicates that there was not 
enough information in the data to determine this parameter. Without additional data 
to input into the model, the lifespan of these two life-stages cannot be accurately 
disentangled. However, the combined predicted lifespan of approximately 55 hours 
does provide an estimate for the duration from cell cycle arrest to stumpy cell death.  
 
From analysis of the parameter distributions of individual mice (Figure 5.21), it 
appears that the total lifespan of a committed cell was lower in mouse 1-3 than in 
mouse 4-6, where the mean from the three mice in each group is 37.8 ± 1.9 hours and 
61.8 ± 3.5 hours respectively. It is not clear why there should be such a clear 
difference in stumpy lifespan between two groups of the experimental infections. 
However, mice 1-3 were housed in the same cage and mice 4-5 were housed in 
another (although all mice originated from the same litter and were infected in a 
random order and were distributed between the two cages at random). It could be 
speculated that some unknown difference between the conditions in the two cages 
had some effect on the within host dynamics. This is, however, merely speculation 
and the reason for this difference remains unknown at this time.  
 
The model states that SIF is lost from the system at an estimated rate of 30% per 
hour (Figure 5.21 and Table 5.1). Initially, a model was produced where loss of SIF 
was dependent on background loss as well as at a slender concentration dependant 
rate, representing the internalisation of SIF by slender cells. The loss of SIF by 
internalisation did not however have any discernable effect on the model and so this 




is not internalised by slender cells, but that this is a minor contributor to the overall 
removal of SIF from the system. It may be that SIF is cleared from the blood of the 
host by host-mechanisms or that SIF is able to enter other cell types and as such, the 
density of slender cells has little effect on the total loss. Without knowing the identity 
of SIF it is not possible to critically assess the model predictions.  
 
The parameters associated with antigenic variation, and the host immune response, 
were discussed previously in section 5.7.4. Briefly, the model predicts that the time 
taken for the activation of the immune response against the infecting variant is 142.2 
± 6.9 hours. The number of variants used during this 30 day infection was predicted 
to be 10.5 ± 0.7 with variability between infections (Figure 5.21 and Table 5.1).  
 
When the model was produced, the immune response against each class of 
differentiated cells was set to be proportional, but different, to the response against 
non-committed slender cells. With one exception, the parameter estimates for the 
immune response for all three classes of differentiated cell type included zero (Figure 
5.21). Thus, given this model, the data does not contain evidence for immune 
clearance of differentiated cells. This does not indicate that immune clearance does 
not occur, but rather that it is not a significant contributor to the loss of each cell 
type. Thus, for committed slender forms and intermediate forms, loss of these cell 
types is primarily by differentiation to the next cell type. For stumpy forms, loss is 
predicted to be primarily by non-immune mediated cell death (i.e. cell senescence).  
 
However, for mouse 2, there was a predicted immune response against the 
committed slender forms (Figure 5.21). It is not clear why this is the case but perhaps 
there is a fine balance between clearance via differentiation and clearance by the 
immune response within the host. Unlike the other five infections, the mouse 2 
infection was predicted to show a lesser reduction in parasitaemia in response to cell 
density, with the parasitaemia only falling dramatically after the onset of the immune 
response (section 5.7.3). Thus, where loss of committed slender cells by immune 
clearance plays only a small role in the other mice, it may be a significant contributor 




there is no qRT-PCR data for day 8 of the mouse 2 infection and microscopy data 
suggest that the predicted parasitaemia on this day may not be accurate (section 
5.7.3). Hence, the rise in immune mediated clearance of committed slender cells in 
mouse 2 may be an artefact of this error in the model.  
 
Finally, the model had a parameter prior of the log10 initial concentration of cells in 
the blood set to N(3, 0.5) as approximately 1000
 
trypanosomes were injected I.P. into 
each mouse, and the volume of blood per mouse was estimated to be approximately 
1ml. The model predicts that, on average, only 190 cells/ml were infected per mouse 
(Figure 5.21 and Table 5.1), with large variability between mice, ranging from as 
little as 41 to as high as 590 cells/ml. Indeed, the actual volume of blood in the 
mouse will not be 1ml which will cause the infecting concentration to vary from the 
predicted value. Also, as the cells are infected I.P. many of the cells may not 
successfully enter and establish infection in the bloodstream.  
 
5.7.8 Induction of stumpy formation is better explained by SIF 
than parasite density 
Having established a mathematical model which was a good fit to the quantitative 
biological data, this model could then be used to test hypotheses regarding the 
within-host dynamics. For instance, various models previously have used density-
dependent differentiation to account for stumpy formation rather than SIF-induced 
differentiation (Lythgoe et al., 2007; Turner et al., 1995; Tyler et al., 2001). Thus, Dr 
Savill removed SIF-induced differentiation from the model and replaced it by 
density-induced differentiation (see Appendix C). The parameters were then 
optimised for this new model. The adequacy of the model to explain the data was 
assessed by comparing the mean standardised residuals of each time point from each 
mouse to its 95% expected interval (Figure 5.22A), as had been carried out for the 












Figure 5.22 Density-dependent differentiation does not provide a good fit to the data. (A) The 
standardised residuals of each data point from each mouse (blue crosses) for both parasitaemia (upper 
panel) and PAD1 expression (lower panel). The mean of the standardised residuals from the six mice 
is shown as a solid red line. This mean lies out with the expected 95% interval on 8 days for the 
parasitaemia and 3 days for PAD1 expression and there are numerous outliers in this model. (B) The 
measured and predicted infection dynamics for parasitaemia (crosses and lines, respectively) 
according to the model is shown in upper panels. The measured log2 PAD1 expression (crosses) 
compared to the predicted log2 PAD1 expression (lines) is shown in lower panels. In all cases the 50% 





As can be seen in Figure 5.22A the mean of each time point lies outwith the 95% 
interval and there are numerous outliers, where the standardised residual is more than 
about 3 standard deviations from zero, at numerous days for both parasitaemia and 
PAD1 expression, suggesting a poor fit of the model to the data. Furthermore, 
analysis of the fit of the model to the data in individual mice (Figure 5.22B), reveals 
numerous data points lying outwith the model predictions. Comparing the likelihood 
of each of the two models, reveals that the SIF-induced differentiation model is 10
68 
times more likely than the density-dependent differentiation model (Appendix C). As 
such, the data provides huge support for SIF-induced differentiation in vivo.  
 
5.8 Discussion  
5.8.1 A method for the quantitative analysis of parasitaemia and 
stumpy formation in vivo has been established 
During a chronic trypanosome infection, the level of parasitaemia fluctuates but is 
maintained below a lethal threshold. These fluctuations and the maintenance of a 
sub-lethal parasitaemia are controlled by both the slender to stumpy transition and 
antigenic variation. Furthermore, given that the stumpy forms are the transmissible 
forms, stumpy formation is important for transmission and fluctuations in stumpy 
formation could impact on transmission capacity, especially given that tsetse bites 
can be rare (Baylis, 1997). However, the within-host dynamics of the slender to 
stumpy transition have not been well characterised previously, largely due to the 
difficulty in quantifying stumpy formation. Studies have been carried out using 
morphology to distinguish between cell types, but this can be subjective and is time-
consuming. Furthermore, morphology may not be an accurate way to distinguish 
differentiating forms (section 5.8.7). 
 
Here, a qRT-PCR method was established whereby RNA was extracted from a 
starting volume of 10µl of whole blood from an infected mouse and used to analyse 
parasitaemia and relative PAD1 expression. Parasitaemia was measured by 
monitoring TbZFP3 transcript expression and comparing to a standard curve (section 




2006), and it was confirmed in section 5.4.2 that transcript expression is indeed equal 
in slender and stumpy forms. The limit of detection of parasitaemia was 10
6
 cells/ml, 
due to the limited starting volume and the dilution steps required along the 
processing pathway which was satisfactory for mouse infections where the 
parasitaemia is predominantly higher than 10
6
 cells/ml but would need improved for 
analysis of infection in other hosts, such as cattle, which would be relevant in the 
field (section 5.8.9).  
 
Stumpy formation was monitored via the expression of PAD1 mRNA which is up-
regulated in stumpy forms compared to slender forms and is a functionally relevant 
marker: PAD1 protein expression correlates with capacity to differentiate to the 
procyclic life stage (Dean et al., 2009). Expression was normalised to parasitaemia 
and the changes in PAD1 expression over time therefore represent a change in the 
PAD1 expression of the population.  
 
This method has various future uses, as will be discussed in section 5.8.10. Here, the 
utilisation of this method allowed parasitaemia and PAD1 expression to be monitored 
during the infection of six mice with T.b. brucei AnTat1.1 over the course of a 30 
day period. As well as analysis of infection dynamics by qRT-PCR, traditional 
analyses of morphology and cell cycle status were also performed for the first peak 
of parasitaemia over 4-9dpi. The combined analyses allowed the temporal order of 
events during early infection to be dissected (section 5.8.3).  
 
5.8.2 Quantitative data has been incorporated into a 
mathematical model for stumpy formation  
Having generated a large amount of quantitative data in section 5.6, this data was 
incorporated into an existing model of stumpy formation (section 5.7). Mathematical 
models are useful tools for the analysis of complex within host dynamics: they allow 
unknown parameters to be estimated and once generated, allow the impact of 
changes, such as introduction of a drug or presence of a competing strain, to be 




The model was fitted to the data that had been generated in section 5.6 for both 
parasitaemia and PAD1 expression. The raw data input into the model was the 
calculated parasitaemia, as was used in section 5.6, and the total PAD1 expression of 
the population, before normalisation to parasitaemia. By analysing parasitaemia and 
PAD1 expression every day for 30 days during infection in six mice, this produced 
over 350 data points to which the model could be fitted. The model provided a good 
fit the experimental data on all days except day 4, where the predicted parasitaemia 
was lower than the actual parasitaemia in five of the mice (section 5.7.2). This 
implies that there is some factor missing or incorrect in the model during this first 
peak. An underestimation of parasitaemia at this early time point may imply that the 
duration of the slender cell cycle was overestimated at the early stage of infection. 
Perhaps the rate of proliferation is faster during the first days of infection compared 
to later in infection. Overall, however, this model does provide a very good fit to the 
data and as such could be used to estimate associated parameters and make 
predictions about the system.   
 
5.8.3 The order of changes in the trypanosome population early 
in infection   
By comparing traditional morphological and cell cycle analysis with qRT-PCR 
analysis for parasitaemia and PAD1 expression the temporal order of events during 
differentiation from slender to stumpy forms in vivo, at the population level, were 
monitored. This can only be analysed during the first peak of parasitaemia where the 
population is originally composed of almost entirely slender cells so the process is 
somewhat synchronised and also no SIF has yet accumulated. The differentiation 
process is not simply a morphological switch but rather a series of events that occur 
in response to a parasite-derived signalling factor, SIF, including commitment to 
differentiate in response to SIF, appropriate changes in gene expression, cell cycle 
status, metabolism and morphology.  
 
A summary of the temporal order of events in the population during the first peak of 




is shown in Figure 5.23. The changes that occurred during the first peak of 
parasitaemia, including parasitaemia, morphology, cell cycle status and PAD1 
expression was similar in all six infections suggesting that these are a highly co-
ordinated series of events.  
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Figure 5.23 The order of events of the population during the first peak of parasitaemia.  During 
the first wave of parasitaemia, the parasitaemia rises as slender forms predominate in the infection. As 
cell cycle arrest begins, the parasitaemia plateaus, the population becomes predominantly intermediate 
and the first stumpy forms appear. PAD1 expression rises with the appearance of differentiating cells 
and then plateaus for the remainder of the first peak of the infection. The population becomes 
predominantly stumpy in morphology, almost all of the population is cell cycle arrested and the 





5.8.4 The order of events during differentiation of an individual 
cell  
By combining the empirical data and modelling data generated here, the temporal 
order of events during stumpy formation in an individual cell can be mapped (Figure 
5.24) and the timing of these events can be predicted. Tyler et al., established that 
commitment and division occurred before morphological change, and that nuclear-
encoded mitochondrial genes that were up-regulated in stumpy forms compared to 
slender forms showed up-regulation of the mRNA, but not protein, before 
morphological change (Tyler et al., 1997). From the analyses in this chapter, it also 
appears that for PAD1, a non-mitochondrial stumpy specific gene, there is also up-
regulation of mRNA expression prior to morphological change. The PAD1 protein is 
not up-regulated until after morphological change (Dean et al., 2009). Further, the 
model generated in section 5.7 further confirms that commitment to differentiation 
precedes cell cycle arrest and predicts that a committed slender cell undergoes 
approximately 3 further divisions after the point of commitment such that the 
committed slender lifespan if approximately 14-15 hours. The model also predicts 
that the committed slender cell will continue to produce SIF for approximately 10 
hours, or two cell divisions, after the point of commitment (section 5.7.7). The 
differentiating cell will then undergo cell cycle arrest prior to the detectable change 
in morphology, although the process of changing morphology may begin at the same 
point in time. These cell cycle arrested forms are termed intermediates and they do 
express at least some stumpy-specific proteins. After morphological change is 
complete the cell is considered fully stumpy. From the point of commitment to 
stumpy cell death is estimated to be approximately 70 hours, with the time since cell 























Figure 5.24 The order of events in an individual cell during stumpy formation. After the point of 
commitment the committed slender cell begins to express some stumpy-specific mRNA but will 
undergo further divisions before cell cycle arrest. After cell cycle arrest there is a detectable change in 
cell morphology such that the cell is described as intermediate and at least some stumpy-specific 
proteins become expressed. At the end of morphological change the cell is fully stumpy. The 
estimated time from the point of commitment to stumpy cell death is approximately 70 hours, with 
cell cycle arrest at approximately 14-15 hours.  
 
5.8.5 The proportion of transmission stages is high throughout 
infection  
At the initial stage of infection PAD1 mRNA levels were very low and rose with the 
first peak of infection. This correlates with a rise in the number of cells in the 
population differentiating to the transmissible stumpy form. When parasitaemia fell 
after the first peak of infection, relative PAD1 mRNA expression of the population 
remained high and although it did fluctuate with parasitaemia throughout infection, it 
did not fall below detection at any point after the first peak. Indeed, even when 
parasitaemia was low the PAD1 mRNA expression relative to the number of cells in 
the population remained high. This indicates that even at low parasitaemia, the 
number of differentiating or differentiated form remained high. Further, by 
mathematical modelling, it was predicted that the proportion of non-committed 
slender forms was generally low (section 5.7.3). Although increases in these forms 
were observed, these were generally short-lived. This low proportion of non-
committed slender forms and high proportion of differentiated forms has two key 
implications in infection dynamics: firstly, the proportion of transmission competent 




functionally switch the VSG coat this may reduce the number of variants used in a 
given period, thus prolonging antigen variant chronicity.  
 
Antigenic variation has been shown to display a degree of order or hierarchy that is 
caused by a combination of differential activation rates and the slender to stumpy 
transition, with multiple variants being expressed simultaneously (Lythgoe et al., 
2007; Morrison et al., 2005). Only slender cells are able to functionally switch to the 
next variant, as stumpy forms are cell cycle arrested and so will not be able to 
populate the next wave of parasitaemia. Therefore, if there are fewer slender cells in 
the population, there will be fewer cells able to switch to a new variant and as such 
fewer variants will be used in a given time frame. Thus, maintaining a low 
proportion of slender cells could prolong antigen chronicity by extending the useful 
life of the VSG repertoire.  
 
Trypanosome infections can last for months to years and as such, reservoirs, such as 
infected humans and livestock, will play a crucial role in the epidemiology of both 
human and cattle disease. Although a single trypanosome is capable of causing a 
tsetse infection (Maudlin and Welburn, 1989), it has been shown that cattle 
infections can have intermittent periods where they are not infective to the tsetse 
vector (Van den Bossche et al., 2005). The transmission potential of an infection 
could be impacted by both total parasitaemia and the proportion of transmissible 
stages in the population. For instance, if the parasitaemia is so low that no 
trypanosomes are taken into a tsetse blood meal then the infection is not 
transmissible at that point; similarly, if there are very few transmissible forms such 
that only slender forms are taken into a blood meal then this would also reduce 
transmission potential. When parasitaemia is high, however, the proportion of 
transmissible forms in the population does not seem to affect tsetse infectivity 
(Janelle et al., 2009), indicating that at high parasitaemia, such as in mouse models, 
there is less of a requirement for a high proportion of transmissible forms to be tsetse 
infective. Here, the proportion of stumpy cells in the population, as determined by 
microscopy, reached over 75% in the first peak of parasitaemia and then the number 




throughout the later stage of infection. Other studies have also observed close to 
100% stumpy formation in the first week of T.b brucei infection (Balmer et al., 2009; 
Tyler et al., 2001; Tyler et al., 1997; Van Den Abbeele et al., 1999). Indeed, even at 
low parasitaemia, the proportion of differentiated cells remained high (section 5.6). 
This implies that these infections remain transmission competent throughout 
infection.  
 
In contrast, a recent analysis of morphology in T.b gambiense mouse infections did 
not observe a high proportion of stumpy forms (Janelle et al., 2009). The 
parasitaemia rose to over 10
8
 cells/ml in the first wave if infection and then, in most 
cases, fell as would be expected. The mice used were immunocompromised and 
therefore this fall in parasitaemia was only due to stumpy formation and not immune 
clearance, yet in all cases intermediate and stumpy forms represented less than 30% 
of the total population. Firstly, it may be that there is a considerable difference in the 
rate of stumpy formation between different sub-species. It is indeed known that 
growth rates vary between strains (Turner et al., 1995) which may impact on stumpy 
formation and different strains induce different host responses, which will impact on 
virulence and disease progression (Morrison et al., 2010). It seems very likely 
therefore that different sub-species and different strains will have differences within 
host dynamics and transmissibility. Alternatively, it may be that during stumpy 
formation in T.b. gambiense, morphological change occurs later in the differentiation 
pathway than in T.b. brucei, such that early intermediate cells are scored as slender 
forms for a longer period or the committed slender cell lifespan is longer, meaning 
that more morphologically slender forms are present but that many of these are 
already committed to differentiation. It would be interesting to use the qRT-PCR 
method established in this thesis to monitor stumpy formation with different strains 





5.8.6 The mathematical model supports SIF induced 
differentiation in vivo   
Stumpy formation has been shown in vitro to be caused by the parasite-derived SIF 
(Vassella et al., 1997) which essentially reports on the population density. However, 
due to the lack of identification of SIF it has not been possible to characterise the role 
of SIF in vivo. Therefore, most mathematical models incorporating stumpy formation 
have used a density-dependent model whereby the rate of differentiation is 
proportional to the total number of cells in the population (Lythgoe et al., 2007; 
Turner et al., 1995; Tyler et al., 2001). Although SIF-induced differentiation will be 
greatly affected by population density, it will provide different dynamics than density 
alone. For example, in the density-induced model, as parasitaemia falls stumpy 
formation will also fall: on the contrary, in the SIF-induced model, SIF will remain 
in the system after parasitaemia falls and delay the fall in rate of stumpy formation. 
Here the model had been produced to include SIF-induced stumpy formation. To test 
if this provided a better or worse fit to the data, SIF-induced differentiation was 
replaced with density-induced differentiation and the adequacy of each model to 
explain the data was compared. The SIF-induced model produced a greatly better fit 
to the data than the density-dependant model, supporting SIF-induced differentiation 
in vivo. Without the identity of SIF, it is not possible to measure the concentration or 
rate of loss of SIF in the system and thus it is not possible to test the predictions 
made here. Given future characterisation of SIF, the model could be refined with 
empirical evidence regarding SIF dynamics.  
 
5.8.7 Morphology is not an accurate tool for the analysis of 
stumpy formation  
Differentiation between life stages involves a complex series of events in order to 
alter the phenotype of a cell to adapt to changing environmental conditions. In the 
case of the slender to stumpy differentiation the proliferative cell will receive the SIF 
signal, transmit that signal through the cell and respond by altering gene expression, 
cell cycle status, metabolism and, most obviously, morphology. Indeed, morphology 




were identified  and how the slender and stumpy stages were named (Vickerman, 
1965a). The morphological change during stumpy formation is continuous, and as 
such, intermediate forms can be observed. Functionally these intermediate forms 
represent cells that are in the process of differentiation and may have already 
undergone many of the other changes associated with stumpy formation.  
 
There are various problems with the use of morphology as a way to monitor stumpy 
formation. Firstly this method is subjective; the presence of morphologically 
intermediate forms complicates analysis by making it difficult to distinguish between 
cell types. Furthermore, as discussed in section 5.8.4, commitment to differentiation 
has been shown to occur before final cell division and morphological change and the 
mRNA levels of stumpy specific genes rise before cell cycle arrest (Tyler et al., 
1997), which was supported by the prediction in this thesis that committed slender 
cells express PAD1 mRNA before cell cycle arrest. It was also demonstrated here 
that very early cell cycle arrested intermediate forms are likely being scored as 
slender in morphology, suggesting that cell cycle arrest also precedes detectable 
morphological change. Hence, it appears that morphological change is actually a 
very late marker in the process of differentiation and as such it may be easy to 
underestimate the number of differentiating forms.  
 
The use of PAD1 as a molecular marker for stumpy forms, as used here in vivo by 
qRT-PCR and in vitro in Chapter 4, removes the subjective nature of the analysis, 
and provides an early marker for differentiation. Indeed, PAD1 mRNA expression 
was shown to increase in the absence of full morphological change in response to 
stumpy-inducing drugs in Chapter 4: since PAD1 expression is an earlier marker for 
differentiation than morphology, it appears these drugs were able to initiate the early 






5.8.8 Possible improvements to the mathematical model 
When mathematical models are produced, they aim to explain the available data as 
well as possible in as simple a way as possible. Clearly, for complex biological 
systems simple mathematical models will not be able encompass all the factors that 
are influencing that system; especially when experimental data regarding many of the 
factors are unknown. As discussed in section 5.8.2, a mathematical model for stumpy 
formation was fitted to the data that had been generated in section 5.6. These 
infections were carried out in immunocompetent mice and as such the host immune 
system and trypanosome antigenic variation were required to be taken into account in 
the model. However, no data regarding the host immune response or antigenic 
variation throughout the infection was collected. Thus, a simple model of the 
immune system and the antigen switching was incorporated in order to reduce the 
number of unknown parameters. 
 
Firstly, in the model of the immune system, there was a delay in the response to of 
the immune system to the infecting variant, but not to later variants. It may improve 
the model to incorporate a time delay between the responses to each variant to 
account for the time taken to raise an immune response to each variant. Indeed, in 
two experimental cattle infections, the VSG-specific transcripts were, in some cases, 
detected over a week before the immune response specific to that variant could be 
detected (Morrison et al., 2005).  
 
To incorporate antigenic variation a simple sequential switching model was used 
whereby the first variant could only switch to the second variant which could only 
switch to the third and so on, with the rate of switching between two variants 
different for each pair. This simple model still resulted in the prediction of multiple 
variants expressed simultaneously and requires less unknown parameters to be 
incorporated into the model. However, the model did predict a slower switch rate 
between the first and the second variant than was observed (section 5.7.4). To 
improve the model regarding antigenic variation, it may be useful to incorporate a 
model similar to that produced by Lythgoe et al., whereby the rate of switching away 




system, with differential probabilities of activation of each individual variant 
(Lythgoe et al., 2007). This model may be more biologically correct and produces a 
hierarchical model of expression where variants with a high activation rate are 
expressed earlier in infection and those with a lower activation rate are expressed 
later in infection. However, inclusion of such a model would require a much greater 
number of unknown parameters to be included in the model since no data regarding 
antigen switching was collected here.  
 
Finally, the error in the measured parasitaemia and PAD1 expression was assumed, 
based on previous studies of malaria infection in mice (Mideo et al., 2008; Miller et 
al., 2010). However, if the errors had been empirically calculated for the assay 
developed here, this would have reduced the number of assumptions in the model 
and may have allowed the model to be more accurately fitted to the data. This could 
have been determined by collecting two or more blood samples from a mouse at the 
same time point and processing the samples simultaneously. Given that processing 
three slender and three stumpy standard curve samples simultaneously resulted in 
very consistent results (section 5.4), the errors would be expected to be low and 
therefore similar or less than the assumed errors, although this analysis did not 
account for error during blood sampling.  
 
5.8.9 Possible improvements to the qRT-PCR method 
The qRT-PCR method established here provides a way in which to quantify stumpy 
formation and parasitaemia in vivo using only a 10µl sample. However the limit of 
detection of parasitaemia was 10
6 
cells/ml blood due to the small starting volume and 
the number of dilutions that were required throughout the protocol in order to DNase 
treat the sample and prevent inhibition during cDNA production and PCR. To 
improve the method it may be useful to attempt to collect a greater volume of blood 
per day or to try different reagents throughout processing to determine if fewer 
dilutions could be carried out. In the mouse infections, the parasitaemia was high 
enough during the chronic stage of infection that the detection was not limited. 




parasitaemia can range from above 10
6 
cells/ml to less than 10
2 
cells/ml (Desquesnes 
and Davila, 2002; Morrison et al., 2005; Rurangirwa et al., 1986). Much larger 
samples can be collected from cattle; millilitre volumes can be collected every day 
compared to micro litre volumes from mice. Therefore, with some time developing a 
new protocol, it should be possible to extend this method to allow for analysis of 
experimental cattle infections as well as monitoring natural cattle infections in the 
field (section 5.8.11).  
 
Here, PAD1 was used to monitor stumpy formation throughout infection. This qRT-
PCR method could also be used to monitor up-regulation of mRNA expression of 
mitochondrial markers of stumpy formation in order to further elucidate the order of 
events during stumpy formation. Additionally, recent whole genome microarray 
analysis has identified that a large number of genes are differentially expressed 
between slender and stumpy forms (Jensen et al., 2009; Kabani et al., 2009).  By 
using qRT-PCR to monitor the rise in expression of genes, other than PAD1, that are 
up-regulated in stumpy formation, during the first wave of infection, it may be 
possible to identify groups of genes that are up-regulated simultaneously, implying 
similar mechanisms of gene regulation and common RNA-binding complexes, or 
determine which genes are early markers of differentiation and which genes are late 
markers.  
 
5.8.10 Future applications of the qRT-PCR method and the 
mathematical model in laboratory infections 
Firstly, it would be potentially interesting to use the qRT-PCR method established 
here to analyse the within-host dynamics in chronic infections with different strains 
of trypanosome in order to establish the variability in stumpy formation between 
strains. It would perhaps also be useful to analyse infection in different mouse 
strains, given that different strains show different susceptibility to trypanosomiasis 
(Antoine-Moussiaux et al., 2008) in order to determine the degree to which the 





This method could also be used to monitor stumpy formation under different 
conditions in order to determine if the parasite is able to alter the rate of stumpy 
formation in response to these conditions. It is not known if trypanosomes are able to 
alter stumpy formation in response to changes, other than parasite density, in the 
environment such as the presence of competing strains or availability of host 
resources. The dynamics between proliferation and stumpy formation may be able to 
be altered by a change in the rate of replication or the rate of production of, or 
response to, SIF. Furthermore, there may be changes in the rate of loss of SIF in the 
host dependent on host factors. To determine if indeed changes in differentiation do 
occur, this method could potentially be used to analyse the effect of host health on 
stumpy formation. It has been observed that host glucose levels can fall drastically in 
infected mice just before host death (Balmer et al., 2009). It may be expected that if 
the host is very near to death, and the parasites could perhaps detect this in some 
way, then they would maximise transmission potential and therefore increase stumpy 
formation. Stumpy formation could be monitored late in infections prior to host death 
to determine if this is indeed the case. If an increase in stumpy formation was 
observed, this would indicate that the trypanosome can monitor the health of the host 
in some way, thus detecting changes in their environment, and respond accordingly.  
 
At least 8.8% of trypanosome infections in the field are thought to contain more than 
one parasite strain, which is likely to affect within-host dynamics and as such, have 
an effect on the parasitaemia, virulence and the transmission capacity of the infection 
(Balmer and Caccone, 2008; Balmer et al., 2009; Turner et al., 1996). Mixed 
infection can reduce overall parasite virulence compared to single infections (Balmer 
et al., 2009), with parasite strains suppressing the growth of each other during 
infection (Balmer et al., 2009; Turner et al., 1996). It is also not known if, and how, 
the parasite detects the presence of a second strain within the host. The effect of 
competition on one strain appears to be dependent on the density of the other 






As discussed above, it is not known if trypanosomes can alter their response to SIF, 
but this could be a key factor in competition. It has been predicted that the parasites 
may reduce stumpy formation in the presence of a competitor in order to increase the 
number of proliferative slender forms in the population and to therefore out-compete 
the other strain (Pollitt et al., in review). Alternatively, it may be that the strain with 
the higher growth rate is able to increase to a greater density than the other before the 
total population density reaches a higher density before stumpy formation begins. In 
either case, if the parasites cannot distinguish between the SIF produced by each 
strain, then perhaps this is involed in the density-dependent suppression of one strain 
on another (Balmer et al., 2009) and it may be that the SIF produced by the 
dominating strain causes stumpy formation in the other strain at low parasitaemia, 
thus preventing an increase in parasitaemia of that second strain. Now that a method 
for quantify stumpy formation during infection has been established it may be 
possible to modify this in order to determine if stumpy formation varies between 
strains and if this is altered by the presence of a competing strain, thus demonstrating 
if trypanosomes are able to detect and alter stumpy formation in response to presence 
of a second strain. To do this, a means in which to distinguish between the two 
strains and between stumpy formation of the two strains would be necessary.  
 
For similar analysis regarding gametocyte production in malaria infections, Wargo et 
al., used strain-specific qRT-PCR primers for the analysis expression of a 
gametocyte specific gene (Wargo et al., 2007). However, for PAD1, which is a 
member of an 8-gene family, only a very limited region of the gene allowed for 
specific amplification. Thus, it may not be possible to design strain-specific PAD1 
primers, although this has not been investigated. As an alternative, transgenic 
pleomorphic cell lines could be created which couple the PAD1 3’UTR which 
controls stumpy-specific gene expression (Chapter 3 and 4), with unique sequences, 
such as a reporter genes, in order that different strains could be identified. 
Alternatively, Balmer and Tostado have created different fluorescently labelled 
strains of T.b. brucei and T.b. rhodesiense such that they can be distinguished in co-
infections (Balmer and Tostado, 2006). They established a method whereby two 




monitored by FACS from only 5µl of mouse blood (Balmer and Tostado, 2006). 
Importantly, the use of FACS allows two populations to be separated: it may be 
possible to therefore develop this method for the purposes of monitoring differences 
in stumpy formation in a mixed infection by separating the two strains and then 
carrying out qRT-PCR on the two populations.  
 
A further application of both the model and the qRT-PCR method would be to 
predict and investigate the impact of stumpy-inducing compounds, on within-host 
dynamics. In Chapter 4 a drug screen was carried out to identify compounds which 
could potentially induce stumpy-formation at low parasitaemia. Although these 
compounds will need validated and their effect measured in vitro, the qRT-PCR 
method could be used to validate the ability of the drugs to induce stumpy formation 
and the model could be used to predict the effect of these compounds on the infection 
dynamics. Inducing stumpy formation may cause decreased parasitaemia and, if able 
to cause complete stumpy formation would cause eradication of the parasite. 
Alternatively, the induction of stumpy formation may temporarily cause 
parasitaemia, and therefore SIF concentration, to fall, but then due to a lack of SIF in 
the system following treatment, the parasitaemia may surge and the effect would 
therefore be short-lived. The model could potentially predict such problems and be 
used to predict the most appropriate treatment regime. The qRT-PCR method could 
then be used to monitor the effects in vivo on within-host dynamics and to test the 
predictions made by the model. 
 
Mouse models are a valuable tool to analyse many aspects of trypanosome infection, 
including differences between strains and the effect of competition during infection 
(Antoine-Moussiaux et al., 2008; Balmer et al., 2009; Morrison et al., 2010; Turner 
et al., 1996). However, it would also be interesting to analyse natural trypanosome 





5.8.11 Future applications of the qRT-PCR method and the 
mathematical model in the field 
As discussed in section 5.8.9, it should be possible to modify the qRT-PCR method 
established here for use in analyses of cattle infections. If this were achieved it would 
then be possible to monitor stumpy formation in natural infections in the field. 
Samples could be collected daily from cattle in affected regions and transferred 
directly into RNA lysis solution (see Chapter 2). Samples could then be frozen and 
stored before being transferred back to the laboratory for analysis. Then, both the 
changes in parasitaemia and stumpy formation during natural chronic infections 
could be tracked over time. This would provide information regarding the dynamics 
of long term chronic infections, potentially identifying if there are large fluctuations 
in stumpy formation or if the proportions of stumpy forms remains similar 
throughout infection. This data could then be incorporated into the mathematical 
model to determine: (1) if the model is suitable for natural cattle infections, or if it 
needs additional factors to be considered and, (2) what parameter estimates are 
calculated from these natural infections. Thus, some of the similarities and 
differences between experimental mice infections and natural cattle infections could 
be ascertained. 
 
Given the potentially complex within-host dynamics of trypanosome infections, 
stumpy formation could play an important role in disease progression and 
transmission in endemic areas. Overall, there is a plethora of exciting experiments, 
analysing stumpy formation in both laboratory and field infections, that could be 
carried out following the establishment of this qRT-PCR method, which could 














































The African trypanosome differentiates between different life-stages in order to 
adapt to and prepare for the different environmental conditions it must encounter 
throughout its life cycle. As such, the parasites must be able to detect and respond to 
their external environment to cause changes in gene expression which in turn results 
in changes in metabolism, proliferation status and morphology. Such changes in gene 
expression must occur largely through mechanisms of post-transcriptional regulation, 
rather than by the effects of transcription factors as seen in most eukaryotes.  
 
One such life-stage transition is the density-dependent differentiation of proliferative 
slender forms to the cell-cycle arrested, transmissible stumpy forms in the 
bloodstream of the mammalian host. This differentiation is triggered by a parasite-
derived signalling factor used to report on population density rather than large scale 
changes in environmental temperature, pH or nutrients. Stumpy formation plays a 
crucial role in trypanosome infection dynamics, prolonging host survival, and 
therefore duration of infection, ensuring transmissibility between hosts and 
contributing to ordered antigenic variation. Despite the importance of stumpy forms, 
fairly little is known about the mechanisms controlling density signalling, stumpy 
formation, the mechanisms of control of stumpy-specific gene expression and the 
dynamics of stumpy formation in vivo. This has largely been due to a lack of 
molecular markers to distinguish stumpy forms, with traditional methods relying on 
morphological analysis, which is subjective, time-consuming and complicated by the 
presence of morphologically intermediate forms that arise during differentiation. By 
comparison, much is known about the molecular events causing bloodstream to 
procyclic differentiation and differential gene expression between these two forms 
has studied more extensively. This is largely due to the ability to clearly and 
efficiently distinguish bloodstream from procyclic forms molecularly by their surface 
protein coats, as well as the ability to chemically induce the differentiation process in 
the laboratory.  
 
Recently, the first stumpy-specific surface protein PAD1 was identified. PAD1 is up-
regulated at both the level of mRNA abundance and protein expression during the 




competence to differentiate to the procyclic life-stage, providing the first functional 
marker for stumpy forms and transmission competence. The aims of this thesis were 
to exploit the stumpy-specific expression profile of PAD1 in order to further 
understanding of control of stumpy-specific gene expression and of stumpy 
formation both in vitro and in vivo.  
 
Firstly, the PAD1 3’UTR was shown to be responsible for repression of expression 
during the slender life-stage and for up-regulation of gene expression upon 
differentiation to the stumpy life-stage in both monomorphic and pleomorphic cell 
lines. The PAD1 3’UTR is the first stumpy-specific 3’UTR that has been 
experimentally analysed; it is able to repress expression in monomorphic slender 
forms with regulation exerted at both the level of mRNA abundance and translation. 
Further, the creation of a series of reporter cell lines in monomorphic cell lines, 
where section of the PAD1 3’UTR were deleted and analysed for reporter gene 
expression, revealed that there are at least two repressive elements which act to 
prevent inappropriate gene expression in slender forms, again controlling both 
mRNA abundance and protein expression.  
 
There is much still to be learned about differential control of gene expression in 
trypanosomes between life-stages; few RNA-binding proteins have been 
characterised and the mechanisms by which gene expression is altered by 
environmental cues is not well understood. During the slender to stumpy transition 
there are large changes in gene expression, including global translational repression, 
in response to a single environmental cue, reporting on parasite density. Additional 
analysis of the PAD1 3’UTR, identifying more defined repressive elements or motifs, 
and identification of interacting RNA-binding proteins would further contribute to 
the understanding of repression of expression during the slender life-stage and up-
regulation and escape of global translational repression during the stumpy life stage.  
 
The changes in gene expression, as well as cell morphology, metabolism and 
proliferation status that occur during the slender to stumpy transition are the result of 




response is reportedly induced by the parasite-derived SIF, yet despite being 
characterised in 1997 as a small soluble molecule, or group of molecules, released 
into the extra cellular environment, the identity of SIF is not yet known. Moreover, 
no components of the stumpy induction pathway have been described. Despite the 
ability for cell permeable cAMP to mimic SIF, implicating cAMP signalling in this 
pathway, the hydrolysis products of cAMP analogs have since been shown to have a 
more potent effect, arguing against a classical cAMP signalling pathway. 
Identification of SIF would provide a much enhanced capacity for analysis of stumpy 
formation. Much of the analysis of bloodstream to procyclic differentiation has been 
facilitated by the ability to induce differentiation by high concentrations of CCA. 
This would provide a biologically relevant method of inducing stumpy formation and 
aid in the identification of the downstream pathway and study molecular changes in 
the cell throughout the transition. Further, knowing the identity of SIF may aid 
understanding into ability, or lack of ability, for trypanosomes to vary their response 
to SIF depending on conditions within the host. Finally, drugs which mimic its 
activity could potentially be informatively designed in order to drive stumpy 
formation with prospective therapeutic effects. 
 
Hence, next in this thesis, both pleomorphic and monomorphic reporter cell lines that 
can report on stumpy formation in vitro were created for the analysis of conditioned 
media and of chemical inducers of stumpy formation. In the pleomorphic cell line, 
the reporter gene was down-regulated in slender forms and up-regulated in stumpy 
forms harvested from in vivo infections and responded to cell density in vitro 
indicative of appropriate reporter gene expression for analysis of stumpy formation. 
Despite the promising potential of this cell line, no response was observed upon 
treatment with conditioned media, expected to contain the elusive SIF. In the absence 
of a positive control, the explanation for this is not yet clear: it may be that the 
conditioned media generated here does not contain SIF suggesting some component 
has been lost or destroyed during processing or that some other requirement for 
stumpy formation, as well as SIF, is not fulfilled under the conditions used here. 
Further experimentation with this cell line, including recreating the conditions used 




pleomorphic cell line could be successfully used to track SIF activity in conditioned 
media, the identity of this unknown factor could be discovered by comparative mass 
spectrometry. The activity of candidate compounds identified by mass spectrometry 
could then be analysed out of the context of conditioned media for validation. This 
pleomorphic cell line therefore has excellent potential and given more time could be 
a very useful resource.  
 
Given the lack of advancement in identifying SIF in over 13 years, since its initial 
characterisation, a second approach to understanding the molecular events that occur 
during stumpy formation was also taken. Monomorphic reporter cell lines were 
created and used to analyse previously reported chemical inducers of stumpy 
formation. If monomorphic cell lines are simply unable to receive the SIF signal then 
perhaps molecules which induce stumpy formation in monomorphic cells are acting 
downstream in the stumpy induction pathway. Identification of pathway components 
would provide a starting point for the characterisation of the remainder of the 
pathway, potentially including the identity of SIF and the mechanism by which the 
SIF pathway leads to global changes in gene expression and the formation of stumpy 
forms.  
 
The analysis of monomorphic reporter cell lines treated with chemical inducers of 
stumpy formation confirmed that monomorphs are not incapable of stumpy 
formation per se, although, how similar these “stumpy-like” cells are to naturally-
derived stumpy forms is not clear. Reporter gene expression in these cell lines 
correlated with cell cycle arrest and an increased capacity for differentiation to the 
procyclic life-stage, demonstrating that where an up-regulation of reporter gene 
expression was observed, other indicators of stumpy formation were also seen. 
Hence, these cell lines can be used for the analysis and identification of stumpy-
inducing compounds in vitro in laboratory adapted strains. This allowed for the 
establishment of a high-throughput assay for stumpy formation in monomorphic cell 
lines. This assay was used to screen 6000 kinase inhibitors for their stumpy-inducing 
potential with two objectives: firstly, compounds able to induce stumpy formation at 




may be acting on components of the stumpy induction pathway and could therefore 
lead to their identification. Upon receipt of the results from the drug screen, the 
candidate compounds identified with need to be experimentally validated further. 
Any kinase inhibitors which can be confirmed as causing stumpy-formation can then 
be used to search for the molecule(s) which it inhibits. This drug screen therefore has 
huge potential to identify components of the SIF pathway. As previously mentioned, 
identification of one component involved in stumpy formation would greatly 
increase the capacity to study the remainder of the pathway by searching for 
interacting proteins both up and down-stream.  
 
As well as a lack of understanding of the molecular events causing stumpy formation 
in individual cells, there is also fairly little known regarding the temporal order of 
events during stumpy formation in vivo and the effects that stumpy formation has on 
infection dynamics and transmission. Therefore, next, a quantitative method to 
analyse parasitaemia and stumpy formation in vivo was developed here. Stumpy 
formation was monitored early in mouse infections by traditional morphological and 
cell cycle analysis, as well as by qRT-PCR for PAD1 expression. The resulting 
analysis allowed the definition of the co-ordinated order of events in the generation 
of stumpy forms in the population early in infection. 
 
Further, PAD1 expression was monitored throughout chronic mouse infections 
revealing dominance of transmissible forms, which has important consequences on 
infection dynamics. Firstly, there is no prolonged periods of a low proportion of 
differentiated forms suggesting that the infection is transmission competent 
throughout infection, which may be crucial when tsetse bites are rare. Secondly, as 
only slender cells are functionally competent for antigenic variation, a low 
proportion of slender cells throughout infection will result in a reduced use of the 
antigen repertoire than if there were a high proportion of slender forms, potentially 
prolonging antigen chronicity.  
 
Dr Nick Savill, University of Edinburgh, then incorporated the quantitative data into 




parameters relating to infection dynamics in vivo. Importantly, this model 
incorporated SIF-induced stumpy formation and it was demonstrated that an 
equivalent model incorporating density-induced differentiation did not provide as 
good a fit to the quantitative data, supporting a quorum-sensing mechanism for 
differentiation in vivo rather than absolute cell density. Combining data from both the 
experimental analysis and the mathematical model, it was possible to define the 
temporal order of events that occurred during differentiation of an individual cell, 
with a cell undergoing further cell divisions following commitment to differentiation 
and both cell cycle arrest and up-regulation of mRNA expression of stumpy-specific 
proteins preceding morphological change.  
 
Both the qRT-PCR technique and the improved mathematical model provide 
valuable tools for future analysis of within host dynamics both in the laboratory and 
the field. These tools can be used for the analysis of potential differences in stumpy 
formation between strains, the effect of environmental factors, such as resources and 
competition, on stumpy formation and the within-host dynamics of chronic infections 
in the field. The model can also be used to predict the effects of stumpy-inducing 
compounds, or other therapeutic compounds, on the infection dynamics in vivo and 
may direct informed experimental analysis.  
 
Stumpy forms play an important role in the life-cycle of the trypanosome; 
influencing transmissibility, prolonged host survival and antigenic variation but have 
been under studied due to the lack of tools to distinguish the life-stage. Overall, the 
methods created, and the data then generated in this thesis, provide a valuable step 
forward towards fully understanding the mechanisms and order of events underlying 
stumpy formation, control of stumpy-specific gene expression and the role of stumpy 
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Appendix A: Chemicals and Solutions  
Unless otherwise stated, chemicals were purchased from Sigma Aldrich.  
 
Cloning and DNA manipulations 
 
Miniprep Solution I:  50mM Glucose 
    25mM Tris-HCl pH 8 
    10mM EDTA pH 8 
    Autoclaved 
 
Miniprep Solution II:   0.2M NaOH 
    1% SDS 
 
Miniprep Solution III:  5M KOAc  
 
6x DNA Gel loading buffer: 0.25% bromophenol blue 
    0.25% xylene cyanol 
    30% glycerol 
 
1x TAE   40mM Tris-Acetate 
    1mM EDTA 




10x MOPS:   23.13g MOPS 
    50mM Na-Acetate pH 7 
    10mM EDTA 
Made up to a final volume of 500ml with dH2O 
Autoclaved and stored in the dark at 4°C  





RNA Gel Loading Buffer:  150µl formamide 
    83µl formaldehyde (37%) 
    50µl 10x MOPS 
    0.01% Bromophenol blue 
    50µl glycerol  
    167µl dH2O 
 
20x SSC:   3M NaCl 
    0.3M Tri Sodium Citrate 
 
Hybridisation buffer:  12.5ml 20x SSC 
    25ml formamide 
    100µl 10% SDS 
    10ml 10% DIG Block 
 
Maleic Acid buffer:   100mM Maleic Acid 
    150mM NaCl 
    pH adjusted to 7.5 with NaOH and autoclaved 
 
10% DIG Block: 10g Blocking Reagent (Roche 14497700) dissolved in 
100ml Maleic Acid buffer 
 Autoclaved and stored at -20°C 
 
RNA Wash Buffer:  498.5ml Maleic Acid   
  0.3ml Tween-20 (Fisher BP337-100) 
 
RNA Detection Buffer: 100mM Tris-HCl pH 9.5 
  100mM NaCl 







Trypanosome work  
 
HMI-9 Media: HMI-9 media was purchased as a powder (Gibco 074-
90915N). One bottle of powder was dissolved in 4 
litres of dH2O, to which 15.12g NaHCO3 and 71.5µl -
mercaptoethanol was added and the pH was adjusted to 
7.5.  
 
Mowiol:   10% w/v Mowiol (Calbiochem 4759204) 
     25% w/v Glycerol 




10x PBS:   1.37M NaCl 
    27mM KCl 
    100mM Na2HPO4 
    18mM KH2PO4 
    pH to 7.4 with HCl or NaOH 
 





















Appendix B: Predicted structures of the PAD1 3’UTR 
deletion series 
Using Sfold analysis (http://sfold.wadsworth.org) (Ding et al., 2005; Ding and 
Lawrence, 2003), the secondary structure of each of the deletion constructs in the 
PAD1 3’UTR deletion series created in Chapter 3 was predicted using position 710nt 
as the polyadenylation site. The resulting secondary structures for each deletion are 
shown below. The results of this analysis are discussed in Chapter 3.  
 
Full length PAD1 3’UTR   PAD1 3’UTR 1-21 
        
PAD1 3’UTR 1-145    PAD1 3’UTR 1-207 




PAD1 3’UTR 1-265    PAD1 3’UTR 1-354 
                    
 
PAD1 3’UTR 1-391    PAD1 3’UTR 1-502 
                   
 





Appendix C: The mathematical model for 
trypanosome within-host dynamics 
The quantitative data generated in Chapter 5 was incorporated into a mathematical 
model by Dr Nick Savill, University of Edinburgh. Details of how the model is 
constructed; how the model is fitted; and how the parameters are estimated, as 
described by Dr Savill, are detailed below.   
 
C.1 Construction of the model 
The model is constructed as follows. Let the concentration of non-committed slender 
cells of variant type v  at time t  be )(tlv . The initial infection by variant type 1 is at 
time 0=t .  Switching between variants is sequential, i.e., variant v  switches to 
variant 1+v and no other.  This is different than other models (Lythgoe et al., 2007) 
where one variant may switch to a number of different variants. We made this 
assumption in the first instance to reduce the number of parameters in the model. It 
turns out, however, that our simpler model can give rise to multiple variants being 
expressed simultaneously (see Chapter 5). It can, therefore, be justified, even though 
it may not be biologically correct. 
 
Non-committed slender cells replicate at rate α  (i.e., a cell-cycle time of αln2/ ). 
They are cleared by a time-dependent, variant-specific immune response at rate 
)(trv .  They become committed to differentiate at rate )(tfβ , where )(tf  is SIF 
concentration, and β  the differentiation rate.  Switching from variant v  to variant 
1+v  is at variant specific rate vω . Thus the differential equations that describe the 



















vvvv      
where ν  is the total number of variant types that appear in a mouse during the 












v tltL            
 
Let the age of differentiated cells since becoming committed to differentiation be 
a and let ),( tadv  be the age distribution of differentiated cells of variant type v  at 
time t . 
 
Differentiated cells fall into three classes: replicating, committed slender cells, non-
replicating intermediate cells and non-replicating stumpy cells. All committed cells 
of variant type v  are cleared by the immune system at a rate proportional to the 
clearance rate of non-committed slender cells of the same type, i.e., )(trv . Thus 
committed slender cells are cleared by the immune response at rate )(trvcδ . At age 
cτ  they become intermediate cells.  Intermediate cells are cleared at rate )(trviδ . 
They become stumpy cells at age iτ . Stumpy cells are cleared at rate )(trvsδ . They 
die at age sτ .  Committed slender cells replicate with rate α .  Thus the partial 
differential equations that describe the dynamics of the age distribution of each 
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The boundary conditions on these equations are determined by differentiation of non-
committed slender cells into age 0=a , i.e., )()(),0( tltftd vv β= , and stumpy death 
at age sτ , i.e., 0),( =td sv τ . 
 
Let ),( taD  be the age distribution of differentiated cells of all variant types at time 












v tadtaD           
 
Let )(tC  be the total concentration of committed slender cells, let )(tI  be the total 
concentration of intermediate cells, let )(tS  be the total concentration of stumpy 




























        
 
SIF is produced by non-committed slender cells and committed cells up to age fτ . 
SIF is removed at rate γ . Thus the differential equation describing the dynamics of 
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Note that, because SIF is not measured, its concentration is on a dimensionless scale. 
We can therefore assume that a slender cell produces 1 unit of SIF per hour. SIFs 
effect on the differentiation of slender cells is quantified through β . 
 
PAD1 is only expressed in differentiated cells. It is scaled relative to the PAD1 
expression of mouse 5 on day 4. It rises linearly from 0 up to a level 1ρ  in cells from 
age 0 to age pτ  respectively. It then rises or falls linearly to a level 2ρ  in cells just 
before they die at age sτ . Let )(ap  be the relative PAD1 expression of cells of age 









































Let )(tP  be the total relative PAD1 expression per ml of blood at time t . It is found 
by multiplying the concentration of cells of age a  by their relative PAD1 expression 









The immune response against trypanosomes is multifactorial and highly complex, 
and only qualitatively understood at best. A detailed mathematical model of the 
immune response is, therefore, of little use when no data is available to fit to. Instead, 
we use a single variable )(trv , that determines the clearance rate of each variant type 
v .  We assume that the immune response against variant type v  is activated at a rate 
ψ  by replicating slender cells of variant type v , and self-enhances at rate φ . We 
also assume that the initial immune response to the first variant is only activated after 
a certain time rτ . The differential equations that describe the immune-mediated 






















Naive mice are infected with non-committed slender cells of variant type 1 at a 
concentration λ . Therefore the initial conditions are λ=)0(1l , 0)0( =vl  for 
ν,,2=v , 0)0,( =adv  for all v  and a , 0)0( =vr  for all v , and 0)0( =f . These 
imply λ=)0(L , 0)0,( =aD  for all a  and 0)0()0()0()0()0( ===== PTSIC . All 





Independent variables  
t  Time since infection h 
a  Age of differentiated cells h 
Dependent variables  
)(tlv  
Concentration of non-committed slender cells of variant type v cells ml
-1
 
),( tadv  









)(tf  SIF concentration dimensionless 
)(tL  Total concentration of non-committed slender cells cells ml
-1
 
)(tC  Total concentration of committed slender cells cells ml
-1
 
)(tI  Total concentration of intermediate cells cells ml
-1
 
)(tS  Total concentration of stumpy cells cells ml
-1
 
)(tT  Total concentration of all cells cells ml
-1
 




)(tP  Total relative PAD1 expression per ml of blood ml
-1 
Functions  
)(ap  Relative PAD1 expression of cells of age a cells
-1 
Parameters  
ν  Number of variant types dimensionless 
α  Replication rate of slender cells h
-1
 
β  Differentiation rate h
-1
 
γ  SIF removal rate h-1 
cδ  Proportionality constant for immune-mediated clearance of committed 
slender cells 
dimensionless 
iδ  Proportionality constant for immune-mediated clearance of intermediate 
cells 
dimensionless 
sδ  Proportionality constant for immune-mediated clearance of stumpy cells dimensionless 
cτ  Lifespan of committed slender cells h 
iτ  Lifespan of intermediate cells h 
sτ  Lifespan of stumpy cells h 
pτ  Duration of initial rise in PAD1 expression h 
fτ  Duration of SIF production of committed cells h 
rτ  Time until initial activation of immune response h 
1ρ  Relative PAD1 expression of cells age pτ   cells
-1 
2ρ  Relative PAD1 expression of cells age sτ  cells
-1
 
φ  Self-induced growth rate of immune response h
-1
 
ψ  Committed slender cell-induced growth rate of immune response h-1 
λ  Initial concentration of variant type 1 cells ml
-1
 









C.1.1 Cell-Concentration induced differentiation 
Other studies have suggested that differentiation is cell-concentration induced rather 
than SIF induced (Lythgoe et al., 2007; Turner et al., 1995; Tyler et al., 2001).  We 
tested this hypothesis by removing )(tf  from the model and replacing )(tfβ  by 





















and by changing the boundary condition )()(),0( tltTtd vv β ′= . 
 
The predicted dynamics of the model with concentration-induced differentiation and 
the standardised residuals are shown in Chapter 5. This model gives a poor fit to the 
data with several outliers and systematic biases particularly around the first peak. We 
can quantify how much our belief in the two models changes given the data. The 
ratio of our posterior beliefs in the two models is given by the (integrated) likelihood 
ratio (also called an evidence ratio or a Bayes factor) of the models given the data 
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where model1 is the SIF-induced differentiation model and model2 is the 
concentration-induced differentiation model. (The symbol '|' means 'given' or 
'conditional upon'). The likelihoods are products over all mice because we assume 














If our prior beliefs in the two models are equal, i.e., our prior knowledge base gives 
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Of course, our prior knowledge base may lead us to have a stronger belief in one of 
the models, and therefore this ratio will not equal 1. The model fitting algorithm 
calculates the likelihoods: these are 4671)model | Prob(data
−= e  and 
624
2 )model | Prob(data
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Thus the data overwhelmingly support the SIF-induced differentiation model 
irrespective of our initial belief in either model. 
 
C.2 Model fitting, parameter estimation and adequacy of fit 
 
C.2.1 Likelihood 
The measurement errors in the ZFP3 and PAD1 Ct values are assumed to be 
normally distributed. In other studies, the standard deviation of the errors in log10-
transformed concentrations derived from qPCR is approximately 0.20 (Mideo et al., 
2008; Miller et al., 2010). This means that the standard deviation of the errors in Ct 
values (which are on a log2 scale) is approximately 0.2log210 which equals 0.66. 
 
The model is fitted to each mouse's log10-transformed parasite concentrations and 
relative Ct-values for PAD1 expression. Let 2.0=Lσ  be the standard deviation in the 
normally distributed errors of log10-transformed parasite concentrations, and let 
66.0=Pσ  be the standard deviation in the normally distributed errors of log2-





For particular numerical values of the model parameters, the model is solved 
numerically for each mouse. In order to quantify the fit of the model with these 
parameters to the data we proceed by calculating the log-likelihood of the model 
solution at each data point.  The value of the likelihood is given by the normal 
probability density function because the errors are normally distributed. So, for an 
observed parasite concentration )(data tL , at time t  above the detection limit (about 
10
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where )(xφ  is the normal probability density function. For an observed parasite 
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where )(xΦ  is the normal cumulative distribution function. For an observed relative 
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The lowest log2 relative PAD1 expression is -7.52, we take this value as the detection 
limit, although it may be smaller.  For a relative PAD1 expression below the 




























ln model10  
 
The total log-likelihood for a mouse is the sum of the log-likelihoods over all the 
data for that mouse. 
 
The parameter posterior distribution is found by multiplying the likelihood by the 
prior distributions, which are given in the next section. Samples from the posterior 
are drawn using an adaptive population based Markov chain Monte Carlo algorithm 
(Miller et al., 2010; Savill et al., 2009). 
 
C.2.2 Parameter Priors 
The number of variant types ν  that arose during the experiment is unknown. On the 
one hand there must be more than one because of the multiple peaks in parasite 
concentration, but on the other we, do not want the model to over-fit the data with 
hundreds of variant types. We therefore chose a prior of 1+NT(0,5) which allows for 
tens of variant types but penalises the model for having too many. (Note, NT(µ,σ) is a 
normal probability density function with mean µ, standard deviation σ but truncated 
at 0.) Slender cell-cycle time has been estimated to be around 4-5 hours, (Seed and 
Black, 1997; Vassella et al., 1997) although Savill and Seed (2004) estimated it 
around 2 hours. We therefore chose a prior on α  as NT(0.1,0.1) in order to 
incorporate this uncertainty. Savill and Seed (2004) estimated the differentiation rate 





removal rate γ  was estimated to be between 0.2 and 1.4h-1 (Savill and Seed, 2004), 
we therefore chose a prior NT(0.5,0.5). There is no quantitative prior information 
about immune-mediated clearance of committed cells. It is thought, however, that the 
immune system is less effective at clearing stumpy cells than slender cells (Engstler 
et al., 2007). We therefore chose priors of Uniform(0,1) for cδ , iδ , sδ  to reflect this 
uncertainty. Savill and Seed (2004) estimated the committed slender cell lifespan cτ , 
to be between 8 and 12h, we therefore chose a prior of NT(10,4). Vassella et al 




activity (when cells become morphologically stumpy) to be between 8 and 10h. Savil 
and Seed (2004) estimated this to be between 3 and 8h.  We therefore chose a prior 
of NT(6,6) on the lifespan of intermediate cells iτ . Black et al., (1982) estimated the 
lifespan of stumpy cells sτ , to be between 24 and 36h. Turner et al., (1995) 
estimated it to be between 48 and 72h, and Savill and Seed (2004) around 58h but 
with very wide confidence intervals. We therefore chose a prior of NT(48,24) to 
cover this uncertainty. The initial rise in PAD1 expression is thought to last until the 





))= NT(16,7). Peak total relative PAD1 expression is about 2
5
. This 
occurs at a peak parasitaemia of around 10
8.5
 parasites/ml which is composed mainly 











) on 1ρ  and 2ρ . Savill and 
Seed (2004) suggested that committed slender cells produced SIF, we therefore set 
the prior for the duration of SIF production of committed cells fτ  as NT(10,4). Mice 
were infected intra-peritoneally with about 10
3
 slender cells. We therefore have a 
prior of N(3,0.5) on log10λ.  In Lythgoe et al., (2007) switch rates between variants 
were allowed to vary over six orders of magnitude with an average switch rate of 
0.01 per population doubling, which is about 0.0014h
-1
 for a cell-cycle time of 7h. 
We therefore had a very broad prior on vω10log  of N(-6,2). The prior on the initial 
activation of the immune response rτ , was taken as NT(168,24), i.e., around 7 days 
as is usual in acute infectious diseases of naïve animals. The growth of the immune 
responses against variants should occur on the order of several days. We therefore 
take broad priors onφ  and ψ  of NT(0.1,0.1) and NT(10
-8
,10
-8
) respectively. 
  
 
